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General Introduction
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Stress adaptation and its main regulatory pathways
“Stress” has been defined for the first time as “a nonspecific response of the body
to any threatening demand” by János Selye in 1936. A more recent and widely
accepted definition of stress was given by McEwen (2000): “Stress may be defined
as a real or interpreted threat to the physiological or psychological integrity of an
individual that results in physiological and/or behavioral responses”. According to
the classical stress concept the dynamic equilibrium or homeostasis of the body is
continuously challenged by factually or potentially noxious stimuli (e.g. de Kloet
et al., 2005; McEwen, 2007). Stressors are perceived by the sensory system sending
afferents to the limbic system including the hippocampus/amygdala complex,
prefrontal cortex, mesocortical/mesolimbic systems and arcuate nucleus (Tsigos
and Chrousos, 2002). In turn, the limbic system controls the two main effector
limbs of stressor inputs, namely the brainstem for very fast, almost instantaneous
reactions, and the hypothalamus for short-term and long-term reactions (Tsigos
and Chrousos, 2002; Smith and Vale, 2006). For very fast responses, limbic centers
and visceral and sensory afferent pathways control the locus ceruleus in the
brainstem. This noradrenergic area is a main regulatory center of the sympathetic
adrenomedullary system, which is responsible for the short-term reaction to
stressors, often referred to as the FFF (‘fight, fright or flight’) response. The system
controls the activity of the main organs in the body, such as heart, lungs, skeletal
muscles, smooth muscle layer of vessels, and the gastro-intestinal system (Tsigos
and Chrousos, 2002; Thomson and Craighead, 2008).
For the short-term and long-term responses to stressors, the limbic system
and brainstem pathways activate the hypothalamo-pituitary-adrenal (HPA-) axis
via the parvocellular part of the paraventricular nucleus of the hypothalamus (PVN),
which produces corticotropin-releasing factor (CRF). This neuropeptide arrives
via axonal transport in the median eminence of hypothalamus. In this neurohemal
organ CRF is released into portal vessels to reach the anterior lobe of the pituitary.
Here, CRF acts on CRF1 receptors to stimulate endocrine corticotrope cells to
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release the pro-opiomelanocortin (POMC)-derived adrenocorticotrope hormone
(ACTH) into the general circulation. In the adrenal cortex ACTH stimulates the
production and release of the glucocorticoid hormones, cortisol (in humans and
fish) and corticosterone (in other vertebrates). These steroids have effects on various
organs, such as the circulatory, digestive and immune systems and various endocrine
glands. In this way the release of glucocorticoids leads to profound changes in the
physiology of the organism, adjusting metabolism, growth, reproduction and
immune response (for reviews see Tsigos and Chrousos, 2002; Leonard, 2006;
Kyrou and Tsigos, 2007; Beddoe and Lee, 2008). This adaptation facilitates the
organism’s successful answer to the threatening challenges (“coping with stress”).
For the termination of the HPA-axis-induced stress response glucocorticoids also
act on the brain, exerting inhibitory feedbacks on the corticotrope cells in the anterior
lobe of pituitary, on the CRF-neurons in the PVN, and on various higher brain
centers involved in the control of the PVN-CRF neurons (e.g. de Kloet et al., 2005;
Thomson and Craighead, 2008) (Fig. 1). One of these centers, the Edinger-Westphal
nucleus (EW) in the midbrain, is the main subject of this PhD thesis research.
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Figure 1. The classical HPA axis. The CRF produced by the parvocellular part of the PVN
reaches the median eminence via axonal transport. Then, the neurohormone is secreted into
primary capillaries that, via portal veins reach the anterior lobe of the pituitary gland. Via CRF
1 receptors, CRF stimulates the secretion of ACTH, which reaches the adrenal cortex via the
systemic circulation and enhances the production of glucocorticoid hormones (i.e.,
corticosterone or cortisol). Apart from having heterogeneous effects on nearly all peripheral
organs, these hormones control the HPA-axis via negative feedbacks, inhibiting CRF at the
hypothalamic and ACTH at the pituitary level. (Modified after Nussey and Whitehead, 2001)
Dysregulation of the HPA-axis
Various conditions, both external (e.g. prolonged, severe stressors) and internal
(e.g. acquired or genetically determined diseases of body or mind) may lead to
dysregulation of the HPA-axis. As a result, termination of the stress response may
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be delayed or will not even take place, resulting in a prolonged or even continuously
abnormal pattern of corticosteroid release. In turn, this may result in the occurrence
of various pathologies, such hypothyroidism, inflammations, obesity, diabetes mellitus
and autoimmune diseases such as Hashimoto’s thyroiditis and rheumatoid arthritis
(Chrousos, 1995; Tsigos and Chrousos, 2002; Swaab et al., 2005; Golden, 2007; Bao
et al., 2008; Nieuwenhuizen and Rutters, 2008). Moreover, the prolonged (several
months) release of high amounts of corticosteroids may evoke psychopathologies,
such as anxiety, anorexia nervosa, obsessive compulsive disorder, and major
depression, which not rarely ends with suicide (for reviews see Westrin, 2000; Tsigos
and Chrousos, 2002; Kluge et al., 2007; Lo Sauro et al., 2008).
In view of the crucial role of the HPA-axis in regulating homeostasis and
in the pathogenesis of severe diseases of body and mind, it is not surprising that
various animal models have been developed to study the mechanisms underlying
the control of HPA-axis functioning. These studies, often carried out with special
rat strains and transgenic mice, have suggested that the proper functioning of the
HPA-axis does not only depend on the type, strength and duration of the stressor,
but also on the gender and the age of the organism, and on the time of the day it
was exposed to the stressor. However, it is largely obscure how these factors
influence the stress response, e.g. if they act independently or interact with each
other, and if they influence the HPA-axis in a direct way or via other, stress-sensitive
brain centers. This can be illustrated as follows.
a. The type, strength and duration of stressors
The degree of activation of the HPA-axis (as revealed by elevated titers of CRF,
ACTH and CORT and increased expression in the PVN and corticotrope cells of the
early immediate gene c-Fos) depends on the type of stressor. For instance, pain stress
causes a much more dramatic activation of the PVN than an immunological stressor
like lipopolysaccharide administration (Gavrilov et al., 2008). Also, Chowdhury et
al. (2000) showed that the severity and type of stressor influences the activation of
the rat PVN, as severe immobilization causes much higher c-Fos activation than the
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milder restraint stressor. Kwon et al. (2006) also demonstrated that the duration of
exposure to the stressor is important to the way the HPA-axis reacts. For instance,
upon repetitive stress the HPA-axis initially becomes activated but after some time
habituates, normalizing its glucocorticoid output, whereas a chronic stressor like
unpredictable chronic mild stress, eventually upsets normal functioning of the HPA-
axis, leading to maladaptations and, consequently, to anxiety and stress-related
disorders (Blackburn-Munro and Blackburn-Munro 2001; Joëls et al., 2003).
b. Gender
Both somatic diseases and stress-related mood disorders show sex-dependent
differences in their appearance and prevalence (Desai and Jann, 2000; Gorman, 2006;
Goldstein and Gruenberg, 2007). For instance, in males cardiovascular diseases and
diabetes mellitus occur more often than in females, whereas in the latter autoimmune
diseases prevail. Some of these sex-differences correlate with differences in HPA-
axis functioning. For instance, during psychological stress males reveal a stronger
increase in cortisol than females, which correlates in the long-term with higher risk
for cardiovascular disease and diabetes mellitus (Traustadóttir et al., 2003).
Furthermore, disturbed interactions between the HPA-axis, gonadal steroids and the
immune system not only negatively affect the male’s immune response and
reproduction but also increase the risk for psychopathologies (for reviews see Da
Silva, 1999; Kudielka and Kirschbaum, 2005). However, hardly anything is known
about possible sex-differences in stress-responsivity of brain centers that control
HPA-axis activity. Obviously such knowledge would strongly help to understand the
causes of sexual differences in stress-induced psychopathologies and, hence, would
open avenues to develop sex-specific therapies for such diseases.
c. Age
It has been well established that the organism’s capacity to cope with stressors
and, therefore, its vulnerability to stress-induced diseases, are not constant during
life. Both in rodent models and in humans the peri- and postnatal period (Heim and
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Nemeroff, 1999) as well the period of adolescence (Haring et al., 1991) seem to be
stages in which stressors are most effective in evoking chronic, adverse effects on
physiology and psychology. Negative early life events associated with
psychopathologies in humans are, for instance, maternal insufficiency, familial
neglect and sexual abuse (Bremne and Vermetten, 2001; Gilmer and McKinney,
2003; de Kloet et al., 2005). Rodent maternal separation (MS) studies have indicated
that such harmful early life events do not only act upon the HPA-axis but also
affect other stress-related brain areas (Bremne and Vermetten, 2001; Andersen and
Teicher, 2004; Lippmann et al., 2007). The precise mechanisms by which significant
life events experienced in a vulnerable phase of life, act in later life, are largely
unknown.
d. Daily rhythm(s)
There is ample evidence that the capability of an organism to cope with stress
depends on the phase of the day-night light cycle. For instance, Atkinson et al.
(2006) found that HPA-axis responses in rats differ depending on the time of the
day the animals were exposed to noise stress. Furthermore, Dunn (1972) and Kant
et al. (1986) reported diurnal changes in response to stress, in numerous hormonal
variables, most of which being related to the diurnal activity of the HPA-axis: for
instance, in rodents, the corticosterone titer shows a maximum at the end of the
light phase, in line with the fact that rodents are most active in the dark. (For the
same reason, humans reveal a cortisol peak in the early morning.) Probably, the
diurnal rhythm in HPA-axis activity is controlled by the main clock center in the
brain, the hypothalamic suprachiasmatic nucleus (SCN). This nucleus expresses
the so-called clock genes, Per1 and Per2, which are responsible for its diurnal
secretory activity. The SCN is thought to impose its rhythm on the HPA-axis by
innervating the PVN (Vrang et al., 1995; Dai et al., 1997). Recently, it became
evident that in addition to the PVN, various other stress-related brain centers possess
diurnal rhythms that may control diurnal HPA-axis activity, such as the oval nucleus
of the bed nucleus of the stria terminalis, the central and basolateral nuclei of the
17
amygdala, and the dentate gyrus. However, the precise relationships between type
of stressor, regulatory brain center and rhythmicity of the HPA-axis are largely
unknown. In this thesis research, these three factors influencing the stress response,
will receive explicit attention.
The CRF peptide family
With regard to the structure of the stress axis, Selye already hypothesized the
existence of a hypothalamic factor that would influence the functioning of the
pituitary gland and of the adrenal cortex, but he could not isolate this compound
(Selye, 1936). The purification of CRF, the key regulator of the classical HPA-
axis, was eventually achieved by Vale, in 1981 (Vale et al., 1981). CRF binds two
types of CRF receptor, CRF1 and CRF2. As the sites of CRF-release did not always
appear to match with the distribution of these receptors, the existence of other,
unknown ligands for CRF1 and CRF2 was predicted. Indeed, new members of the
CRF-peptide family were discovered that bind CRF1 and CRF2: the discovery of
urocortin 1 (Ucn1; Vaughan et al., 1995) and, more recently, of urocortin 2 (Ucn2;
Hsu and Hsueh, 2001; Reyes et al., 2001) and urocortin 3 (Ucn3; Hsu and Hsueh,
2001; Lewis et al., 2001) indicated that CRF is not the only neuropeptide involved
in regulating the stress response. This picture becomes even more complex by
adding CRF-binding protein (CRFBP) to it: by binding CRF and Ucn1, CRFBP is
able to decrease the titers of these ligands in the blood and, possibly, in the brain
and pituitary gland (Behan et al., 1995). Consequently, numerous receptor-ligand
interactions may occur offering a large variety of regulatory opportunities. The
respective ligands differ in their affinities between CRF1 and CRF2, allowing
complex competitive actions for the same receptor and multiple regulations of
targets that possess both receptors (see e.g. Bale and Vale, 2004).
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Physiology of Ucn1
Our research group is focusing on the role of Ucn1, which is a 40 amino-acid
neuropeptide and shows 45% sequence homology with CRF. Ucn1 binds both CRF1
and CRF2, with highest affinity for the latter (Vaughan et al., 1995). The intracellular
signaling pathways of Ucn1 via CRF2 include activation of the cyclic-adenosyl-
monophosphate/protein kinase A/C-responsive element binding (cAMP/PKA/
CREB) cascade and action on C-responsive element (CRE) sites (Hauger et al.,
2006). As Ucn1 acts on both CRF receptors, its function critically depends on the
receptor make-up of its target. Initially, Ucn1 was considered as an anxiogenic
peptide, like CRF, because both peptides increase anxiety when acting via CRF1.
Pharmacological studies, however, suggest that Ucn1 has anxiolytic effects as well,
and is at least in part responsible for the anxiolytic properties of benzodiazepines
and the selective agonist of the metabotropic glutamate (mGLU) receptor, LY354740
(for review see Kozicz, 2007). Linden et al. (2004) observed that systemic
administration of LY354740 selectively induces c-Fos in the npEW via the mGLU
receptor, while transgenic mice lacking the mGLU receptor do not have this feature.
These notions are further supported by Zalutskaya et al. (2007), who found that
Ucn1-deficient mice show increased anxiety when exposed to acute stress. In
addition, Vetter et al. (2002) reported increased anxiety behavior of Ucn1-deficient
mice in open field and elevated plus maze tests.
Most relevant in the context of the present research, is that Ucn1, in addition
to its role in anxiety behavior, appears to be involved in the stress adaptation
response, as it increases ACTH and glucocorticoid titers in the blood (Vaughan et
al., 1995). In 1999-2001 two laboratories independently showed for the first time
that Ucn1 mRNA expression increases upon acute stress in the rat Edinger-Westphal
nucleus (EW) (Weninger et al., 1999, 2000; Kozicz et al., 2001b), suggesting that
Ucn1 in this nucleus would act as a stress neuropeptide, a notion that was further
substantiated by our laboratory, using rodents and various stress paradigms (e.g.
Kozicz, 2007; Kozicz et al., 2008).
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Ucn1 in the Edinger-Westphal nucleus
Ucn1 is expressed both in the periphery (gastrointestinal tract, heart, lymphoid
organs, endothelium, synovial tissue, placenta and blood) (Petraglia et al., 1996;
Bamberger et al., 1998; Okosi et al., 1998; Kohno et al., 2001; Chatzaki et al.,
2003; Kimura et al., 2002; Charles et al., 2006) and in the central nervous system
(Kozicz et al., 1998; Yamamoto et al., 1998; Bittencourt et al., 1999; Korosi et al.,
2007). In the brain, Ucn1-containing perikarya are present in the lateral superior
olive, PVN, supraoptic nucleus of the hypothalamus, lateral hypothalamic area,
substantia nigra, and in numerous cranial nerve nuclei in the brainstem (Kozicz et
al., 1998; Bittencourt et al., 1999). However, the vast majority of Ucn1-containing
nerve cells (about 80%) occur in the EW, which is located in the ventral portion of
the periaqueductal gray matter.
According to its classical anatomical description (Standring et al., 2005),
the EW is called ‘accessory nucleus of the oculomotor nerve’ and belongs to the
oculomotor nuclear complex. The EW contains parasympathetic, preganglionic,
cholinergic neurons that project to the ciliary ganglion. The postganglionic fibers
arising from this ganglion enter the eyeball and innervate two intrinsic muscles of
the eye: the sphincter pupillae muscle, which is responsible for pupil constriction,
and the ciliary muscle involved in eye lens accommodation. Recently, it became
clear that Ucn1-containing neurons of the EW are not cholinergic and, hence, are
not involved in innervation of the ciliary ganglion (Weitemier et al., 2005; Kozicz,
2007). Since they are located dorsomedially to the (preganglionic) EW, and since
the preganglionic cholinergic cells lack Ucn1-immunoreactivity (Weitemier et al.,
2005; Kozicz, 2007), these Ucn1-positive neurons are currently considered to
constitute an anatomically and functionally distinct neuronal population designated
‘non-preganglionic Edinger-Westphal nucleus’ (npEW).
Previously, in addition to Ucn1, catecholamines and many other
neuropeptides have been found in the EW. The presence of cholecystokinin
(Maciewicz et al., 1984), cocaine and amphetamine-regulated transcript peptide
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(CART; Brischoux et al., 2002), neuropeptides B and W (Singh and Davenport,
2006) and nesfatin 1 (Brailoiu et al., 2007) have been shown in npEW neurons,
more particularly in Ucn1 perikarya (Kozicz, 2003; Kozicz et al., unpubl. res.).
Axon terminals containing neuropeptide Y (Yamazoe et al., 1985), orexin A (Nambu
et al., 1999) and pituitary-adenylate cyclase activating peptide (PACAP; Hannibal,
2002) were observed juxtaposed to Ucn1-neurons, indicating peptidergic inputs to
these neurons. Also monoaminergic axon terminals containing serotonin (Clements
et al., 1985), noradrenalin and dopamine (Kwiat and Basbaum, 1990) occur in the
npEW. Efferent connections of Ucn1 neurons were studied by Bittencourt et al.
(1999) who showed that besides many areas receiving weak urocortinergic inputs,
the lateral septal nucleus (LS) and the dorsal raphe nucleus (DR) are main targets
of Ucn1 terminals arising from perikarya in the npEW, which was supported by
more recent studies (Bachtell et al., 2003b; Turek and Ryabinin, 2005a,b).
Interestingly, both DR and LS contain CRF receptors and have been implicated in
anxiety and stress (Vaughan et al., 1995; Van Pett et al., 2000), and therefore, these
areas could be important sites of Ucn1 action in stress (mal)adaptation.
The npEW and stress
Kozicz et al. (2001b) and others have demonstrated that upon acute stress, Ucn1-
containing npEW neurons show strong c-Fos-immunoreactivity (Bachtell et al.,
2003a,b; Turek and Ryabinin, 2005a,b) and increased Ucn1 mRNA expression
(Weninger et al., 2000). This response is transient, as it disappears within hours. In
this respect, the dynamics of the npEW are similar to that of the HPA-axis in response
to acute stress. Therefore, it has been concluded that during acute stress, the HPA-
axis and npEW act in parallel. However, upon chronic stress the HPA-axis habituates
its response, whereas the npEW does not and remains showing elevated activity up
to three weeks of chronic challenge (Korosi et al., 2005). Moreover, CRF-deficient
mutant mice revealed Ucn1 mRNA over-expression in the npEW (Weninger et al.,
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1999, 2000), whereas mutants over-expressing CRF showed decreased Ucn1 mRNA
(Kozicz et al., 2004). Based on these results the idea has arisen that during chronic
stress the HPA-axis and the npEW-Ucn1 system do not act in parallel but in an
“inverse-like” manner, probably complementing and/or controlling each other’s
functioning (Kozicz, 2007).
Aims of this PhD research
The aim of this PhD research was to extend the existing knowledge about the role
of the npEW and its Ucn1-neurons in the stress response, with particular attention
to the four aspects of this response described above: type of stress, gender, age and
diurnal rhythmicity. For that purpose several morphological, morphometrical,
immunological and molecular-biological techniques have been applied.
In Chapter 2 we demonstrate how different acute stressors differentially
influence the activity of the Ucn1-neurons in the npEW. Next, we show the effect
of MS, as a paradigm for early life experience, on the activity of the npEW-Ucn1
system, with special attention to possible long-lasting changes in Ucn1 mRNA
expression (Chapter 3). In view of the involvement of the neurotrophin, brain-
derived neurotrophic factor (BDNF) in neuronal plasticity and early life stress-
related responses (Lippmann et al., 2007), the possible effect of MS on the
expression of this protein has also been included in the study. In Chapter 4 the
significance of the catecholamines noradrenalin and dopamine for the regulation
of the stress response by npEW-Ucn1 neurons is investigated, and in Chapter 5 a
similar study on neuropeptide Y is presented. In Chapter 6 the diurnal rhythmical
character of the npEW system is demonstrated for both Ucn1 and the clock peptide
Per2. Finally, in Chapter 7, the findings of this thesis research are discussed and
integrated, to construct a model for the ways the npEW controls, together with the
HPA-axis, the mammalian stress response.
22
23
Chapter 2
Urocortinergic Neurons Respond in a Differentiated
Manner to Various Acute Stressors in the
Edinger-Westphal Nucleus in the Rat
Balázs Gaszner, Valér Csernus and Tamás Kozicz
J Comp Neurol (2004) 480:170-179
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Abstract
Corticotropin-releasing factor (CRF) was implicated as being major contributor
to the neurochemically mediated central regulation of stress response, but an
increasing body of evidence suggests that besides CRF, other members of this
neuropeptide family, such as urocortin (Ucn) may also play a role in modifying the
efferent components of immune, endocrine and behavioral responses to stress. The
distribution of Ucn in the rat brain has been demonstrated, with the most abundant
Ucn-immunoreactive perikarya present in the Edinger-Westphal nucleus (EW).
Acute pain and immobilization stressors recruit EW neurons, but the activation
pattern of EW Ucn neurons in response to various acute systemic and neurogenic
challenges has not been compared in a single study. Therefore, we combined
quantitative Fos-imaging, as a marker for neuronal activation, with Ucn
immunohistochemistry, to visualize neurons induced by intravenous lipopolysaccharide
(LPS), ether inhalation, restraint, hyperosmotic and hypotensive hemorrhage
challenges. Neurons in the EW responded with the strongest Fos-induction to LPS,
but ether and restraint stress also resulted in massive Fos-immunoreactivity. On
the contrary, the hyperosmotic and hypotensive hemorrhage stressors did not
activate urocortinergic neurons in this brain area. This challenge-specific
recruitment of EW neurons was independent from stress-induced adrenal response.
The biological significance and the stressor-specific activation of EW urocortinergic
neurons has been discussed.
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Introduction
Stress is a nonspecific response of the body to any external or internal challenge
that leads to secretion of corticotropin-releasing factor (CRF) a hypophysiotropic
peptide that is a major regulator of the hypothalamo-pituitary-adrenal (HPA)
axis (see Chadwick et al., 1993). In addition to CRF, newly added members of
the CRF peptide family, such as Ucn (also named Ucn1) (Vaughan et al., 1995),
Ucn 2 (also known as stresscopin-related peptide; Hsu and Hsueh, 2001; Lewis
et al., 2001) and Ucn 3 (also named stresscopin; Hsu and Hsueh, 2001; Reyes et
al., 2001) contribute to the adaptation to stress. Although evidence has been
accumulated suggesting that central actions of Ucn may account for some stress-
related effects originally attributed to CRF (Skelton et al., 2000; Spina et al.,
1996), the understanding of the role(s) of Ucn is largely elusive.
In the brain of several vertebrate species, Ucn displays a central distribution
distinct from and more limited than that of CRF (Merchenthaler et al., 1982; Kozicz
et al., 1998; Bittencourt et al., 1999; Iino et al., 1999; Morin, 1999; Kozicz et al.,
2002; Vasconcelos et al., 2003). Intriguingly, the most dominant site of Ucn-
immunoreactivity (ir) in the rat brain is the EW (Bittencourt et al., 1999; Kozicz et
al., 1998; Yamamoto et al., 1998), a compact, cholinergic brain structure primarily
involved in oculomotor adaptation (Westphal, 1887; Burde and Williams, 1989).
However, the high variety of afferent and efferent connections between the EW
and non-oculomotor brain areas (Loewy et al., 1978; Sugimoto et al., 1982;
Bittencourt et al., 1999), suggests that this nucleus is also involved in the control
of diversity of important non-oculomotor functions.
Acute pain stress results in the activation of Ucn-ir neurons in the EW,
peaking at 2-4 hours after stress, suggesting a role of EW Ucn in adaptation to
stress (Kozicz et al., 2001b). In concert with these results, Weninger et al. (2000)
observed that Ucn mRNA expression in the EW was up-regulated 3 hours after
restraint stress. Interestingly, the EW Ucn mRNA level is clearly up-regulated in
CRF-deficient mice (Weninger et al., 2000), whereas in CRF-over expressing mice
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we found a down regulation of the EW Ucn message (Kozicz et al., 2004). These
data support the hypothesis of an inverse relationship between CRF- and Ucn-
containing neuronal systems, and suggest the possibility that besides CRF, an
entirely different stress-regulatory pathway for Ucn in EW exists (Weninger et al.,
1999; Skelton, 2000). These challenging findings make Ucn an intriguing novel
neuropeptide in the biology of stress adaptation, with possible clinical implications.
Analyses of expression patterns of the protein product (Fos) of the inducible
immediate early gene c-fos as a marker of neuronal activation (Bullitt, 1990; Smith
et al., 1997) have been proved to be useful in studying the recruitment of various
brain areas and revealing differential activation patterns of effector neuron
populations throughout the central nervous system in response to various types of
acute stress. The present study was undertaken to build on this observation, by
comparing the activation pattern and phenotype of EW neurons activated in response
to various acute physiological and psychological stressors. Part of these results
has been reported in abstract form (Kozicz et al., 2001a).
Materials and methods
Animals
Albino, Wistar-R Amsterdam male rats, weighing 225-250 g at the time of arrival,
were housed in standard plastic cages (40x25x20 cm), in a temperature- and
humidity-controlled environment. Rats were maintained on a 12-hour light/12-
hour dark cycle (lights on 6:00 A.M.) and were allowed ad libitum access to tap
water and rodent chow throughout the experiment. Animals were acclimatized to
these housing conditions for one week before any experimental manipulation. All
efforts were made to minimize the number of animals used and their suffering. All
procedures were conducted in accordance with the Declaration of Helsinki, and
the animal use guidelines approved by the Pécs University, Medical Faculty
Advisory Committee for Animal Resources based on the Law of 1998. XXVIII on
Animal Care and Use in Hungary.
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Stress paradigms
Ether stress: Animals (n=4) were kept in a closed glass container with a metal grid 3
cm above the bottom (diameter 30 cm; height 20 cm; the animals could freely move
around in this container), saturated with ether vapor (a piece of cotton infiltrated with
ether was placed in the closed glass container under the metal grid 5 min before the
experiment), until they collapsed and frequency of breathing slowed down till a
frequency of 25-30 / min, which took about 1-2 min. Then the animals were returned to
their home cage. The survival time was 30 or 120 min after the challenge. The control
rats (n=4) were placed in a similar glass container for 2 min, but without ether challenge.
Lipopolysaccharide stress: Four rats received, through an indwelling
endogenous jugular catheter (implanted under halothane anesthesia 3 days before
the challenge), 100 µg/kg-body weight lipopolysaccharide (LPS; E. coli, serotype
055:B5; Sigma Chemical Co., Germany;) in 300 µl pyrogen-free saline, 30 or 120
min prior sacrificing the animals. The control animals (n=4) received 300 µl
physiological saline (non-pyrogenic) i.v.
Restraint stress: rats (n=4) were placed in a plastic restrainer (diameter 45
mm, length 200 mm, with several ventilation holes) for 30 or 120 min. The animals
could move their limbs but were unable to turn around in the restrainer. Control
animals (n=4) were handled similarly as the challenged animals, but they were not
placed in the restrainer.
Hyperosmotic stress: rats (n=4) received 0.018 ml/g body weight 1.5 M
NaCl solution (non-pyrogenic) intraperitoneally (i.p.) (Senba and Ueyama, 1997).
The control animals (n=4) received 0.018 ml/g body weight physiological saline
(non-pyrogenic). The survival time was 30 or 120 min after i.p. injection of
hypertonic or physiological saline.
Hypotensive hemorrhage stress: an estimated 15% of the blood volume was
withdrawn slowly (over 15 minutes) from a jugular catheter (n=4) implanted under
halothane anesthesia 3 days before the challenge (for details, see Chan and Sawchenko,
1994). Control animals (n=4) were handled similarly, but were not challenged. All
animals were killed 30 or 120 min after the challenge/sham treatment.
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Blood sampling and hormone assays
Animals were deeply anesthetized with Nembutal (100 mg/kg body weight; Sanofi,
Budapest, Hungary) for fixation, and after opening the chest cavity a small opening
was cut in the left ventricle. Just before starting fixation, 0.5 -1.0 ml blood samples
were collected into ice-chilled EDTA-containing tubes and centrifuged (3000 rpm;
10 min). Plasma aliquots of 50 µl were stored at –20 oC until assay. Corticosterone
measures were determined by radioimmunoassay (RIA). A mixture of 5 µl of serum
and 100 µl assay buffer (ASB, 0.5 M PBS containing 1 g/l gelatin and 1 g/l sodium
azide, pH 7.4) was extracted with 1 ml diethyl-ether. The dried extract was
reconstituted with 1.25 ml ASB from which two parallel determinations were made.
Each tube contained 500 µl extract (content of 2 µl sample), tritiated corticosterone
(12,000 cpm; Perkin-Elmer, Boston, MA, USA, NET-399, 90-120 Ci/mmol) and
15 nl/tube CS-RCS-57 antiserum (1:47,000 final dilution) in a total volume of 700
µl. For standard, Calbiochem corticosterone was used in a 9 step series ranging 15
to 4,000 fmol. After an overnight incubation at 4 oC, the bound and free steroids
were separated with dextran-coated charcoal. Radioactivity was measured in a
two-phase liquid scintillation system. The sensitivity of the assay is 30 fmol/tube.
The antiserum showed 19%, 7.1%, 5.5%, 5.1% and 3.0% cross reactions with
progesterone, deoxycorticosterone, testosterone, dihydroprogesterone and
androstenedione, respectively. With other natural steroids, the antiserum showed
<1% cross reactions. The inter- and intra-assay coefficients for variation were 9.2
and 6.4%, respectively, indicating the high accuracy of the method.
Immunohistochemical characterization
Fixation: after taking blood samples for hormone assay (within one minute after
deep anesthesia) the animals were transcardially perfused with 50 ml of 0.1 M
sodium phosphate-buffered saline (PBS; pH 7.4), followed by perfusion with 250
ml of 4% ice-cold paraformaldehyde. Then, brains were carefully removed and
kept in the fixative for 4-24 hours.
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DAB immunohistochemistry: sections from animals challenged by various
stressors were used at the same time to allow immunolabeling to be performed
under similar conditions, using common reagents and processing conditions.
Coronal sections of the forebrain were cut at 25 µm using a Lancer Vibratome
(Ted Pella, CA, USA). After 4x15 min washes in 0.1 M PBS, 0.1% Triton X-100
solution (T-9284; Sigma, Budapest, Hungary) in PBS was used for 10 min to enhance
antigen penetration. After an additional 3x5 min washes in PBS, sections were
placed for 1 hour in5% normal goat serum in PBS to block non-specific binding
sites. All steps were carried out at room temperature (RT), under continuous, gentle
agitation. After a brief wash in PBS, sections were transferred into vials containing
the primary antiserum. The polyclonal (rabbit) anti c-Fos antiserum (c-Fos(4); sc-
52; Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA) was used at a dilution
of 1:500. Sections were first incubated for 48 hours in the primary antiserum at 4
oC, followed by 4x15 min washes in PBS, and an incubation in the secondary anti-
rabbit antiserum (Vector ABC Elite Kit PK-6101; Vector Labs), for 1 hour at RT.
After a 3x15 min washes in PBS, sections were incubated in the ABC reagent
supplied with the ABC Elite Kits (Vector Labs), for 1 hour at RT. For the
development of immunostaining, 10 mg 3-3'-diaminobenzidine (D 5637; Sigma)
in 50 ml Tris buffer (pH: 7.6) was used for approximately 10 min. The reaction
was controlled under a stereomicroscope, and was stopped in Tris buffer. After
several washes in PBS, sections were treated for silver-gold intensification. First,
they were washed in 5% thioglycolic acid (T 6750; Sigma) for 1 hour, to block
non-specific tissue argyrophilia. After thioglycolic acid residues had been removed
by 4x15 min washes in 2% sodium acetate solution, sections were placed in
developer, as described by Merchenthaler et al. (1989). Development was monitored
under a microscope, and took approximately 10 min. placing the sections in a 1%
acetic acid bath for 1 min stopped the reaction. Then the were washed in 2% sodium
acetate for 10 min, followed by a 10 min gold toning in 0.05% gold chloride (G4022;
Sigma) in 2% acetic acid on ice. The reaction was stopped by a wash in 2% sodium
acetate for 10 min. Following a 10 min wash in 3% sodium thiosulphate (S 7143;
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Sigma) and a rinse in 2% sodium acetate and PBS, sections were incubated in
polyclonal (rabbit) Ucn antiserum (PBL5779, a generous gift from Dr W.W. Vale,
The Salk Institute, La Jolla, CA, USA) at a dilution of 1:5,000. The incubation time
was 48 hours at 4 oC. Ucn-immunoreactivity was detected using the ABC technique
with the DAB chromogen, as described above. Sections were studied with a Nikon
Microphot FXA microscope equipped with a Spot RT Color digital camera. Selected
double-stained sections were further processed for semi-thin sectioning.
Embedding for semi-thin sectioning: areas of interest in selected sections
were punched out under a stereomicroscope. The punches (diameter: 2 mm) were
placed in ice-cold 1% osmium tetroxide in PBS, for 1 hour. To remove the osmium
residues, punches were washed two times in PBS. For dehydration, they were
carried through a graded alcohol series (30%, 50%, 70%, 90%, 96%, 2 x absolute
alcohol), 10 min in each. Then, they were immersed in a mixture of epoxy resin
(Eponate 12 Kit; Ted Pella, Redding CA, USA) and absolute alcohol (2:1) for 60
mins, and then in the pure epoxy resin, for 16 hours at RT. Finally, punches were
flat-embedded between two plastic cover slips, and polymerized in the resin, for
24 hours at 56 oC. Then one of the plastic slips was removed with a fine needle,
and a resin-filled gelatin capsule was placed over the punch. After another 48
hours at 56 oC, the other plastic slip was removed as well, and semi-thin and ultra-
thin sections were cut using a diamond knife on a Sorvall ultramicrotome and
examined in a Jeol 1200 (Jeol Ltd., Tokyo, Japan) electron microscope. Semi-thin
(1 µm) sections were studied under a light microscope.
Double semi-thin immunofluorescence labeling: using a Vibratome 25 µm
thick coronal sections were cut, collected into PBS, and further processed as free-
floating sections. After 4x15 min washes in PBS and incubation in 0.5% Triton X-
100 solution (Sigma) for 30 min, the sections were placed into a solution of 5%
normal donkey serum (Jackson Immunoresearch Labs, Inc., West Grove PA, USA)
in PBS for 1 hour, and then incubated for 48h at 4 oC in a mixture of polyclonal
(goat) anti-Fos (sc-52G; Santa Cruz) at 1:50 and the polyclonal (rabbit) anti-Ucn
at 1:30,000. After incubation, sections were washed for 10 min in 5% normal donkey
31
serum followed by several washes in PBS. A secondary antiserum cocktail (Cy2
conjugated anti-goat IgG, 1:50, and Cy3 conjugated anti-rabbit IgG, 1:100) were
used for 3 hours. All secondary antisera were obtained from Jackson
Immunoresearch Labs, Inc. After several washes in PBS, they were mounted on
glass slides, cover slipped with an antifade mounting solution (Vectashield, Vector
Labs, Burlingame, CA, USA), and studied under a Nikon Microphot FXA
epifluorescence microscope equipped with a Spot RT Color digital camera. From
selected double-labeled 1 µm sections, the EW was punched out under a stereo
microscope, washed in PBS for 1 hour and further processed for semi-thin sectioning
as detailed above, but without osmification. The semi-thin sections were studied
under the Nikon microscope.
Antisera characterization and controls
Specificity of the Ucn-antiserum for immunohistochemistry has previously been
reported (Bittencourt et al., 1999). The specificity of the Fos-antiserum was tested
by absorbing it with the native FOS-peptide (sc-52P; Santa Cruz). Furthermore, if
the primary antisera (Ucn or Fos) were omitted or replaced by non-immune mouse,
goat or rabbit sera at a dilution of primary antisera, no immunoreaction was observed.
Cell counting
Differences in the relative amounts of Fos and Ucn expressing cells were made at
the midlevel of the EW (approximately Bregma -3.2 to -3.7 mm) on the basis of
Nissl-stained sections. Fos and Ucn-ir structures were counted in regularly spaced
(100 µm) series of 5-6 sections per animal/experimental group. The counts were
made by an individual who was familiar with the morphology of the rat midbrain
but not with the aims of the study. Neurons with clear and strong immunoreactivity
were considered labeled. For the mathematical correction of cell counts for section
thickness we used a formula from Floderus (1944), which yielded a correction
factor of nearly 1 (0.965); therefore no mathematical correction of cell counts for
section thickness was applied.
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Statistical analysis
Five or six representative sections of the EW per animal were used to produce a
single value for Fos-ir and Ucn-ir. Statistical analyses were carried out on average
values of each experimental group including controls (n=4), and expressed as means
± standard error of the mean (SEM). A random selection procedure was maintained
throughout the study. Data were tested by one-way ANOVA (α=5%) using Statistica
(StatSoft, Tulsa OK, USA).
Digital imaging
Digital images of sections, using the software supplied with a Spot RT Color digital
camera were taken at a resolution of 1200x1600 pixels. Images were imported into
Adobe Photoshop 7.0, digitally processed (cropped, histogram levels, brightness,
contrast and sharpness were adjusted), and assembled into plates at a resolution of
400 dpi.
Results
General considerations
Using the highly specific antiserum to Ucn enabled us to immunostain Ucn-ir
perikarya in the EW. The distribution of Ucn-ir cells in this area was in concert
with previously demonstrated localizations of Ucn-ir. Fos-ir nuclei were detected
in sections at the level of the EW, in response to various but not all stressors. Fos-
ir nuclei were always present in the periaqueductal gray following all challenges
used as internal controls for the reliability of Fos-immunohistochemistry. Since no
statistical difference was found between the mean values of controls in the five
experimental groups, controls were combined to produce a single mean value of
Fos-ir and Ucn-ir cell counts.
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Hormonal responses
Plasma corticosterone levels were significantly increased (p< 0.01; F=31.21-ether,
F=55.25-restraint, F=10.78-LPS, F=13.55-osmotic and F=12.85-hemorrhage vs.
basal) in response to all stressors 30 min after challenge (Fig. 1). Two hours after
acute ether stress corticosterone levels were not significantly different form control
levels (p>0.05), whereas after 120 min of hyperosmotic and hypotensive hemorrhage
challenges, corticosterone titers were not significantly different (p>0.05) from those
after 30 min of these challenges (Fig. 1). Restraint and LPS stress during 120 min
revealed clearly increased corticosterone titers (p<0.01; F=16.07-restraint; p <0.01;
F=29.77-LPS) vs. 30 min. Basal (pre-stress) corticosterone titers were similar
(p<0.05) among all groups (Fig. 1).
Figure 1. Adrenal responses of rats subjected to various types of acute stress. Mean ± SEM
plasma corticosterone. *p < 0.05 vs. respective control (n = 4).
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Recruitment of EW neurons following various types of acute stress
Quantitative Fos-imaging revealed that in non-challenged rats only occasional
activation of EW neurons had taken place, in average 0.8±0.4 at 30 min and 1.9±0.1
at 120 min neurons per section (Figs. 2A and 3). Since this activation pattern of
Fos was similar in all controls of various stressor types, we show a representative
control image from the LPS group (Fig. 2A).
In challenged animals, quantitative Fos-immunohistochemistry revealed
that acute ether stress resulted in a higher number of Fos nuclei 30 min (10.5±2.3;
p<0.01; F=15.47) as well as 120 min (21.8±0.5; p<0.01; F: 1826) after the challenge
(Figs. 2B and 3) as compared to the number of Fos-ir nuclei in control, non-stressed
rats (0.8±0.4 at 30 min and 1.9±10.1 at 120 min) (Figs. 2A and 3). Restraint stress
also caused a reliable elevation (p<0.01; F=58.64 at 30 min and p<0.01; F=2940 at
120 min) in Fos-ir nuclei after 30 min (9.6±0.9) and 120 min restraint (19.8±0.3)
(Fig. 2C and 3) vs. control. EW neurons responded with the strongest Fos-induction
to acute LPS stress both at 30 min (11.6±1.4 Fos nuclei per section; p<0.01; F=85.49)
as well as at 120 min (24.4±0.3 Fos nuclei per section; p<0.01; F=79.36; Figs. 2D
and 3). Interestingly, 120 min after acute immune challenge the number of Fos
nuclei (Fig. 3) was significantly higher than all other stressor groups (p<0.05;
F=13.3-ether; p<0.05; F=10.55-restraint; p<0.01; F=40.94-osmotic and p<0.01:
F=59.99-hemorrhage vs. LPS).
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Figure 2. Stressor-specific Fos-induction in the Edinger-Westphal nucleus (EW). Brightfield
photomicrographs of immunoperoxidase preparations to show Fos-ir expression in the EW
in response to various acute stressors and non-challenged controls 120 minutes post-stress.
Very low levels of expression can be seen in the EW in control animals (A) and in rat after
hyperosmotic (E; Osm) and hypovolemic hemorrhage (F; Hem) challenges. Ether (B),
restraint (C) and lipopolysaccharide (D; LPS) stressors provoked a robust Fos. aq, cerebral
aqueduct; PG, periaqueductal gray. Scale bar in F = 50 µm (applies also to A-E).
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Testing two systemic stressors, the hyperosmotic and hypotensive hemorrhage
challenges, no difference in the activation of EW neurons was observed vs. control
rats (Figs. 2E, F and 3). Hyperosmotic challenge induced 4.2±0.6 and 2.8±0.2 Fos
nuclei 30 and 120 min after the challenge, respectively. After 30 and 120 min of
hypotensive hemorrhage stress 3.2±0.4 and 2.0±0.2 Fos-ir nuclei, respectively,
were counted. None of these means were significantly different (p>0.05) from
control means. However, comparing these systemic stressors to LPS, ether and
restraint stressors, significantly higher Fos counts were revealed after 30 and 120
min. No rostrocaudal difference was observed in Fos counts at the midlevel of the
EW (approximately Bregma –3.2 to –3.7mm). These results provide evidence that
various acute stressors recruit EW neurons. Furthermore, this activation was
stressor-specific and showed no close correlation with the corticosterone titer.
Figure 3. Relative strength of Fos-induction in the EW following acute stress vs. non-
stressed control rats. Vertical bars represent the mean number ± SEM (n=4) of Fos-ir nuclei
30 and 120 min after ether, restraint, lipopolysaccharide (LPS), hyperosmotic (osmotic)
and hypotensive hemorrhage (hemorrhage) stress, respectively. *p< 0.01 vs. control.
37
We also quantified the numbers of Ucn-neurons in the EW in the various
experimental groups. In control animals, the mean number was 19.3±2.8 at 30 min
and 22.9±1.2 at 120 min (Fig. 5). Following ether stress the average number of
Ucn cells was 19.7±2.4 at 30 min and 22.7±0.4 at 120 min (Figs. 4A,B and 5). In
restraint challenged rats 19.4±2.8 and 19.8±0.3 Ucn-ir neurons were seen in the
EW after 30 and 120 min (Figs. 4C,D and 5) of stress, respectively. In the LPS
stress group the average number of Ucn cells was 19.8±4.3 at 30 min and 24.4±0.3
at 120 min (Figs. 4E,F and 5). Half an hour after hyperosmotic stress 19.3±2.5
urocortinergic neurons were counted, whereas at 120 min this umber was 21.3±0.3
(Fig. 4G and 5). Acute hypotensive hemorrhage stress induced 21.1±1.5 and
20.1±0.7 Ucn cells at 30 and 120 min, respectively (Fig. 4H and 5). No significant
difference (p>0.05) was observed between any of the 30 min experimental groups.
However, the number of urocortinergic neurons was clearly higher in the LPS
(p<0.01; F=47.32 vs. control) and ether stress groups (p<0.05; F=8.27 vs. control)
than in the 120 min controls. Similarly, higher numbers of Ucn-ir neurons were
found after restraint vs. hemorrhage stress (p<0.05; F=6.81), ether vs. hyperosmotic
(p<0.05; F=8.92) and hemorrhage stress (p<0.05; F=11.69), and in LPS vs. ether
stress (p<0.01; F=26.2), and LPS vs. hyperosmotic (p<0.01; F=71.17) and
hemorrhage (p<0.01; F=50.05) stress. Interestingly, the number of Ucn-positive
perikarya in the 120 min restraint, hyperosmotic and hemorrhage stress groups
were not higher than in the controls (p>0.05; F:2.09-control vs. restraint; p>0.05;
F=0.02-control vs. hyperosmotic; p>0.05; F=2.99-control vs. hemorrhage), whereas
120 min after an acute immune challenge (LPS) more Ucn-ir cells were observed
(Fig. 5) than in all other experimental groups (p<0.01; F=26.2 in ether; p<0.01;
F=22.61 in restraint; p<0.01; F=71.17 in hyperosmotic; p<0.01; F=50.05 in
hemorrhage). These results provide evidence that the number of Ucn-ir neurons
reliably increase upon distinct types of acute stress.
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Figure 4. Representative brightfield photomicrographs of 30-µm-thick (A,C,E,G,H) and 1-
µm-thick semithin (B,D,F and insets) sections of double-labeled immunoperoxidase staining
[silver intensified Fos-ir (black nuclei) and Ucn-ir (light gray cytoplasm)] in the EW of rats
killed 120 min after ether, restraint, LPS, hyperosmotic and hemorrhage challenges. Note
the prominent Fos-induction in Ucn-neurons after ether (A,B), restraint (C,D), and LPS
(E,F) stresses. Acute hyperosmotic (G and inset) and hemorrhage (H and insert) challenges
did not provoke Fos-ir. aq, cerebral aqueduct; PG, periaqueductal gray. Scale bars = 50 µm
in H (applies to A,C,E,G,H); 10 µm in B,D,F; 20 µm in insets.
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Finally, we tested, whether EW neurons recruited by acute stresses, exhibit Ucn-ir,
and used the percentage ratio of Ucn-ir neurons exhibiting Fos-ir in the EW as a
measure for comparison between the various stress conditions. In control animals
4±3.1% (30 min) and 8.3±0.9% (120 min) of Ucn cells were Fos-positive (Fig. 7).
This ratio was 51.8±14.6% after ether, 45±4.1% after restraint, 60.3±7.2% after
LPS, 22±4.9% after hyperosmotic and 12.8±2.4% after hypotensive hemorrhage
challenges for 30 min. The ratio of Fos nuclei/Ucn cells was reliably higher
95.3±0.9% (p<0.01; F=51.90 ether vs. control; Figs. 6A,B and 7), 89.3±0.5%
(P<0.01; F=68.46 restraint vs. control; Figs. 6 C,D and 7) and 94.3±1.3% (p<0.01;
F=18.39 LPS vs. control; Figs. 6 E,F and 7) 2 hours after ether, restraint and LPS
stress. The ratio of Ucn cells co-localized with Fos-ir was not significantly different
(p>0.05) in the hyperosmotic and hypotensive hemorrhage stress groups from
controls or from each other, at 120 min. Interestingly, LPS stress induced a higher
number of Ucn-ir cells than restraint (p<0.05; F=12.76), hyperosmotic (p<0.01;
F=30.38) and hemorrhage (p<0.01; F=21.98) challenges, at 120 min. Ether stress
resulted in a higher ratio of Fos/Ucn vs. restraint, hyperosmotic and hypotensive
hemorrhage groups (p<0.05; F=37.56 ether vs. restraint; p<0.01; F=58.32 ether vs.
hyperosmotic; p<0.01; F=32.60 ether vs. hemorrhage). This ratio in restraint stress
was different from that in all stressor groups (p<0.01; F=37.56 restraint vs. ether;
p<0.05; F=12.76 restraint vs. LPS; p<0.01; F=88.84 restraint vs. hyperosmotic;
p<0.01; F=3632 restraint vs. hypotensive hemorrhage). These results indicate that
the number of Ucn-ir neurons in the EW increases after acute stress, and this increase
is stressor-specific. The significance of this finding and possible mechanisms
underlying this phenomenon will be discussed.
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Figure 5. Histogram showing data expressed as percentages of the EW urocortinergic neurons
expressing Fos in rats killed 30 and 120 minutes after various types of acute stress. Mean ±
SEM (n=4). *p < 0.05 and **p < 0.01, vs. control.
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Figure 6. Representative, double-labeled (A,C,E) and semithin (B,D,F) immunofluorescence
images depicting neurons colocalizing Ucn-ir (red fluorescence) and Fos-ir (green
fluorescence) in the EW from rats killed 2 hours after ether (A,B), restraint (C,D) or LPS
(E,F) stress. aq, cerebral aqueduct; PG, periaqueductal gray. Scale bars = 50 µm in A (C,E);
10 µm in B,D,F.
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Discussion
Our study revealed that not only the strength but also the pattern of EW Fos-
activation was stressor-specific. This activation seemed to be independent from
the stress-induced adrenal corticosterone response, since corticosterone titers were
similar between the five stressors at the 30 min time point. Although corticosterone
titers were different at 120 min time (high in LPS and restraint stress, but low in
ether, hyperosmotic and hemorrhage challenges), no correlation between these
values and Fos induction could be observed. Since these results indicate that
neuronal activation in the EW is not primarily driven by alterations in blood
corticosterone titer, the exact mechanisms resulting in recruitment of EW neurons
upon acute stress remains at future issue.
This study also revealed a clear stressor-specific increase in the number of
EW urocortinergic cells. To explain this interesting finding, we hypothesize that
there are cells in the EW that in non-stressed, fully adapted animals do not express
Ucn, or express it below the detection level of immunohistochemistry, whereas
acute threats induce immediate early genes such as c-fos, which consecutively
activate transcriptional processes resulting in an increased expression of EW-Ucn
with intracellular peptide levels above the sensitivity of immunohistochemistry.
Therefore, the increase in Ucn-ir neuron numbers may represent inactive-silent
Ucn neurons responding to acute challenges. This hypothesis is supported by our
finding that at the 30 min time point no significant difference was seen in cell
numbers of any experimental group vs. the respective controls. Furthermore, the
demonstration that Ucn mRNA levels in the EW significantly increased 2-4 hours
after acute challenges in (Weninger et al., 2000; Kozicz et al., 2001b) further
supports our hypothesis. However, in none of these studies the number of cells
was counted that expressed Ucn mRNA in control vs. experimental groups. It is
also noteworthy that these changes in Ucn cell numbers seem also to be independent
from the blood corticosterone titer.
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Stressor-specific activation pattern of Fos in the EW
Cellular localization of immediate early gene expression in response to various
stressors has been performed using in situ hybridization or immunohistochemistry
in several brain areas (for review see Senba and Ueyama, 1997). However, whether
the stress-induced distinct activation patterns of brain areas are specific for the
type of stressor and/or the kind of brain area remains at issue. The literature suggests
that stress-regulatory circuits recruited by a particular stressor are crucially
dependent on stimulus attributes. It is common among scientists in the field to
distinguish stressors into two categories: systemic, or homeostatic or physiological
(such as cardiovascular, osmotic and immune challenge) and neurogenic or
emotional or psychological (such as immobilization, restraint, pain and electrical
foot shock) (for review see Sawchenko et al., 2000; Dayas et al., 2001). Herman
and Cullinan (1997) using another approach, also postulated the existence of two
stress regulatory pathways: the ‘processive’ and the ‘systemic’ stress circuitry.
According to these authors, systemic stressors such as respiratory (ether),
cardiovascular (hypotensive hemorrhage and hyperosmotic challenge) and immune
(LPS) challenges are of immediate survival value and require immediate attention.
On the contrary, processive stressors, such as restraint or chronic pain are multimodal
stimuli that need sequential stimulus assembly before they obtain physiological
meaning. Dayas et al. (2001) concluded that the brain utilizes category-specific
pathways to drive stress responses, which may have significant implications for
the classification of stressors based on the recruitment patterns of neurons in the
brain. Is it then possible to assign stressors to categories merely based on expression
patterns of Fos in the EW too? In our opinion, it is not. Neurons were dramatically
activated following neurogenic stressors such as restraint (present study),
immobilization (Weninger et al., 2000) and acute pain (Kozicz et al., 2001b), but
systemic stressors such as ether and LPS (present study) also resulted in a strong
increase in Fos-ir. On the contrary, other types of systemic stress such as
hyperosmotic and hypotensive hemorrhage stress (present study) did not induce
EW neuron activity. Therefore, our results challenge the hypothesis that all brain
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areas induced by acute challenges utilize stress-category specific pathways that
would allow classification of stressors based on neuronal activation footprints left
in the brain by them. For this reason, we suggest that stress-induced activation of
distinct neuronal structures in the EW is rather specific for this neuronal circuitry
and not for stimulus attributes. Thus, stress-induced activation patterns of neuronal
structures may not always be used to categorize stressors and vice versa.
Sawchenko et al. (2002) found a stress-induced response that was temporally
differentiated in hypophysiotropic neurons of the paraventricular hypothalamic
nucleus (Viau and Sawchenko, 2002). They observed Fos expression in CRF cells in
this nucleus after a single 30 min episode of acute restraint that was slightly decreased
in animals killed 2 hours after the challenge. On the contrary, EW Ucn neurons
moderately respond to stressful stimuli within an hour, and their activation peaks 2-
4 hours after the challenge (Weninger et al., 2000; Kozicz et al., 2001b; the present
study). In a previous experiment we showed that this activation is maintained for up
to 8 hours, then gradually decreases to control level 24 hours after initiating stress
(Kozicz et al., 2001b). This raises the intriguing possibility that EW-Ucn neurons, in
contrast to the hypothalamic CRF system, respond over a long time course to acute
stress, thereby probably anticipating to renewed stressful experiences.
Biological significance of Ucn in EW
The biological significance of Ucn perikarya in the EW remains to be elucidated,
although Ucn has been suggested to regulate many diverse physiological, behavioral
and endocrine functions related to stress (for review see Skelton et al., 2000).
Understanding the significance of interactions between Ucn, CRF and CRF
receptors will advance our knowledge on the role of Ucn in stress regulation and
adaptation.
In CRF-deficient mice EW-Ucn is significantly up regulated (Weninger et
al., 2000), suggesting an inverse relationship between CRF and Ucn. Our recent
observation that EW Ucn is down-regulated in mice that over-express CRF (Kozicz
et al., 2004), not only strengthens this hypothesis but also supports the notion that
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besides the well-known central regulator of HPA axis activity, CRF, a second
pathway is involved in co-ordination of stress responses (Skelton, 2000) in which
Ucn interacting with CRF receptors may play a central role.
Ucn is promiscuous for the so-far known two CRF receptor types (CRF1
and CRF2), although it binds CRF2 with much higher affinity (40 times) than the
CRF1 (De Souza, 1995; Perrin et al., 1999; Gammatopoulos et al., 2001).
Interestingly enough, mice deficient for CRF2 display anxiety-like behavior and
hypersensitivity to stress (Bale et al., 2000, 2002), whereas studies on CRF1-null
mice, reveal a central function for CRF1 in mediating anxiety and neuroendocrine
stress responses (Smith et al., 1998; Timpl et al., 1998). Furthermore, mice lacking
the CRF gene exhibit normal stress-induced behavior, which can be specifically
blocked by CRF1 antagonists (Weninger et al., 1999), whereas Ucn-deficient mice
show increased anxiety-like behavior (Vetter et al., 2002). These genetic models
provide new clues for the existence of distinct receptor pathways that mediate
CRF/Ucn actions and co-ordinate the initiation, maintenance and recovery phases
of the stress response. Moreover, recent advances in this field yielded a model in
which CRF1 plays a role in the acute phase of the stress response, whereas CRF2
would be acting during the recovery phase independently from glucocorticoid-
mediated negative feedback (Coste et al., 2001; Reul and Holsboer, 2002). The
relatively late onset, longer duration and corticosterone-independent manner of
stress-induced activation of EW-Ucn suggest that Ucn, acting through the CRF2,
may be central in the recovery phase of the stress response. In addition, the intriguing
possibility exists that EW-Ucn acting through the CRF2 modulates stress-induced
anxiety-like behavior (anxiolytic effect), opposing the actions of CRF on CRF1.
In summary, in this study we have demonstrated the stressor-specific
activation of EW-Ucn neurons that is independent from the blood corticosterone
titer. Our results further support the notion that besides CRF, driving the major
stress regulatory pathway, an entirely different stress adaptation regulatory brain
center exists, consisting of the stress-sensitive urocortinergic neurons in the EW
(Weninger et al., 1999; Skelton, 2000).
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Abstract
Although mood disorders are frequently genetically determined and to some degree
sex-dependent, the concept of ‘early life programming’, implying a relation between
perinatal environmental events and adult mood disorders, has recently gained
considerable attention. In particular, maternal separation (MS) markedly affects
various stress-sensitive brain centers. Therefore, MS is considered as a suitable
experimental paradigm to study how early life events affect brain plasticity and,
hence, cause psychopathologies like major depression. In adult mammals, the
classical hypothalamo-pituitary-adrenal (HPA-) axis and the urocortin 1 (Ucn1)-
containing non-preganglionic Edinger-Westphal nucleus (npEW) respond in
opposite ways to chronic stressors, raising the hypothesis that MS, which is known
to evoke adult mood disorders via the HPA-axis, will affect npEW dynamics as
well. We have tested this hypothesis and, moreover, studied a possible role of brain-
derived neurotrophic factor (BDNF) in such npEW plasticity. By triple
immunocytochemistry we showed that BDNF and Ucn1 coexist in rat npEW-neurons
that are c-Fos-positive. Quantitative immunocytochemistry revealed that MS
increases the contents of Ucn1 and BDNF in this nucleus. Furthermore, in both
males and females, the c-Fos response of npEW-Ucn1 neurons upon MS was blunted
in MS, a phenomenon that was concomitant with dampening of the HPA
corticosterone response in females but not in males. Based on these data we suggest
that besides the HPA-axis, the BDNF-containing npEW-Ucn1 system is affected by
MS in a sex-dependent manner, which supports the idea that the latter system also
plays a role in the appearance of sex differences in the pathogenesis of stress-
induced mood disorders.
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Introduction
Adaptation to stressful stimuli is a complex process in which the classical
hypothalamo-pituitary-adrenal (HPA-) axis plays a central role (for reviews see;
Smith and Vale, 2006; de Kloet et al., 2007; Gunnar and Quevedo, 2008). The
present study concerns the significance of a more recently discovered brain center
with a putative role in stress adaptation, the non-preganglionic Edinger-Westphal
nucleus (npEW). In addition, particular attention will be paid to the possible
involvement of brain-derived neurotrophic factor (BDNF) in the npEW response
to maternal separation (MS). The rationale for this study is explained as follows.
Urocortin 1 (Ucn1) has high sequence identity to corticotropin-releasing
factor (CRF) and binds with high affinity both CRF receptor types (Perrin and
Vale, 1999). The main production site of Ucn1 in the vertebrate brain is the npEW
(Kozicz et al., 1998, 2002; Yamamoto et al., 1998; Bittencourt et al., 1999;
Vasconcelos et al., 2003; Horn et al., 2008; May et al., 2008). An increasing body
of evidence indicates that Ucn1 plays a role in stress adaptation (Skelton et al.,
2000; Gysling et al., 2004; Kozicz, 2007): (1) acute stress recruits npEW-Ucn1
neurons in a stressor-specific fashion (Weninger et al., 1999, 2000; Kozicz et al.,
2001b; Gaszner et al., 2004), (2) chronic stress elicits a non-habituating activation
of npEW neurons concomitant with significant down-regulation of Ucn1 expression
(Korosi et al., 2005), (3) Ucn1-deficient mice show increased anxiety-like behavior
(Vetter et al., 2002) and impaired adaptation to repeated restraint and cold stress
(Zalutskaya et al., 2007), (4) the neurochemical make-up of the npEW in human
patients with major depression who had committed suicide appears to be sex-
specifically affected (Kozicz et al., 2008) and, finally, (5) support for a role of
Ucn1 in stress adaptation comes from studies of animal models in which the CRF-
system was genetically modified; more specifically, CRF-over-expressing mice
showed decreased Ucn1 expression in the npEW (Kozicz et al., 2004) whereas
Weninger et al. (2000) reported up-regulation of Ucn1 mRNA in the npEW of
CRF-knockout mice. Interestingly, in both of these mutant mice, the stress response
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by the npEW was intact (Weninger et al., 2000; Kozicz et al., 2004). Together
these results strongly support the notion that the npEW-Ucn1-neurons form a distinct
stress-sensitive brain area functionally linked to the HPA-axis (Kozicz, 2007).
Whereas animals and man are generally capable to cope successfully with
stressors, it appears that adverse life experiences and chronic stressors are often
associated with increased vulnerability to mood disorders such as anxiety and major
depression (for reviews see Holmes et al., 2005; Smith and Vale, 2006; de Kloet et
al., 2007; Gunnar and Quevedo, 2008). Although involvement of the HPA-axis in
such maladaptation is beyond dispute, the nature and extent of central neuronal
mechanisms leading to the development of stress-related mood disorders are not
well understood. The significance of sex-differences in the stress response by the
HPA-axis is underlined by the fact that stress-related mood disorders affect the
function of this axis and that females are more often affected by major depression
than males. Obviously, maladaptive stress responses leading to long-lasting
psychopathologies often occur as a result of interplay between genetic factors and
non-genetic influences like environmental hazards during vulnerable phases of
life (Caspi et al., 2003; Seckl and Meaney, 2006). Such an environmental hazard
could be early-life stress and, more specifically, ‘neglectful’ postnatal maternal
care (the maternal separation paradigm, MS). MS causes robust long-lasting and
partially sex-specific changes in various behavioral and neurochemical aspects, in
both rodents and humans (Rinne et al., 2002; Nemeroff, 2004; de Kloet et al.,
2005; Slotten et al., 2006; Moffett et al., 2007) and also exerts profound adverse
effects on the HPA-axis. For instance, Plotsky et al. (2005) demonstrated that adult
male rats previously exposed to MS possess increased plasma adrenocorticotrope
hormone (ACTH) and corticosterone (CORT) titers, as well as increased CRF-
immunoreactivity, CRF mRNA contents and CRF1 amounts in the hypothalamic
paraventricular nucleus (PVN). The importance of maternal care for proper HPA-
axis functioning is further corroborated by the observation that pups of Long-Evans
rat dams with high-grooming activity exhibited decreased PVN-CRF mRNA
expression and lowered ACTH and CORT titers in response to MS (Liu et al.,
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1997). Moreover, MS-stressed rats revealed decreased numbers of hippocampal
glucorticoid receptors, HPA-axis hyperactivation, and behavioral and cognitive
deficits (Aisa et al., 2007). The changes of the HPA-axis upon MS seem to be sex-
specific (Slotten et al., 2006), which may be explained by differences in the feedback
of gonadal hormones on this axis (Faraday et al., 2002; Li et al., 2004). Indeed,
testosterone inhibits (McCormick et al., 2002) whereas estrogen enhances the HPA-
axis stress response (Lund et al., 2006).
The neurotrophin BDNF is widely expressed in the central nervous system
and plays a crucial role in neuronal survival, growth, differentiation and synaptic
plasticity (for reviews see Branchi et al., 2004; Lipsky and Marini, 2007;
Bekinschtein et al., 2008). The effect of MS on BDNF dynamics has been well
documented (Lippmann et al., 2007) but the neuronal mechanisms concerned seem
complex and are not well understood. For instance, adult rats exposed to MS show
decreased BDNF mRNA expression in the hippocampus and the prefrontal cortex
(Roceri et al., 2002, 2004) but Greisen et al. (2005) found increased hippocampal
BDNF protein expression and normal neurogenesis in such rats.
Other brain centers involved in the stress response, like the serotonin-
utilizing dorsal raphe nucleus (DR) and the lateral septal nucleus (LS) receive
urocortinergic inputs from the npEW (Bittencourt et al., 1999; Bachtell et al., 2003b;
Turek and Ryabinin, 2005a,b; Ryabinin and Weitemier, 2006). Since the DR shows
neurotrophin receptor immunoreactivities (Yamuy et al., 2000) and the LS receives
BDNF-immunopositive inputs from midbrain sources (Conner et al., 1997) the
possibility arises that the npEW produces BDNF that helps maintaining neuronal
functioning in the DR and LS during periods of challenging stress. Adding this
notion to the data presented above on the presumed link between the npEW and
the HPA-axis during stress adaptation, we hypothesize that npEW-Ucn1 neurons
produce BDNF and that MS affects both Ucn1 and BDNF dynamics of these
neurons. We have tested this hypothesis with multiple and quantitative
immunocytochemistry to localize and assess the amounts of BDNF and Ucn1 in
the npEW of MS-challenged rats and, then, tested the response of such rats with
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MS history to an acute (restraint) stressor, using quantitative immunocytochemistry
for c-Fos as a marker for neuronal activity, as well as for quantifying the presence
of Ucn1 and BDNF. These data were correlated with the blood CORT titer as a
measure for HPA-axis activity.
In view of our recent observations on npEW-Ucn1 neurons containing the
estrogen β-receptor and expressing Ucn1 mRNA depending on the phase of the
estrous cycle (Derks et al., 2007; N.M. Derks, unpubl. res.) and because of the
clear sex-dependent dysregulation of the npEW-Ucn1 system in depressed patients
who committed suicide (Kozicz et al., 2008) we have extended this study to possible
sex-dependent effects of MS on Ucn1 and BDNF dynamics in the npEW.
Materials and methods
Animal treatment
Sixteen female and sixteen male albino Wistar R Amsterdam rats were bred in our
animal breeding facility at Pécs University. Timed-pregnant animals were housed
individually from gestational day 16 on in standard plastic cages (40x50x20 cm) at
22 oC and 55% humidity, on a 12-hours light/12-hours dark cycle (lights-on: 6:00
AM, light intensity: 200 lux) and were allowed to drink tap water and eat rodent
chow ad libitum throughout the experiments. Nine litters, born within a period of
36 hours, were used. Date of birth is designated as postnatal day one (PND 1). On
PND 2, after pups had been cross-fostered to minimize litter differences, six new
litters were composed. Three experimental groups were formed, each consisting
of two litters, each consisting of 5 male and 5 female littermates per dam, based on
the mode of maternal care: group A: undisturbed pups except for short manipulation
twice a week to change their bedding according to the standard protocol in our
animal facility (animal facility-reared rats, AFR); group B: pups as A, but daily,
between 9:00 and 14:00 h, handled with 15 min of MS (HMS15), as follows: the
same person removed dams in a semi-randomized order from their home cages and
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placed them into a separate cage; pups were put together into a container lined
with home cage nesting material, in an incubator at 32 °C from PND 2-8 and at 30
°C from PND 8-14; after MS, pups were reunited with their dam in their original
home cage; group C: as group B, but MS lasted 180 min (HMS180). On PND 28,
pups of the three groups were weaned and reared according to the standard animal
facility protocol. All subsequent experiments (see below) were performed in
adulthood, between PND 85 and 90.
To test the effect of MS and sex on the stress response, groups A-C were
divided into 3 male and 3 female subgroups. Between PND 85 and 90, all subgroups
were divided again, into 12 groups of 5 animals each (Table 1). Half of the male
and the female AFR, HMS15 and HMD180 groups were exposed to acute restraint
stress, for 120 minutes (‘stress groups’) whereas the other half remained undisturbed
(‘controls’).
Immediately after stress exposure, all animals, including controls, were
processed for further examination, between 10:00 and 11:00 h. For this purpose,
they were deeply anesthetized with nembutal (sodium-pentobarbital; 100 mg/kg
body weight; Sanofi, Budapest, Hungary), their chest cavity opened, a small incision
made in the left ventricle, and a 3 ml blood sample collected in an EDTA-containing
tube, centrifuged at 3,000 g for 10 min, and stored as 50 µl serum aliquots at -20 °C,
AFR HMS15 HMS180
male female male female male female
cont stress cont stress cont stress cont stress cont stress cont stress
Table 1. Experimental groups. Animals were divided into 12 groups based on maternal care
history (first row), sex (second row) and acute restraint stress (stress) exposure (third row).
AFR:, animal facility-reared; HMS15 and HMS180, handling with 15 and 180 mins of
maternal separation, respectively; cont, control. Each group consisted of 5 animals.
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until further use. Meanwhile, rats were transcardially perfused with 50 ml of 0.1
M sodium phosphate-buffered saline (PBS) (pH 7.4), for 2 min, followed by
perfusion with 250 ml of ice-cold 4% paraformaldehyde in 0.2 M Millonig sodium
phosphate buffer (pH 7.4), for 20 min. Then, rats were decapitated and their brains
quickly dissected andpostfixed in the same fixative, for 12 hours.
All animal treatments were conducted in accordance with the Declaration
of Helsinki and the guidelines for animal experimentation approved by the Advisory
Committee for Animal Resources of Pécs University, Medical Faculty, based on
Law of 1998, XXCIII on Animal Care and Use in Hungary.
CORT radioimmunoassay
For CORT radioimmunoassay, 5 µl of blood serum sample was assayed as described
previously (Gaszner et al., 2004) using 3H-corticosterone (12,000 cpm; 90-120 Ci/
mmol, NET-399; Perkin-Elmer, Boston, MA, USA) and CS-RCS-57 antiserum
(Jozsa et al., 2005). The inter- and intra-assay co-efficients of variation were 9.2%
and 6.4%, respectively, indicating the high reliability of the method.
Single immunocytochemistry for Ucn1 or c-Fos with diaminobenzidine
To study the npEW, 20 µm-coronal sections of midbrains were cut on a Lancer
Vibratome (Ted Pella Inc., Redding, CA, USA). Per animal, 5 RNAse-free-handled
series of npEW sections were placed into anti-freeze solution consisting of 30%
glycerol, 20% ethylene glycol and 0.1 M sodium phosphate buffer, and stored at -20
C° until further use. For free-floating diaminobenzidine (DAB; D5637; Sigma
Chemical, Zwijndrecht, The Netherlands) immunocytochemistry, sections were
washed 6x10 min in 0.1 M sodium phosphate-buffered saline (PBS; pH 7.6) to remove
antifreeze solution, and incubated in a quenching mixture of PBS and 3% H2O2 (1:1
v/v), at 20 C° for 30 min. After washing in PBS, sections were incubated in 0.5%
Triton X-100 (Sigma Chemical) in blocking buffer consisting of PBS and 2% normal
goat serum (NGS), for 30 min. Then sections were incubated overnight at room
temperature with an affinity-purified rabbit polyclonal antiserum raised against Ucn1
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(PBL#5779; generous gift from Dr. W.W. Vale, The Salk Institute, La Jolla, CA,
USA) diluted 1:30,000 in blocking buffer, or in polyclonal antiserum raised against
c-Fos (Santa Cruz, sc-52) diluted 1:500 in blocking buffer. After a wash in PBS,
sections were incubated with biotinylated goat anti-rabbit IgG, diluted 1:200 in PBS
containing 2% NGS, for 2 hours at 20 C°. Sections were rinsed in cold PBS, incubated
in avidin-biotin-complex (Vectastain Elite ABC Kit, Vector Laboratories, Burlingame,
CA, USA), for 1 hour at 20 C°, and rinsed with PBS, for 3x10 min, and with Tris
buffer (pH 7.6), for 10 min. Finally, they were treated successively with 0.05% DAB
in the Tris buffer, for 10 min, with 0.02% DAB in this buffer, for 10 min, and finally
with 0.00003% H2O2, for about 10 min; the latter reaction was controlled under a
stereo microscope and stopped with Tris buffer. After 3x10 min washes in PBS,
sections were mounted on gelatin-coated glass slides, air-dried, treated with xylene
for 2x10 min, coverslipped with DePex, and studied with a Nikon Microphot FXA
microscope equipped with a Spot RT color digital camera (Nikon, Tokyo, Japan).
Double immunocytochemistry of Ucn1 and c-Fos with DAB
This procedure was carried out as reported elsewhere (Gaszner et al., 2007). Briefly,
the first immunostaining with anti-c-Fos was performed on sections as described
above, but after stopping the DAB reaction, sections were rinsed in PBS and processed
for silver-gold intensification. After rinsing in 5% thioglycolic acid (Sigma-Aldrich,
Zwijndrecht, The Netherlands) in 2% sodium acetate, for 1 hour and 4x15 min,
sections were physically developed under a microscope, for ca. 10 min, according to
Merchenthaler et al. (1989). After stopping silver development in 1% acetic acid, for
1 min, sections were rinsed in 2% sodium acetate, for 10 min, followed by gold
toning in 0.05% gold chloride (Sigma-Aldrich) in 2% acetic acid on ice, for 10 min.
The reaction was stopped by rinsing in 2% sodium acetate, for 10 min, followed by
a 10 min rinse in 3% sodium thiosulphate (Sigma-Aldrich) and in 2% sodium acetate
in PBS. Then, sections were incubated in the polyclonal (rabbit) Ucn1 antiserum
(1:30,000), overnight at 20 °C. Ucn1-immunoreactivity (ir) was visualized using the
ABC technique with DAB as chromogen, as described above.
56
Single immunofluorescence for BDNF
After antifreeze solution had been removed (see above), sections were incubated
in 0.5% Triton X-100, for 30 min, and subsequently in 2% normal donkey serum
(NDS) (Jackson Immunoresearch, West Grove, PA, USA) in tyramide signal
amplification medium (PBS-BTSA; Perkin Elmer, Boston, MA, USA), for 1 hour
at 20°C. Then they were incubated overnight at 20 °C in rabbit polyclonal anti-
BDNF (Alomone Labs, Jerusalem, Israel), diluted 1:250 in PBS-BTSA. Sections
were rinsed in PBS 3x10 min, and incubated in biotinylated donkey anti-rabbit
IgG (Jackson Immunoresearch Labs), diluted 1:100 in PBS-BTSA. After 3x10
min rinses in PBS, they were placed into streptavidin-conjugated Cy3 (Jackson
Immunoresearch; 1:100), for 2 hours, followed by rinses in PBS, mounted on gelatin-
covered glass slides, coverslipped with anti-fade mounting medium (Vectashield,
Vector Lbs., Peterborough, UK), and studied with a Leica TCS SP2 AOBS confocal
microscope (Leica, Wetzlar, Germany).
Triple immunofluorescence for BDNF, Ucn1 and c-Fos
After antifreeze solution removal, sections were placed in 0.5% Triton X-100, for
30 min, and subsequently in 2% NDS (Jackson Immunoresearch Labs) in PBS-
BTSA, for 1 hour at 20°C. Then, they were treated overnight with a cocktail of
primary antisera: rabbit polyclonal anti-BDNF serum (Alomone Labs) diluted 1:250,
goat polyclonal anti-Ucn1 serum (Santa Cruz) diluted 1:150, and chicken polyclonal
anti-c-Fos serum (Novus Biologicals, Littleton, CO, USA) diluted 1:100 in PBS-
BTSA containing 2% NDS. After 3x10 min rinses in PBS, sections were placed
into biotinylated donkey anti-chicken IgG (1:100), for 1 hour, followed by 3x10
min PBS rinses. Then, they were transferred for 3 hours into the cocktail of Cy2-
conjugated donkey anti-goat IgG (1:100; Jackson Immunoresearch), Cy3-coupled
donkey anti-rabbit IgG (1:100; Jackson Immunoresearch) and streptavidin-
conjugated Cy5 (1:100; Jackson Immunoresearch) in PBS-BTSA. After several
rinses, sections were mounted on gelatin-covered glasses, dried, coverslipped with
the anti-fade mounting medium and studied with the Leica confocal microscope.
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Antiserum characterization and immunocytochemistry controls
The rabbit Ucn1 antiserum had been generated against the whole rat Ucn1 peptide
(amino acids 1-40). Its high specificity has been verified previously by preabsorption
and Western blot analyses (Bittencourt et al., 1999; Turnbull et al., 1999). The goat
polyclonal anti-Ucn1 IgG had been generated against a peptide mapping at C-
terminus of rat Ucn1. Its strong specificity has been reported by Bachtell et al.
(2003a,b). The rabbit c-Fos-antiserum had been raised against the epitope
corresponding to residues 3–16 of the protein, encoded by human c-Fos. Chicken
polyclonal c-Fos antiserum (NB120-14285; Novus Biologicals) was produced by
immunization with the synthetic peptide corresponding to amino acids 168-380 of
human c-Fos. BDNF antiserum (ANT-010, Alomone Labs) had been generated
against the peptide (C)VLEKVPVSKQLK, corresponding to amino acid residues
166-178 of human BDNF (precursor). We confirmed the respective high serum
specificities by preabsorption with the respective synthetic peptides to which they
had been raised (synthetic c-Fos sc-52 P blocking peptide; Ucn1 synthetic peptide,
generous gift from Dr. J.E. Rivier, The Salk Institute; Ucn1 blocking peptide, sc-
1825 P; BDNF blocking peptide ANT-010, Alomone Labs), which abolished staining
in all cases. In addition, primary serum omission or replacement of the serum by
nonimmune goat or rabbit serum at the dilution of the respective primary antiserum,
completely prevented immunoreaction (Fig. 3A-D).
Microscopy, digital imaging and morphometry
For qualitative purposes, digital images were corrected to obtain optimal contrast,
using Photoshop 7.0.1 (Adobe, San Jose, CA, USA). Per animal, the contents of c-
Fos BDNF and Ucn1 in the npEW were estimated by counting all c-Fos-positive
cell nuclei and BDNF- and Ucn1-positive perikarya present in 10 serial sections,
each interspaced by 60 µm, at the midlevel of the npEW (Bregma –5.3 to –6.5 mm;
see Paxinos and Watson, 1997). The intensity of the immunoreaction was measured
in 10 perikarya per section using Image J software (version 1.37, NIH, Bethesda,
MD, USA). Data were corrected for the background density outside the npEW,
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yielding the specific signal density (SSD) per neuron, which was expressed in
arbitrary units (a.u.). The mathematical correction factor for section thickness of
cell counts according to (Floderus, 1944) was nearly 1 (0.965). Therefore no
correction for sections thickness was applied.
All data were expressed as mean and standard error of the mean, per
experimental group. A random selection procedure was maintained throughout all
experiments, and all quantitations were performed according to a double-blind
protocol, by an observer experienced in the anatomy of the midbrain but unaware
of the identity of the sections and the aim of the study.
Statistics
Statistical analyses were performed using multifactorial analysis of variance
(MANOVA; α=5%) after testing for normality (Shapiro-Wilk test; Shapiro and
Wilk, 1965) and homogeneity of variance (Bartlett’s Chi-square test; Snedecor
and Cochran, 1989). As raw CORT titer values were not normally distributed,
square root mathematical transformation was applied. Post hoc analyses were carried
out with Fisher’s test, using Statistica (StatSoft, Tulsa, OK, USA) (α=5%).
Results
CORT measurements
To evaluate the activity of the HPA-axis, we measured the CORT concentration in
blood plasma samples (Fig. 1). MANOVA revealed the significant effect of gender
(F11,60=73.31; p<0.00001) and stress (F11,60=153.32; p<0.00001). Testing the effect
of maternal care on the CORT level we only found a statistically not significant
tendency (F11,60=2.84; p=0.068), but a significant interaction of gender x maternal
care (F11,60=22.73; p<0.00001) was obvious.
Two-way ANOVA showed that maternal care had an obvious effect on
CORT response to acute stress when genders were tested separately (males:
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F5,30=18.69; p<0.0001; females: F5,30=8.07; p<0.01). Both male (F5,30=219.47;
p<0.00001) and female (F5,30=42.91; p<0.00001) animals displayed a clearly
increased (about +100%) response to acute restraint stress compared to controls,
and in addition, in stressed males there was a significant stress x maternal care
interaction (F5,30=6.64; p<0.01). The post hoc test revealed a reduced CORT stress
response in HMS15 males compared to AFR (p<0.001) and HMS180 (p<0.00001)
counterparts, supporting the strong validity of our model in males. In addition,
male stressed HMS180 rats possessed higher CORT levels than AFR (p<0.05) and
HMS15 (p<0.00001) stressed animals. In females, however, stressed HMS15 did
not display a changed CORT response when compared to stressed AFR (p=0.83),
but female HMS180 showed a reduced CORT titer upon stress when compared to
AFR (p<0.039) or to HMS15 (p<0.048). The changed activity of HPA-axis in
females also appeared from the fact that non-stressed female HMS180 possessed a
lower CORT titer than not-stressed AFR (p=0.05) and HMS15 (p<0.01) females.
In addition, neither HMS180 control males and females (p=0.64) nor HMS180
stressed males and females (p=0.54) differed significantly, but females possessed
an about 2.5 times higher CORT titer than males in both stressed and control AFR
and HMS15 groups.
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Figure 1. Corticosterone hormone titer of control vs. acutely stressed rats with various
maternal care histories (mean ± SEM). Light bars: males, dark bars: females. AFR: animal
facility-reared; HMS15 and HMS180: handling with 15 and 180 mins of maternal separation,
respectively. Top letters indicate groups with which significant difference exists (p<0.05).
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Colocalization studies
In order to test our hypothesis that the npEW contains neurons in which Ucn1 and
BDNF coexist, we carried out immunocytochemical fluorescence co-localization
studies. Since, in qualitative respects, the results were similar for all 12 experimental
groups, they will be described for not-stressed, male AFR rats only.
In the midbrain, single labeling with the anti-Ucn1 serum revealed Ucn1-
ir in the npEW only. Numerous Ucn1-ir perikarya as well as various neuronal
processes were observed (Fig. 3E). Single immunolabeling with anti-BDNF showed
numerous BDNF-ir perikarya and neuronal processes throughout the midbrain.
Omission of this serum and its preabsorption with native BDNF abolished staining
(Fig. 3A-D). BDNF-ir was obvious in the motor nucleus of the oculomotor nerve,
periaqueductal gray (PAG), red nucleus (RN), substantia nigra (SN), ventral
tegmental area (VTA), interpenduncular nucleus (IPN) and medial geniculate
nucleus (MGN) (not shown). Most importantly, strong BDNF-ir was present in
perikarya and neuronal processes of the npEW, which revealed distributions similar
to those observed with the Ucn1-antiserum. Double labeling showed that the vast
majority of Ucn1-positive neurons also were BDNF-ir. Only a few BDNF-ir
perikarya were seen to be immunonegative for Ucn1 (Fig. 2).
Since we wanted to use in our quantitative immunocytochemistry studies
the product of the immediate early gene, c-Fos, as a marker for neuronal activation
(cf. Hoffman et al., 1993), we tested the presence of the c-Fos protein using c-Fos-
immunocytochemistry. Single labeling with anti-c-Fos revealed, as expected, many
neurons with a c-Fos-ir nucleus, such as in the PAG, superior colliculus, VTA,
IPN, MGN and, importantly, the npEW, after exposure to acute restraint stress.
62
Double and triple immunofluorescent labeling, including c-Fos-ir, demonstrated
that the majority of Ucn1- and BDNF-ir neurons were recruited by acute restraint
stress (Figs. 2D-K, 3). We also observed c-Fos-ir in some of the BDNF-ir but Ucn1-
immunonegative neurons in the npEW as well as in some neurons in this nucleus that
did not react with either the Ucn1- or BDNF-antiserum and in neurons located outside
this nucleus, namely in the PAG, VTA, IPN and MGN (data not shown).
Figure 2. A-C: co-localization immunofluorescence for BDNF (red, A) and Ucn1 (green,
B). Note that merged image (C) confirms the high-degree of co-existence of Ucn1 and
BDNF in the npEW. D-K: triple immunofluorescence for BDNF (red), Ucn1 (green) and c-
Fos (blue) in the npEW. D-G are low magnification micrographs of the npEW. BDNF (D)
and Ucn1 (E) neurons co-express c-Fos (F) as well, indicated by merged image in (G). H-K
are details of D-G, respectively, indicated by white boxes. Bars A-G: 25 µm; H-K: 2.5 µm.
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Figure 3. Characterization of BDNF-immunolabeling in npEW. A: BDNF-ir perikarya visualized
with BDNF-antiserum. Preadsorption with 10 µg (B), 1 µg (C), and 0.1 µg (D) BDNF abolished
immunoreaction in all cases. Overview of the ventrobasal midbrain area labeled for Ucn1 (E)
and BDNF (F). Note that Ucn1 and BDNF neurons show similar distribution. Schematic drawing
(G) shows anatomy of cross-sectioned midbrain. Rectangular area corresponds to fields depicted
in E and F. aq: cerebral aqueduct, EW: preganglionic Edinger-Westphal nucleus, npEW: non-
preganglionic Edinger-Westphal nucleus, GN: geniculate nucleus, mlf: medial longitudinal
fascicle, PG: periaqueductal gray matter, RN: red nucleus, sc: superior colliculus, SN: substantia
nigra. III: nucleus of oculomotor nerve. Bars A-D: 30 µm; E-F: 100 µm.
64
Quantitative immunocytochemistry
Although the broad set-up of the quantitative study, involving three experimental
conditions (AFR, HMS15 and HMS180), a stressor, two sexes, three antisera, as
well as three read-out parameters (numbers of c-Fos-positive nuclei, numbers of
immunopositive cells, and SSD) would have theoretically allowed for numerous
single-, double- and triple-labeling immunocytochemistry groups to be
quantitatively analyzed, for economical reasons we only performed stainings that
allowed to quantify the following parameters:
a) In single c-Fos staining, the number of c-Fos-neurons, to determine the general
activity of the npEW.
b) In Ucn1 and c-Fos double staining, the number of neurons positive for both
Ucn1 and c-Fos, to determine the activity of the Ucn1-containing npEW neurons.
c) In Ucn1 and c-Fos double staining, the number of neurons positive for c-Fos
only, to determine the activation of non-Ucn1-containing npEW neurons.
d) In single Ucn1 staining, the number and SSD of Ucn1-neurons to determine the
amount of stored Ucn1 in the npEW.
e) In single BDNF staining, the number and SSD of individual npEW-BDNF-ir
neurons to assess the amount of BDNF per neuron.
Quantitative c-Fos immunocytochemistry
In unstressed AFR rats, the number of c-Fos-ir neurons did not differ between males
and females, and this held also for rats who had a history of 15 and 180 min of MS.
Upon stress, the npEW became activated, as the number of c-Fos-ir neurons drastically
increased, in AFR (e.g. in males: 6.80x; p<0.000001) as well as in both MS-groups
(e.g. in male HMS15: 3.75x; p<0.00001, and in females HMS180: 2.81x; p<0.0.0001).
The degree of this increase was independent from sex and from MS, with the exception
of the HMS15 group, where females reacted more strongly (28.66±1.97) than males
(20.56±3.09; p<0.01) and the number of c-Fos-ir neurons was about 10 times higher
in stressed females (2.99±0.78; p<0.0001) than in non-stressed female rats. The
increase in numbers of c-Fos-ir neurons in male HMS15 was about 7–fold higher in
stressed animals (20.56±9.01) than in controls (5.41±1.41; p<0.0001).
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Fig. 4. Quantification of c-Fos-ir in the npEW in stressed and control rats with various
maternal care history. A. Micrographs of the npEW area stained for c-Fos. B. Histogram
shows the number of c-Fos-ir nuclei per section (mean ± SEM; light bars: males, dark bars:
females). Top letters indicate groups with which significant difference exists (p<0.05). aq:
cerebral aqueduct, npEW: non-preganglionic Edinger-Westphal nucleus, PG: periaqueductal
gray matter, AFR: animal facility-reared; HMS15 and HMS180: handling with 15 and 180
mins of maternal separation, respectively. Bar: 40 µm.
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Stress-induced recruitment of npEW Ucn1 neurons
Ucn1-ir neurons that were Fos-ir as well, revealed a similar picture as c-Fos-ir
neurons, as they did not differ between unstressed AFR and MS groups, and
increased in number upon stress in all three experimental groups, in both males
and females, by about 7 times (Fig. 5). Again, the HMS15 animals showed sex-
dependence, as males revealed a stronger reaction to stress than females (+37%;
p<0.01). Remarkably, the stress-induced increase in c-Fos-Ucn1-ir neuron number
in HMS180 male rats (14.6±1.34) was 64% lower than in AFR males (8.25±2.29;
p<0.01). In line with this, stressed HMS180 females (7.26±1.14) revealed a 64%
lower stress induced c-Fos-ir than HMS15 stressed females (13.8±2.43; p<0.01), a
difference that occurred with similar strength in males as well.
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Figure 5. Quantification of c-Fos-ir in Ucn1-neurons. A: representative micrographs showing
double labeled neurons in the npEW. Ucn1-containing perikarya (light brown) show c-Fos
(dark brown or black) nuclear labeling in the npEW upon stress, but in controls co-localization
was rarely seen. B: histogram shows the number of c-Fos-positive but Ucn1-negative neurons.
C: histogram reveals the number of c-Fos-positive nuclei in Ucn1-neurons. Note that Ucn1-
neurons of HMS180 showed a dampened c-Fos response. Means ± SEM; light bars: males,
dark bars: females. Top letters indicate groups with which significant difference exists
(p<0.05). AFR: animal facility rearing; HMS15 and HMS180: handling with 15 and 180
mins of maternal separation, respectively. Bar: 40 µm.
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Quantification of c-Fos positive but Ucn1 negative neurons
By counting the number of neurons positive for c-Fos but negative for Ucn1, we
tested whether these neurons were differentially recruited by MS. It appeared that
MS (F11,60=0.61; p=0.54) and sex (F11,60=0.07; p=0.79) did not influence their
number, but acute restraint did have a strong effect (F11,60=112.79; p<0.000001).
Specifically, in all acutely challenged groups, about 3 times more of these neurons
were c-Fos-ir than in their unstressed counterparts (p<0.001). No effect of MS was
detectable. Based on these results, we conclude that MS specifically affects the
Ucn1-neurons and does not affect the c-Fos response by neurons in the npEW
being negative for Ucn1.
Quantitative Ucn1-immunocytochemistry
As to the amount of Ucn1 present in the npEW, compared to control AFR rats, a
slightly higher number (+18.5%; p<0.03) of cells was present in female HMS15
and a slightly lower number (-33%; P<0.01) in female HMS180 compared to
HMS15 (Fig. 6). No clear stress-effects (F11,60=3.09; p=0.08) or sex-differences
(F11,60=0.92; p=0.32) were seen. When storage of Ucn1, expressed as the SSD, was
examined at the single neuron level, more pronounced effects were observed at
HMS180. Whereas the SSD of Ucn1-ir cells (both c-Fos-positive and c-Fos-
negative) did not differ between the AFR and HMS15 groups, HMS180 revealed
sex-specific effects, as stress increased the SSD of Ucn1-positive cells in male
HMS180 only (by 25% vs. HMS 180 controls; p<0.03). In addition, female HMS
180 controls and stressed animals both showed an increase compared to their AFR
(36%; p<0.001) and HMS15 (21.6%; p<0.01) counterparts.
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Figure 6. Quantification of Ucn1-ir in the npEW. A: representative micrographs showing
Ucn1 labeled neurons in the npEW. B: histogram demonstrates the number of Ucn1 perikarya
per section. C: histogram reveals the specific signal density of Ucn1 neurons expressed in
arbitrary units. Means ± SEM; light bars: males, dark bars: females. Top letters indicate
groups with which significant difference exists (p<0.05). AFR: animal facility rearing;
HMS15 and HMS180: handling with 15 and 180 mins of maternal separation, respectively.
Bar: 40µm
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Quantitative BDNF-immunocytochemistry
As to BDNF, no effect of sex, MS or acute stress on the total number of BDNF-ir
cells could be detected. At the single cell level, however, the SSD of AFR groups
appeared to be lower than after MS (F11,60=28.78; p<0.00001), and especially
stressed female HMS180 (63.14±6.96) possessed a higher SSD than non-stressed
female AFR (29.83±1.89; p<0.0001). No effect of stress or sex on the SSD was
detectable (Fig. 7).
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Fig. 7. Quantification of BDNF-ir in the npEW. A: representative micrographs showing
Ucn1-ir neurons in the npEW. B: histogram depicts the number of Ucn1 perikarya per
section. C: histogram reveals the SSD of BDNF-ir expressed in arbitrary units. (mean ±
SEM; light bars: males, dark bars: females). Top letters (a-l) indicate significant (p<0.05)
differences. AFR, animal facility-reared; HMS15 and HMS180, handling with 15 and 180
mins of maternal separation, respectively. Bar: 40 µm.
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Discussion
In this study we have tested the hypothesis that MS, a significant early-life stressor,
induces sex-specific changes in the responsivity of the rat npEW to acute stress,
and that these changes are borne out in differences in Ucn1 and BDNF dynamics
in this nucleus. Our results support the hypothesis, as will be explained below.
HPA-axis activity shows sex- and MS-dependence
Consistent with results of other laboratories (Rhodes and Rubin, 1999; Slotten et al.,
2006; Renard et al., 2007), we here show that female control (AFR) rats have a
higher CORT titer than male ones, indicating their higher HPA-axis activity. Possibly,
this sex difference is due to a more pronounced negative feedback by sex steroids on
the HPA-axis in males, as testosterone can inhibit the HPA-axis while estrogen may
enhance it (McCormick et al., 2002; Lund et al., 2006). The CORT measurements
moreover show that our MS paradigm worked well as, in accordance with previous
studies on the effect of MS on the CORT titers in adult rat (Meaney et al., 1996; Ladd
et al., 2000), we found that in male HMS15, the CORT titer is substantially decreased.
A remarkable finding in our study was the decreased CORT level in both
unstressed and stressed females that had undergone prolonged MS (180 min). These
findings are in line with those of Slotten et al. (2006), who found decreased CORT
in female but not in male rats chronically exposed to MS. Possibly, this female-
specific decrease in CORT titer upon prolonged MS must be explained from sex-
specific MS-induced changes in HPA-axis functioning (Faraday et al., 2002; Li et
al., 2004). Clearly, the (brain) center(s) responsible for such an induction is/are
elusive. In this respect a relation with the npEW might be considered.
MS affects Ucn1-neurons in a sex-specific way
To assess a possible effect of MS on Ucn1-neurons in the npEW, two main aspects of
these neurons were studied, viz. 1) their Ucn1 content and 2) their cellular activity as
judged on the basis of c-Fos expression in their cell nuclei. We show that the Ucn1-
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contents in HMS15 females and HMS180 males, as revealed by the number of Ucn1-
ir neurons, slightly differed from AFR rats, indicating that MS induces changes in the
secretory dynamics of these neurons, and that these changes are sex-specific with respect
to the duration of the MS challenge. Probably, the differences in the amount of stored
Ucn1 in the npEW are due to a changed ratio between biosynthesis and release of Ucn1
in individual neurons. This assumption is confirmed by the SSD data, as this measure
for the amount of stored Ucn1 per neuron also differs between HSM15 and female
AFR as well as between male HMS180 and AFR. Similarly, such changes were also
seen for the number of immunoreactive perikarya. Furthermore, in HMS180 rats a
clear sex-specific effect of acute stress on the sensitivity of the stress response had
taken place, because the amount of stored Ucn1 was higher in stressed males and lower
in stressed females than in non-stressed males and females, respectively.
As the changed amounts of stored Ucn1 do not indicate if neurons have
become activated or inactivated but just show a changed ratio between production
and release of immunostainable product, we assessed neuronal activity by counting
the number Ucn1-containing neurons that were c-Fos-positive. This number not only
revealed strong responses to stress in both AFR and MS rats but also demonstrated,
in both sexes, a robust decrease in the strength of the stress-induced recruitment of
Ucn1 perikarya in HMS180 compared to HMS15, showing that prolonged MS reduces
the activity and dampens the stress response of the npEW-Ucn1 system.
A remarkable finding is that male HMS15 showed an even stronger stress
response than female HMS15, again revealing the sex-specific capacity of the npEW
to react to stressful stimuli (see also Haeger et al., 2006; Derks et al., 2007; Kozicz,
2007). The increased c-Fos content of Ucn1 neurons upon acute stress in male
HMS15 correlated with a lower CORT titer. Previous studies are in line with this
observation, showing that male rats with a history of 15 min MS have a lower
HPA-axis activity than control rats. This difference has been explained in a
physiological way as the result of adaptive effect of 15 min MS on stress reactivity,
as in nature the dam leaves the pups for short time periods for food acquisition
(Meaney et al., 1996; Ladd et al., 2000).
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BDNF
Our immunocytochemical double and triple labeling studies demonstrate that in
rat npEW neurons BDNF coexists with Ucn1. Moreover, we have found that MS
clearly influences the amount of npEW BDNF contents, because HMS180 and
HMS15 revealed a higher SSD of BDNF-ir than AFR. It is well established that
BDNF can substantially stimulate neuronal differentiation, survival and plasticity
(for reviews see Branchi et al., 2004; Lipsky and Marini, 2007; Bekinschtein et al.,
2008) and that stress-induced neuronal atrophy and cell loss can be accompanied
by reduced BDNF mRNA expression (for review see Martinowich et al., 2007).
Therefore, we suggest that the high BDNF content of the npEW in MS rats reflects
stimulated BDNF action to promote the survival and activity of npEW targets,
such as the DR and LS (see also below). Such an action would differentiate BDNF
from Ucn1, as the latter messenger is assumed to play a role specifically in stress
adaptation, which may explain why Ucn1 and BDNF clearly differed in their
reactions to MS and to acute stress. These different responses of Ucn1 and BDNF
also imply that the Ucn1- and BDNF-containing cells possess a mechanism for
differential release of these messengers, but the nature of this mechanism remains
to be investigated.
Relation between npEW and HPA-axis
Although a study of the various components of the HPA-axis in relation to MS and
stress is beyond the scope of this investigation, the determination of CORT titers
in the various experimental groups supports our hypothesis that the npEW nucleus
and HPA-axis differ from each other not only in their responses to various acute
and chronic stressors in the adult animal, as was shown before (Kozicz, 2007) but
also to MS. Assuming that the CORT titer reflects reasonably well the activity of
the HPA-axis, we can conclude that this activity is not paralleled by that of the
npEW because, in contrast to the number of c-Fos-ir Ucn1-containing cells, the
CORT titer is not blunted in male HMS180 and does not reveal a maximum in
male HMS15. On the other hand, in AFR both systems reveal similar responses to
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acute stress, which adds to previous evidence that the HPA-axis and the npEW
system, although being anatomically distinct, represent two functionally coupled
systems that react in parallel to acute stressors while acting in opposite ways upon
chronic challenges. Interestingly, however, while in HMS180 the HPA stress
response, as appears from the CORT titer, was only damped in females, the npEW
response to stress was blunted in both sexes. This finding may suggest that especially
in females, long-term MS causes a disruption in the relation between the HPA-axis
and the npEW, which may help to explain the well-known sex-dependency of the
occurrence stress-related mood disorders (Desai and Jann, 2000; Gorman, 2006;
Goldstein and Gruenberg, 2007). In support of this notion, we recently reported
sex differences in Ucn1 mRNA expression in the npEW of depressed suicidal victims
(Kozicz et al., 2008).
Possible sites of action of Ucn1 and BDNF
Although the targets of the npEW are not fully known, there is enough evidence to
assume that the nucleus innervates a number of stress-involved brain centers such
as the DR and the LS. Most likely, Ucn1 and BDNF are both released from npEW
efferents into the DR (Bachtell et al., 2003b; Turek and Ryabinin, 2005a,b). Ucn1
could influence DR serotonergic neurons via their CRF1 and CRF2 receptors, which
are known to be Ucn1-sensitive (Van Pett et al., 2000) whereas BDNF could act
via the DR TrkB and p75 receptors of BDNF (Yamuy et al., 2000; Madhav et al.,
2001). As to the LS, strong innervation by a dense Ucn1-ir fiber network was
shown by Bittencourt et al. (1999) and Ryabinin and Weitemier (2006), indicating
its sensitivity for Ucn1 regulation, which might take place via CRF2, because
infusion of the selective CRF2 agonist urocortin 2 into the LS leads to increased
anxiety (Henry et al., 2006). Furthermore, the LS may be innervated by BDNF-
containing nerve fibers as well (Conner et al., 1997).
The sensitivity of the DR-serotonin system for MS has been shown
convincingly, as Lee et al. (2007) reported decreased hippocampal serotonin content
and low serotonin reuptake transporter mRNA expression in the DR of MS rats,
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and Gartside et al. (2003) found that MS reduces the sensitivity of alpha1
adrenoceptors on serotoninergic neurons in the DR. It will be of great interest to
see if the Ucn1- and BDNF-containing neurons of the npEW exert, at least in part,
their MS-related actions via the DR and LS.
Stress-sensitive neurons in the npEW without Ucn1 and BDNF
Neurons in the npEW that lack Ucn1- and BDNF-ir may produce these peptides in
an amount that is below the sensitivity of our immunocytochemical technique.
However, our observation that they react in quite a different way than do the npEW
Ucn1/BDNF neurons, suggests that they are of a different type and function and
produce one or more other types of neurochemical messenger. They may be involved
in the sex-dependent stress response, but they are not sensitive to the blunting
effects of long-term MS. In this respect it is noteworthy that the npEW contains, in
addition to Ucn1 and BDNF, peptides and mRNAs of which the dynamics are
influenced by several stressors. For instance, CART, CCK, the neuropeptides B
and W, and nesfatin-1 have been shown in the rat npEW (Maciewicz et al., 1984;
Brischoux et al., 2002; Singh and Davenport, 2006; Brailoiu et al., 2007). Although
these messengers show co-existence with Ucn1 (Kozicz et al., 2003; and L.T.
Kozicz, unpubl. res.) the possibility that they also occur in non-Ucn1-containing
neurons deserves further investigation.
Conclusions
The rat npEW harbors a large population of neurons that contain both Ucn1 and
BDNF. These messengers show dynamic activity changes upon acute stress, which
are modulated by MS history in a sex-dependent manner, and which differ in a
number of aspects from MS- and acute stress-induced activity changes in HPA-
axis activity, as judged from plasma CORT levels. On the basis of our present data
we propose that MS exerts its negative effects on mood in adult life by acting not
only on the HPA-axis but also on the npEW. We furthermore suggest that npEW
Ucn1-neurons exert their action by regulating other brain centers involved in the
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pathogenesis of mood disorders such as the DR and the LS, possibly involving
BDNF. Our data may be helpful in understanding the sex-dependent pathogenesis
of stress-induced brain diseases such as major depression.
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Abstract
Central stress regulatory pathways utilize various neurotransmitters/neuropeptides,
such as urocortin (Ucn) and catecholamines. Ucn is most abundantly expressed in
Edinger-Westphal nucleus (EW), co-distributed with catecholaminergic terminals.
Acute stress recruits EW neurons, and ascending catecholaminergic pathways also
contribute to the activation of various brain areas in response to stress. We
hypothesized that catecholamine and Ucn interactions in the EW mediated the
recruitment of these neurons in response to stress. Using double-labeling
immunohistochemistry, we found close appositions between Ucn-ir nervous
structures and dopaminergic terminals, but depleting these terminals had no effect
on the activation pattern of EW neurons upon acute immune challenge. From these
results we conclude that dopaminergic terminals innervating EW-Ucn neurons do
not play a major role in mediating the responses of EW neurons upon acute immune
challenge.
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Introduction
Stress is a nonspecific response of the body to any external or internal challenges
that leads to secretion of corticotropin-releasing factor (CRF) a hypophysiotropic
peptide that is a major regulator of the hypothalamo-pituitary-adrenal (HPA) axis
(for review see Chadwick et al., 1993) Monoaminergic neuron populations are
also major contributors to central regulation of stress adaptation, and may contribute
to an increased activation of immediate early genes, like c-fos, in brain areas
responsible for modulation/regulation of stress response (Senba and Ueyama, 1997)
Urocortin (Ucn; Vaughan et al., 1995), a member of the CRF peptide family,
also contributes to the physiology of stress. Although evidence has been accumulated
suggesting that central actions of Ucn may account for some stress-related affects
originally attributed to CRF (Spina et al., 1996; Skelton et al., 2000), the
understanding of the role(s) of Ucn is largely elusive.
Intriguingly, the most dominant site of Ucn-immunoreactivity (ir) in the
rat brain is the EW (Kozicz et al., 1998; Yamamoto et al., 1998; Bittencourt et al.,
1999), a compact, cholinergic brain structure primarily involved in oculomotor
adaptation (Westphal, 1887; Burde and Williams, 1989). However, the complexity
of ascending and descending projections between the EW and non-oculomotor
brain areas (Loewy et al., 1978; Sugimoto et al., 1982; Bittencourt et al., 1999),
suggests that this nucleus is involved in the control of other important biological
functions as well.
Acute pain stress results in the activation of Ucn-ir neurons in the EW,
peaking at 2-4 hours after the stress challenge, suggesting that the EW maintains
activation upon painful stimuli (Kozicz et al., 2001b). In concert with these results,
Weninger et al. (2000) observed a similar activation following immobilization stress.
The aims of the present study were to test whether stress-induced activation
of EW-neurons is mediated by ascending catecholaminergic terminals that are co-
distributed with EW –Ucn perikarya.
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Materials and methods
Albino, Wistar-R Amsterdam male rats, weighing 225-250 g at the time of arrival
were housed in standard plastic cages (40x25x20 cm), in a temperature- and
humidity-controlled environment. Rats were maintained on a 12-hour light/12-
hour dark cycle (lights on: 6:00 A.M.) and were allowed ad libitum access to tap
water and rodent chow throughout the experiment. Animals were acclimatized to
these housing conditions for one week before any experimental manipulation. All
procedures were conducted in accordance with the animal use guidelines approved
by the Pécs University, Medical Faculty Advisory Committee for Animal Resources.
Four rats received, through an indwelling endogenous jugular catheter
(implanted under halothane anesthesia 3 days before the challenge) 100 µg/kg
body weight lipopolysaccharide (LPS; E. coli, serotype 055:B5; Sigma Chemical
Co., Germany) intravenously (i.v.) in 300 µl pyrogen-free saline 2 hours prior
sacrificing the animals. The control animals (n=4) received 300 µl physiological
saline (non-pyrogenic) i.v.
In order to deplete catecholaminergic axon terminals 300 µg 6-
hydroxydopamine hydrobromide (solved in 2 µl physiological saline containing
0.4% ascorbic acid; H-8523, Sigma) was injected intracerebroventricularly (n=4/
group) three days prior to the stressor.
For fixation the animals were deeply anaesthetized with nembutal (Sanofi,
Budapest, Hungary; 100 mg/kg body weight), and transcardially perfused with 50
ml of 0.1 M sodium phosphate-buffered saline (PBS; pH: 7.4), followed by 250 ml
of 4% ice-cold paraformaldehyde solution. Coronal sections of the forebrain were
cut at 25 µm using a Lancer Vibratome (Ted Pella, CA, USA). After 4x15 min
washes in PBS containing 0.1% Triton X-100 (Sigma), incubation followed in 5%
normal goat serum (for Ucn, Fos and dopamine-beta-hydroxylase
immunohistochemistry) or 5% normal horse serum (for tyrosine hydroxylase-TH
immunohistochemistry). The monoclonal (mouse) anti-TH (Cat. nr. 22941)
antiserum (to detect dopaminergic terminals) and the polyclonal (rabbit) anti-
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dopamine-beta-hydroxylase (DBH; Cat. nr. 22806) antiserum (to detect
noradrenergic terminals) were purchased from Diasorin (Stillwater, MN, USA).
The TH antiserum was used at a dilution of 1:10,000, whereas the DBH antiserum
was diluted to 1:4,000. The polyclonal (rabbit) anti c-Fos antiserum (Cat No: sc-
52; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was used at a dilution
of 1:500. The sections were first incubated for 48 hours in the primary TH (for
Ucn-TH double labeling), DBH (for Ucn-DBH double labeling) or Fos (for Ucn-
Fos double labeling) antisera at 4 oC. The Vector ABC Elite Kits (Vector Labs,
Burlingame, CA, USA) was used to detect the immunoreaction. For the development
of immunostaining, 10 mg 3-3'-diaminobenzidine (D 5637; Sigma) in 50 ml Tris
buffer (pH: 7.6) was used for approximately 10 min. After a silver-gold
intensification, as described by Merchenthaler (1989), the sections were incubated
in a solution containing the polyclonal (rabbit) Ucn antiserum (PBL5779, a generous
gift from Dr W.W. Vale, The Salk Institute, La Jolla, CA, USA), which was used at
a dilution of 1:5,000. The incubation time was 48 hours at 4 oC. The Ucn-ir was
detected using the ABC technique with the DAB chromogen, as described above.
Selected double-stained sections were further processed for semithin sectioning as
described in our previous studies (Kozicz, 2001; Kozicz and Arimura, 2001).
The effectiveness of 6-OHDA treatment was evaluated by TH-immunolabeling.
Three series of sections were made from all animals. One for Fos-labeling, one for
Ucn-Fos double labeling, and the last series were used for TH-immunolabeling.
Animals with non-complete depletion of catecholaminergic terminals were removed
from the experimental groups.
Specificity of the Ucn antiserum for immunohistochemistry has previously
been reported (Bittencourt et al., 1999). Furthermore, if the primary antisera (Ucn,
Fos and TH) were omitted or replaced by non-immune mouse or rabbit sera at a
dilution of primary antisera no immunoreaction was observed.
Differences in the relative amounts of Fos-expressing cells were estimated
by simple cell counting. Counts of DAB-stained nuclei (Fos) or neurons (Ucn)
were made at the midlevel of the EW (Bregma: -3.2 to -3.6 mm) in regularly spaced
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series of 10 sections per animal on the basis of Nissl-stained sections. Since the
formula of Floderus (1944) yielded a correction factor of 0.965, no mathematical
correction of counts for section thickness was applied.
Results and Discussion
Numerous Ucn-ir perikarya were found in the EW. Most of these neurons were
piriform, but multipolar neurons with visible primary and secondary dendritic
ramifications were also observed (Fig. 1A-C). At the level of the EW nucleus in
the rat midbrain, several TH-ir perikarya were seen in the ventral tegmental area,
the rostral linear raphe nuclei and in the periaqueductal gray immediately
surrounding the cerebral aqueduct (Fig. 1A,C). Axons of these neurons could be
followed running vertically in the midline of the mesencephalon towards the Ucn-
cell population, giving collaterals to run among Ucn-neurons in the EW (Fig. 1A,C).
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Figure 1. Representative bright-field photomicrographs show the co-distribution of Ucn-neurons
and catecholaminergic terminals (A–C) and the effects of 6-OHDA treatment in the EW (D,E).
Double-labeling immunoperoxidase staining of the EW in panel A depicts the overlapping
distribution of catecholaminergic terminals (TH-ir; black) and Ucn-perikarya (light gray) in this
brain area. aq, cerebral aqueduct; E-WN, Edinger-Westphal nucleus; IHC, immunohistochemistry;
PG, periaqueductal gray. Scale bar: 50 µm. B,C: semithin sections from selected areas of the
EW. Arrows point to catecholaminergic terminals (black dots) juxtaposed to Ucn perikarya or
dendrites (light gray staining). The close proximity of TH-ir terminals to Ucn neuronal structures
suggests synaptic contact sites. Scale bar: 10 µm. Injection of 6-OHDA-depleted
catecholaminergic terminals in the EW (E) vs. non-injected rats (D). Scale bar: 50 µm.
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Several TH-ir axon terminals were detected near the Ucn-ir perikarya and
dendrites (Fig. 1A) suggesting synaptic contacts. Studying semi-thin sections, we
found TH-ir fibers juxtaposed to Ucn-cells and dendrites (Fig. 1B,C) in the EW.
This strongly suggested the existence of synaptic contacts between
catecholaminergic terminals and urocortinergic neuronal structures. To test whether
these terminals were dopaminergic or noradrenergic, we performed TH- and DBH-
immunolabeling combined with Ucn-immunohistochemistry. We found that
exclusively TH-ir terminals contacted Ucn-neurons, and only sparse DBH-ir
terminals were seen lateral to EW Ucn neuron population. This led us to assume
that dopaminergic terminals play a role in activating EW-Ucn neurons in response
to acute challenges. To test this, we depleted the dopaminergic terminals and
expected an abolished or strongly attenuated stress response in the EW. The injection
of 6-OHDA into the lateral ventricle destroyed indeed catecholaminergic terminals
in the EW (Fig 1D vs. 1E). Contrary to our expectations, however, no attenuation
of the Fos-response was observed in the Ucn-neurons in the EW following LPS
stress when compared to stressed, non-injected control animals (Fig. 2A,C vs. 2B,D).
In LPS-challenged rats an average of 25±4 Fos-ir nuclei per section were counted,
whereas in 6-OHDA treated-animals 23±3 Fos-ir nuclei were seen, a difference
that was not statistically different. In animals treated with 6-OHDA but not subjected
to acute immune challenge, no induction of Fos was seen in the EW.
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Figure 2. Acute immune challenge (LPS) results in a large increase in Fos-ir in the EW (A)
and in Ucn neurons (C), but 6-OHDA treatment did not effect the activation pattern of EW
Ucn neurons 2 h after LPS-induced stress (B,D). aq, cerebral aqueduct; E-WN, Edinger-
Westphal nucleus; PG, periaqueductal gray. Scale bars: 25 µm in A; 10 µm B-G.
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Catecholaminergic neuron populations have been implicated as major contributors
to the neurochemically mediated central regulation of stress response. Senba and
Ueyama (1997) suggested that ascending catecholaminergic pathways contribute
to an increased activation of immediate early genes. This can result in a consecutive
neuronal activation of the EW. However, our study failed to prove this hypothesis.
In concert with our data, Bachtell et al. (2002a) also concluded that dopamine did
not produce Fos-induction in EW.
However, it should also be noted that depletion of catecholaminergic
terminals affects noradrenergic mechanisms too. EW neurons are under the tonic
inhibitory control of on α2-adrenoceptors (Verbanck et al., 1991). In our
experimental model, however, no noradrenergic terminals were seen around Ucn-
neurons and, furthermore, no augmentation of Fos-ir was seen following acute
stress, indicating the tonic inhibitory control of noradrenalin on EW urocortinergic
neurons.
In summary, we have demonstrated that stress-induced activation of EW-
Ucn neurons is independent from catecholamine neurotransmission, since depletion
of catecholaminergic terminals did not abolish or augment stress-induced activation
of EW Ucn neurons. Therefore, ascending dopaminergic pathways may not be
major contributors to EW neuronal activation in response to acute immune
challenge.
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Chapter 5
Neuropeptide Y Activates Urocortin 1 Neurons in the
Non-Preganglionic Edinger-Westphal Nucleus
Balázs Gaszner, Anikó Korosi , Miklós Palkovits,
Eric W. Roubos and Tamás Kozicz
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Abstract
Central regulatory pathways promoting stress adaptation utilize various
neurotransmitters/neuropeptides, such as urocortin 1 (Ucn1) and neuropeptide Y
(NPY). Ucn1 is abundantly expressed in the non-preganglionic Edinger-Westphal
nucleus (npEW), where it is co-distributed with neuropeptide Y (NPY)-
immunoreactive (ir) terminals. A special role for both neuropeptides has been
postulated in stress adaptation. Using double-labeling immunohistochemistry, we
observed close appositions between NPY-ir terminals and neurons immunoreactive
for Ucn1 in the rat, as well as in the human npEW. Therefore, we hypothesized that
NPY might control the activity of Ucn1-positive neurons in the npEW. To test this
hypothesis, NPY was injected into the lateral cerebral ventricle of rats resulted in
a strong activation of npEW-Ucn1 neurons as revealed by Fos-
immunohistochemistry. Ucn1 mRNA was also up-regulated in the npEW, 2 hours
after the injection of NPY. In search for the type of NPY receptor that mediates this
NPY-induced recruitment of npEW-Ucn1 cells, we found that the great majority of
Ucn1 cells exhibited NPY Y5 receptor immunoreactivity, and only a few of the
Ucn1 cells co-expressed the Y1 receptor. We concluded that NPY, via Y5 and to a
lesser extent via Y1 receptors exerts a stimulatory action on Ucn1-cells in the
npEW. Further studies are currently in progress to elucidate the significance of
this NPY-Ucn1 interaction in the npEW.
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Introduction
In the mammalian brain, the most abundant expression of urocortin1 (Ucn1) has
been reported in neurons located in the Edinger-Westphal nucleus (EW) (Kozicz et
al., 1998; Bittencourt et al., 1999; Iino et al., 1999; Ryabinin et al., 2005; Weitemier
et al., 2005). The EW is classically known as a cholinergic, preganglionic
parasympathetic nucleus projecting to the ciliary ganglion. However, evidence has
accumulated that the structure and the function of the EW are more complex then
originally thought, and the existence of anatomically and functionally distinct neuron
population within the EW has been postulated (Saper et al., 1976; Burde et al., 1982;
Vasconcelos et al., 2003; Ryabinin et al., 2005; Laursen and Reckling, 2006; L.T.
Kozicz et al., unpubl. res.). This issue, though, was established between 1976 and
1982, but not by papers on Ucn1 published in 1998 and thereafter. Therefore, to
distinguish EW cells that are positive for Ucn1 but do not innervate the ciliary ganglion
from those that exhibit choline acetyltransferase-immunopositivity and do project to
the ciliary ganglion, the terminology of non-preganglionic Edinger-Westphal nucleus
(npEW) has been introduced (Ryabinin et al., 2005; Weitemier et al., 2005).
Ucn1 exerts stress-related effects originally attributed to corticotropin-
releasing factor (CRF) (Spina et al., 1996; Skelton et al., 2000). Indeed, besides
CRF-containing neurons in the hypothalamic paraventricular nucleus (PVN), npEW-
Ucn1 neurons are recruited by various acute stressors (Kozicz et al., 2001b; Gaszner
et al., 2004), and Ucn1 mRNA expression is up-regulated by acute pain and restraint
stress (Weninger et al., 1999; Kozicz et al., 2001b). In addition, these neurons are
sensitive to alcohol as shown in a variety of ethanol consumption experimental
paradigms (Bachtell et al., 2002a,b; Bachtell et al., 2003b; Ryabinin et al., 2002,
Ryabinin and Weitemier 2006). Furthermore, administration of Ucn1 directly into
the central nervous system (CNS) suppresses food intake (Spina et al., 1996),
modulates gastric motility (Kihara et al., 2001) and increases locomotion (Skelton
et al, 2000). Ucn1 involvement in anxiety-related behaviors has also been postulated
(Moreau et al., 1997; Slawecki, 1999; Vetter et al., 2002).
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As to the control of states of anxiety, neuropeptide Y (NPY) has also
attracted considerable attention (Thorsell et al., 2000; Kask et al., 2002). CNS
administration of NPY reduces anxiety in various animal species (Heilig et al.,
1989; Sajdyk et al., 1999) and has an antidepressant-like effect during a forced
swim test in rats (Stogner and Holmes, 2000). Reduced anxiety has also been
observed in rat over-expressing NPY (Thorsell et al., 2000). In addition, in animals
exposed to stress, NPY expression undergoes profound changes, similar to those
of npEW-Ucn1 expression (Thorsell et al., 1998, 1999).
So far, five NPY receptor subtypes have been cloned and designated as Y1,
Y2, Y4, Y5, y6) (Michel et al., 1998; Redrobe et al., 2002). The actions of NPY are
mediated by these rather divergent, G protein-coupled receptors (Redrobe et al., 2002).
Among them, the Y1 and Y5 receptors have received special attention for their
modulatory action in the control of anxiety behavior, because under stressful conditions
both receptors has been reported to produce an anxiolytic-like effect in rats (Heilig et
al., 1993; Wahlestedt et al., 1993; Broqua et al., 1995; Kask et al., 2001; Thorsell and
Heilig, 2002; Sajdyk et al., 2002), although the hypothesis that the NPY receptor Y5
contributes to the anxiolytic-like activity of NPY has to be further tested (Kask et al.,
2001). The Y1 and Y5 receptors occur abundantly in various brain nuclei, including in
the npEW (Dumont et al., 1996; Gerald et al., 1996; Grove et al., 2000; Wolak et al.,
2003). Similarly, NPY and Ucn1-ir neuronal structures have also been reported in this
nucleus (Yamazoe et al., 1985; Smith et al., 1994; Kozicz et al., 1998; Bittencourt et al.,
1999). On the basis of these observations, we hypothesized that NPY might influence
the activity of npEW-Ucn1 neurons via NPY Y1 and/or Y5 receptors. This hypothesis
predicts that endogenous NPY is released in the npEW and consequently, it modulates
their Ucn1 mRNA expression. To test this hypothesis, three experiments have been
performed. First, we studied whether NPY-ir terminals contact Ucn1 neurons in the rat
npEW, second, we identified the NPY Y receptor(s) expressed by these neurons, and
third, we surveyed the effect of intracerebroventricularly (i.c.v.) injected NPY on Ucn1
mRNA expression in the npEW. Finally, to test our hypothesis in the human brain, the
presence of NPY fibers and their possible contacts with Ucn1 neurons have been
investigated in human brain samples.
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Materials and methods
Human brain samples
Brains from three males of 64, 74 and 84 years of age, who died suddenly from
causes unrelated to any diagnosed brain diseases, were obtained from autopsy, 1.5
hrs after death at the Department of Forensic Medicine of the Semmelweis
University Medical School, Budapest, Hungary. Brains were frozen on dry ice and
stored at -80°C.
Animals
In total, 20 male Wistar-R Amsterdam rats, weighing 225-250 g at the time of
arrival, were housed in standard plastic cage (40x25x20 cm; 4 animals/ cage), in a
temperature- and humidity-controlled environment. They were kept on a 12-h light/
12-h dark cycle (lights on 6:00 AM), and were allowed to access to tap water and
rodent chow throughout the experiment ad libitum. Animals were acclimatized to
these conditions for one week before the experiments. Under ketamine/xylazine/
acepromazine anesthesia (25:5:1 mg/kg, s.c.), all animals were stereotaxically
implanted with a 26 ga guide canula terminated in the right lateral ventricle, at
least 7 days before experimentation. During the recovery period, rats were handled
twice a day and mock-injected to acclimatize them to the injection procedure.
Between 11:00 and 12:00 AM on the day of testing, a 33 ga injector was inserted
through the guide canula, and synthetic porcine NPY (Sigma-Aldrich, The
Netherlands; N3266), dissolved in physiological saline (vehicle) was injected over
~1 min. Then, animals were returned to their home cages until decapitation. To
minimize the number of animals used and their suffering, all procedures were
conducted in accordance with the Declaration of Helsinki and the animal use
guidelines approved by the Medical Faculty Advisory Committee for Animal
Resources of Pécs University, based on the Law of 1998, XXVIII, for Animal Care
and Use in Hungary.
94
Procedures
To assess the dose-relationship of NPY-induced Fos-immunoreactivity (ir), a reliable
morphological tool of demonstrating neuronal activation (Bullitt, 1990; Chan et
al., 1993; Cullinan et al., 1995), 5 animals per group received a single injection of
0.1 or 1.0 µg synthetic NPY in 4 µl physiological saline, or physiological saline
alone (‘controls’). The animals were sacrificed 2 h later by perfusion having an
optimal period of time when the maximal Fos-ir response was expected.
Fixation
Under deep anesthesia with nembutal (100 mg/kg body weight; Sanofi-Synthélabo,
Maassluis, The Netherlands), rats were perfused transcardially with 50 ml 0.1 M
sodium phosphate-buffered saline (PBS; pH 7.4), followed by 250 ml of 4% ice-
cold paraformaldehyde in PBS. After removal, the brains were kept in the same
fixative solution for additional 4 hrs.
Sectioning of the brain
Coronal slices (30 µm thick) of human midbrain at the level of the superior colliculus
were cut on a freezing microtome (Microm GmBH, Walldorf, Germany) and slide-
mounted. Through the midbrain of rats (between 5.0 to 7.0 mm caudal to the level
of the Bregma; see Paxinos and Franklin, 2001), 25 µm thick coronal sections
were cut with a Lancer Vibratome (Ted Pella, Redding, CA, USA). To assure the
similar treatment of all brains in all experimental groups, all of the subsequent
staining procedures were carried out simultaneously.
Double immunocytochemistry
After 4x15 min rinses in 0.1 M PBS, 0.1% Triton X-100 (Sigma-Aldrich) in PBS
was applied for 10 min, to enhance antigen penetration. After additional 4x15 min
rinses in PBS, sections were incubated for 1 h in 5% normal goat serum (005-000-
121; Jackson Immunoresearch Labs, West Grove, PA, USA) in PBS, to block non-
specific binding sites. All steps were carried out at room temperature (RT), under
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continuous, gentle agitation. After a brief rinse in PBS, sections were incubated in
polyclonal (rabbit) c-Fos antiserum (1:400; sc-52; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) for 48 h at 4oC, followed by 4x15 min rinses in PBS, and incubation
in secondary anti-rabbit (Vector ABC Elite Kit; PK-6101; Vector Labs, Burlingame,
CA, USA) for 1h at RT. After a 3x15 min rinses in PBS, sections were incubated in
ABC reagent supplied with the ABC Elite Kits (Vector Labs) for 1 h at RT.
Immunostaining was visualized by 10 mg 3-3'-diaminobenzidine (DAB; D 5637;
Sigma-Aldrich) in 50 ml Tris buffer (pH 7.6), for about 10 min; the reaction was
controlled under a stereomicroscope, and stopped in Tris buffer. After several rinses
in PBS, sections were processed for silver-gold intensification. After rinsing in 5%
thioglycolic acid (Sigma-Aldrich) for 1 h to block non-specific tissue argyrophilia,
thioglycolic acid residues were removed by 4x15 min rinses in 2% sodium acetate.
Then, sections were physically developed by monitoring under a microscope for
about 10 min (Merchenthaler et al., 1989). After stopping silver development in
1% acetic acid for 1 min, sections were rinsed in 2% sodium acetate for 10 min,
followed by gold toning in 0.05% gold chloride (Sigma-Aldrich) in 2% acetic acid
on ice, for 10 min. The reaction was stopped by a rinse in 2% sodium acetate, for
10 min. Following a 10 min wash in 3% sodium thiosulphate (Sigma-Aldrich) and
rinse in 2% sodium acetate in PBS, sections were incubated in polyclonal (rabbit)
urocortin 1 antiserum (1:5,000; PBL5779, gift from Dr W.W. Vale, The Salk
Institute, La Jolla, CA, USA), for 48 h at 4oC. Ucn1-ir was visualized using the
ABC technique with DAB as chromogen, as described above. Sections were studied
with a Nikon Microphot FXA microscope equipped with a Spot RT Color digital
camera (Nikon, Tokyo, Japan).
Embedding for epoxy resin sectioning
Areas of interest from selected npEW sections were cut with a surgical blade under
a light microscope. The blocks were placed in 1% osmium tetroxide in PBS, for 1
h. To remove osmium residues, blocks were washed twice in PBS, and dehydrated
in a graded alcohol series (30, 50, 70, 90, 96, 2 x absolute alcohol), 10 min per
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step. Then blocks were immersed in a mixture of epoxy resin (Eponate 12™ Kit;
Ted Pella, Redding, CA, USA) and absolute alcohol (2:1) and subsequently in
pure epoxy resin for 16 h at RT. Blocks were flat-embedded between two plastic
coverslips in epoxy resin, which was polymerized for 24 h at 56 oC. Then, one of
the plastic slips was removed, and a resin-filled gelatin capsule was placed over
the block. After 48 h at 56 oC, the other plastic slip was removed, and 1 µm sections
were cut and a Sorvall ultramicrotome. These semi-thin sections were studied under
a Nikon Microphot FXA light microscope (Nikon, Tokyo, Japan).
Double immunofluorescence labeling
Using a Vibratome (Ted Pella) 25 µm thick coronal sections were cut, collected in
PBS, and processed as free-floating immunocytochemistry. After 4x15 min rinses
in PBS and incubation in 0.5% Triton X-100 (Sigma-Aldrich) in PBS for 30 min,
sections were incubated in 5% normal donkey serum (017-000-121; Jackson
Immunoresearch Labs) in PBS, for 1 h, and incubated in a mixture of primary
antisera, for 48h at 4 oC. The following sera were used: (1) polyclonal (goat) anti-
urocortin 1 at 1:100 (R-20: sc-1825; Santa Cruz); (2) polyclonal (rabbit) anti NPY
Y1 antiserum at 1:1,000 (gift from J.H. Urban, Chicago Medical School, North
Chicago, Il, USA); (3) polyclonal (rabbit) anti-NPY Y5 antisera at 1:5,000 (gift
from K.L. Grove, Oregon Health Sciences University, Beaverton, OR, USA) and
at 1: 200 (gift from J.H. Urban, Chicago Medical School, North Chicago, Illinois,
USA). After incubation, sections were washed for 10 min in 5% normal donkey
serum followed by several rinses in PBS. A secondary antiserum cocktail (Cy2
conjugated anti-goat IgG, 1:50, and Cy3 conjugated anti-rabbit IgG, 1:100) was
applied for 3 h. Both secondary antisera were obtained from Jackson
Immunoresearch Labs. Following several rinses in PBS, sections were mounted
on glass slides, coverslipped in antifade Vectashield (Vector Labs, Burlingham,
CA, USA), and studied with a Leica DMRBE microscope connected to a Leica
DC 500 digital camera (Leica Microsystems, Wetzlar, Germany).
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Antiserum characterization
The Ucn1 antiserum was generated against the whole rat Ucn1 peptide (amino
acids 1-40; for details see Turnbull et al. (1999). The NPY-Y1 antiserum was raised
against the C-terminal peptide consisting of amino acids 363-382 of the NPY-Y1
receptor; LKQASPVAFKKISMNDNEKI (for details see Wolak et al., 2003). We
used two different NPY-Y5 antisera in this study. One was generated against the
extracellular loop 3 and parts of transmembrane domains VI/VII of the rat NPY Y5
receptor; VTDFNDNLISNRHFKLVYCIC representing amino acids 400-420 (for
details see Wolak et al., 2003). The other NPY-Y5 was raised against the third
intracellular loop of the rat NPY-Y5 receptor; EVKPEESSDAHEMR (for details
see Grove et al., 2000). The polyclonal (rabbit) anti c-Fos antiserum was generated
against the epitope corresponding to residues 3-16 of the protein encoded by human
c-fos. The high specificity of all antisera was controlled by preadsorption with the
synthetic peptides (0.1 and 1.0 µg/ml diluted antiserum) used to generate the
respective antisera. Preadsorption with 0.1 µg synthetic peptide completely
abolished immunoreactivity in the rat npEW in all cases. In addition, the specificity
of the Fos, Ucn1, NPY-Y1 and Y5 antisera were also verified previously by
preadsorption and Western analysis (for details see Bittencourt et al., 1999; Turnbull
et al., 1999; Grove et al., 2000; Wolak et al., 2003).
Radioactive in situ hybridization
Radioactive in situ hybridization was carried out using 33P-labeled antisense and
sense cRNA probes encoding for Ucn1 both in the rat and human npEW. The Ucn1
probe was synthesized from a full length 579 bp Ucn1 cDNA subcloned in
pBluescript-SK+ plasmid (Stratagene, La Jolla, CA, USA; a gift of Dr P.E.
Sawchenko, The Salk Institute). Paraformaldehyde-fixed human and rat midbrain
sections (see above) were mounted onto pretreated slides (Superfrost/Plus, Menzel-
Glazer, Braunschweig, Germany) and then incubated in 4% paraformaldehyde in
0.1 M borax buffer, for 30 min. After rinsing 5x3 min in PBS and drying in a
vacuum desiccator for 1 h, they were preincubated with 10 µg/ml proteinase K
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(25530; Invitrogen, Breda, The Netherlands), for 10 min at 37oC, dehydrated, and
dried again under vacuum, for 2 h. Probes were applied for hybridization at about 107
cpm/ml, for 16 h at 58 oC, in a solution containing 25 ml deionized formamide, 3 ml 5
M sodium chloride, 100 µl 0.5 M EDTA (pH 8.0), 1 ml 50x Denhardt’s solution, 10 ml
50% dextransulfate and 1.6 ml MQ water. Then, sections were treated with 10 µg/ml
ribonuclease A (Roche, Mannheim, Germany), for 30 min at 37 oC. Rinses in 2x, 1x
and 0.5x SSC containing 1 mM DTT were followed by rinsing in 0.1x SSC, for 30 min
at 65 oC. Sections were dehydrated, defatted in xylene, rinsed in absolute ethanol, air-
dried, coated with Kodak NTB-2 liquid autoradiographic emulsion (Interscience,
Markham, Ontario, Canada), and exposed in a desiccated, light-tight box, for 5 days at
4 oC. They were developed in Kodak D-19 (Sigma Chemical), for 3.5 min at 14 oC,
rinsed briefly in distilled water, fixed with Kodak fixer (Sigma Chemical), rinsed in
running tap water for 30 min, dehydrated, and coverslipped with Entellan.
Image analysis
Digital images were taken at a resolution of 1200x1600 dpi using a Leica DMRBE
optical system with a Leica DC 500 digital camera (Leica Microsystems) connected
to an IBM computer running Scion Image software (version 3.0b; NIH, Bethesda,
MR, USA). Per animal, the amount of Fos-protein in the npEW was estimated by
counting Fos-positive cell nuclei at the midlevel of the npEW (Bregma –5.3 to –
6.5 mm; see Paxinos and Franklin, 2001) in 4 serial sections interspaced by 75 µm.
Double-labeled neurons were only counted when both Fos nuclear labeling and
cytoplasmic Ucn1-staining were clearly visible. The in situ signal for Ucn1 mRNA
was only taken into account, when its silver grain density was >5 times the silver
grain density of the background (measured outside the npEW). The mathematical
correction factor for section thickness of cell counts according to (Floderus, 1944)
was nearly 1 (0.965) and therefore, no correction for sections thickness was applied.
In digital images of in situ hybridized sections the optical density (OD) of the
Ucn1 mRNA signal was determined and corrected for the silver grain density of
the background, as described above.
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Statistical analysis
Per experimental group, numbers of Fos-positive cells and the OD of Ucn1 mRNA
labeling were expressed as means ± standard error of the mean (SEM). Differences
between group mean values were tested for statistical significance by one-way
analysis of variance (ANOVA) followed by multiple comparisons of individual
groups with Tukey’s post hoc test (α=5%) using Statistica (StatSoft, Tulsa OK,
USA), after testing for normality (Shapiro-Wilk test; Shapiro et al., 1965) and for
homogeneity of variance (Bartlett’s Chi-square test; Snedecor and Cochran, 1989).
Digital imaging of illustrations
Digital images of sections were taken at 1200x1600 dpi using the software supplied
with the Leica DC 500 digital camera. They were imported into Adobe Photoshop
7.0, if necessary digitally adjusted as to gray levels as well as sharpness, and
assembled into plates at a resolution of 400 dpi.
Results
Distribution of Ucn1 and NPY in the human npEW
We first studied the distribution of Ucn1 and NPY in the human npEW. In situ
hybridization revealed a clear expression of Ucn1 mRNA (Fig. 1A,B). Several 20-
30 µm large, multipolar Ucn1-immunopositive neurons were also seen (Fig. 1C).
Immunocytochemistry revealed a dense network of varicose axons with strong
NPY-ir (Fig. 1D). Most of these fibers were located in the middle portion of the
npEW, whereas the rostral and caudal parts of the nucleus exhibited only sparse
NPY-ir. We distinguished two types of NPY-ir fibers. The first was thick, with
irregularly arranged large boutons, the second was much thinner, with long
intervaricose segments and small boutons (Fig. 1D).
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Figure 1. Distribution of Ucn1 and NPY-ir in the npEW of the human brain. A: Ucn1 mRNA
expression in the human npEW. B: high-power photomicrograph of the area marked in A,
depicting Ucn1 mRNA expressing neurons. C: Ucn1-ir cells in caudal npEW. D: NPY-ir
terminals in the midlevel of the npEW. Note the two types of NPY-ir fiber terminal, i.e., thick,
with irregularly arranged large boutons, and thin, with long intervaricose segments and small
boutons. aq, cerebral aqueduct; PAG, periaqueductal gray; npEW, nonpregang-lionic Edinger-
Westphal nucleus. Scale bars: 200 µm in A; 40 µm in B; 20 µm in C; 10 µm in D.
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NPY innervates Ucn1 neurons in the npEW
To determine whether NPY-ir fibers innervate Ucn1 neurons in the rat and human
npEW, we performed double-labeling immunocytochemistry.
The rat npEW: a large number of NPY-ir cells were present in the
periaqueductal gray area (PAG; Fig. 2A), and numerous Ucn1-ir cells were seen in
the npEW (Fig. 2A). In several cases, the axons of NPY-positive cells in the PAG
could be followed running ventrally towards the npEW, and formed terminal
networks in close proximity to Ucn1-ir cells (Fig. 2B). On semi-thin sections, several
NPY-positive boutons were observed in a close proximity to Ucn1-ir neurons (Figs.
2C,D), suggesting the presence of NPY synapses on these neurons. The double-
labeling immunofluorescence approach confirmed these findings (Fig. 2E,F).
The human npEW: double-labeling fluorescence immunocytochemistry showed
NPY fibers and boutons terminating in close proximity to Ucn1-ir perikarya (Fig.
2G), suggesting that NPY-containing fibers contact these neurons synaptically.
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Figure 2. Codistribution of Ucn1 and NPY in the npEW in the rat and the human brain. A: low-
magnification image of the rat midbrain at the level of the npEW depicting NPY-ir neurons in the
periaqueductal area and Ucn1 cells along the npEW midline. B: high-power photomicrograph of
the rat npEW showing several NPY-ir terminals in close proximity to Ucn1 perikarya. C:
photomicrograph of a representative semithin section from the rat npEW depicting NPY-ir fiber
terminals juxtaposed to Ucn1 cells. D: area encircled in C is enlarged. Note that several NPY-ir
boutons are juxtaposed to Ucn1 perikarya and dendrites, suggesting the presence of synaptic contacts
(arrows). E,F: double-immunofluorescence labeling showing Ucn1 neurons (red) innervated by
NPY-ir fiber terminals (green) in the rat npEW. G: an NPY-ir fiber (red) is in close apposition to a
Ucn1-cell body (green) in the human npEW. Scale bars = 50 µm in B,C,E-G; 10 µm in D.
103
Colocalization of Ucn1 and NPY Y receptor subtypes in rat npEW
To identify NPY receptor subtypes in the rat npEW, we tested the expression of
NPY Y1 and Y5 receptors. Double-labeling immunofluorescence revealed a large
number of Ucn1-ir neurons (Fig. 3A,D) that co-existed with many NPY Y5 receptor-
ir perikarya (Fig. 3B). The immunoreactivity was concentrated around the cell
nucleus; neither dendritic nor axonal labeling was seen (Fig. 3B). Merging images
of Ucn1-ir and NPY Y5 receptor-ir cell bodies revealed that the vast majority of
Ucn1-ir neurons were immunoreactive for NPY Y5 (Fig. 3C,G). Only few NPY
Y5-ir cells were observed without Ucn1-ir, but all of the Ucn1-neurons exhibited
NPY Y5-staining.
In contrast to the large number of NPY Y5-positive cells, only a few NPY
Y1-positive neurons were detected in the npEW (Fig. 3E). Approximately two-
third of these NPY Y1-positive neurons reveled Ucn1-ir (Figs. 3F and H), and one-
third was Ucn1-negative. Given the small number of NPY Y1-positive cells, only
a small proportion of npEW Ucn1-perikarya showed NPY Y1 receptor staining as
compared to staining for NPY Y5 receptor.
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Figure 3. Colocalization of Ucn1 and NPY receptor Y5 and Y1 in the rat npEW. A-C:
Ucn1-neurons (A) coexist with neurons expressing NPY Y5 receptor-ir. C: the merged
image of A,B reveals that the vast majority of Ucn1-ir neurons were immunoreactive for
NPY Y5 as well. Area encircled is enlarged in G. D-F: Ucn1-cells (D) coexist with NPY
receptor Y1 immunopositive cells (E) in the rat npEW. Image F depicts the merged image
of D,E (boxed area is enlarged in H). Note that a relatively small number of Ucn1-cells
exhibit NPY receptor Y1-ir as well (arrow). There are also a few neurons that only exhibit
NPY receptor Y1–ir (arrowhead). Scale bars = 50 µm in A-F; 20 µm in G,H.
105
The effects of intracerebroventricularly injected NPY on npEW-Ucn1 neurons
To test if NPY is controlling npEW-Ucn1 neuronal activity, 0.1 µg and 1.0 µg
synthetic NPY were injected in to the lateral ventricle and surveyed the effects on
npEW neuronal activity compared to rats injected with physiological saline
(controls).
NPY-induced recruitment of npEW neurons was assessed by Fos-
immunohistochemistry. In controls, 13.0±2.2 cell nuclei/section showed Fos-
labeling (Fig. 4A,E) while twice as many (25.2±2.4) Fos-ir nuclei/section were
seen two hours after injection of 0.1 µg synthetic NPY (Fig. 4B,F). Rats injected
with 1.0 µg synthetic NPY exhibited a similar number (25.5±1.5) of Fos nuclei/
section (Fig. 4C,G). ANOVA showed differences across the experimental groups
(F2,13=11.67; p<0.003), and subsequent analysis with Tukey’s test revealed that the
increased Fos-ir was statistically significant for both groups of NPY-injected rats
(P<0.01; Fig. 4D), whereas these groups did not differ from each other (P>0.05;
Fig. 4D).
In contrast to the strong increase in npEW-Fos nuclei after NPY injection,
the numbers of Ucn1-ir neurons were very similar between controls (28.7±1.6)
and after injecting with 0.1 µg NPY (29.7±0.4) or 1.0 µg NPY (27.8±0.6 Ucn1);
the groups did not differ significantly (F2, 13=0.78; p<0.49; Fig. H).
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Figure 4. Light microscopy photomicrographs showing expression pattern of Fos-ir and
the colocalization of Fos- and Ucn1-immunoreactivities in the rat npEW in the different
experimental groups. A-C: Fos expression in control animals (A), and in rats injected with
either 0.1 µg (B) or 1.0 µg (C) of synthetic NPY i.c.v. D: relative strength of Fos induction
in the npEW following i.c.v. injection of physiological saline (control) and various doses of
synthetic NPY. Bars represent the means ± SEM (n = 5 rats/group). The asterisks above the
bars represent significant difference vs. control (p<0.001). E-G: colocalization of Fos and
Ucn1 immunoreactivities in the rat npEW in control (E), injected with 0.1 µl (F), and 1.0 µl
(G) of NPY i.c.v. H: a number of Ucn1-ir neurons in the npEW. Bars represent the means ±
SEM (n = 5 rats/group). *p<0.001. I: histograms showing data expressed as percentages of
Ucn1-immunopositive cells expressing Fos in the npEW in the various experimental groups.
Bars represent the means ± SEM (n = 5 rats/group). *p<0.001. aq, cerebral aqueduct; mlf,
medial longitudinal fascicle; npEW, non-preganglionic Edinger-Westphal nucleus; PAG,
periaqueductal gray. Scale bars = 100 µm in A-G.
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Colocalization of Fos and Ucn1 in the npEW
To support our hypothesis that injection of synthetic NPY controls npEW-Ucn1
neurons, we tested if NPY injection-induced Ucn1 mRNA expression would be
concomitant with increased Fos-ir. For this purpose, we used the percentage ratio
of Ucn1-ir neurons exhibiting Fos-ir as a parameter. While only 25±6.4% of Ucn1
cells showed Fos-ir in controls (Fig. 4E), this percentage was as high as 71.3±1.5%
and 84.0±6.0% in rats injected with 0.1 µg and 1.0 µg synthetic NPY, respectively
(Fig. 4F,G). Statistical analysis showed a strong difference (F2, 13=36.72; p<0.0001;
Fig. 4I) across the experimental groups, and Tukey’s test demonstrated that both
concentrations of NPY strongly increased the ratio of Ucn1-cells expressing Fos
(p<0.001; Fig. 4I); no difference was seen between groups injected with synthetic
NPY (Fig. 4I).
Expression of Ucn1 mRNA in npEW in the experimental groups
To determine if the expression of Ucn1 mRNA in the npEW is influenced by NPY
administration, we performed quantitative in situ hybridization, which showed
strong differences between the experimental groups. The ANOVA revealed a strong
significance (F2,13=8.9; p<0.007; Fig. 5D) across the experimental groups, and
Tukey’s test demonstrated that both concentrations of NPY strongly increased the
amount of Ucn1 mRNA (injected: OD=19.1±3.7 after 0.1 µg NPY and 22.4±2.1
after 1.0 µg NPY, vs. 7.5±1.6 in control rats; p<0.001; Fig. 5A-D). The NPY injected
groups were not significantly different from each other (Fig. 5D; p>0.05). Finally,
we counted the number of Ucn1 mRNA-expressing neurons per section of the
npEW. The ANOVA (F2,13=3.93; p>0.059) showed that the number of Ucn1 mRNA-
expressing cells increased from 14.5±1.6 in controls to 21.0±2.5 in animals injected
with 0.1 µg NPY (Fig. 5E), and to 20.6±1.1 in rats injected with 1.0 µg NPY (Fig.
5E); the numbers of Ucn1 mRNA expressing cells was not different between the
NPY-treated groups.
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Figure 5. Representative darkfield photomicrographs showing expression patterns of Ucn1
mRNA in the npEW following i.c.v. injections of either physiological saline (A) or 0.1 µg
(B), or 1.0 µg (C) synthetic NPY. npEW, non-preganglionic Edinger-Westphal nucleus. D:
relative strength of Ucn1 mRNA expression in the npEW in the various experimental groups.
Bars represent the means ± SEM (n = 5 rats/group). The asterisks above the bars represent
significant difference vs. control (p<0.001). E: average number of Ucn1 mRNA-expressing
neurons in the npEW. Bars represent the means ± SEM (n = 5 rats/group). *p<0.001. Scale
bars = 50 µm in A-C.
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Discussion
In the last decade much attention has been devoted to the neuropathology of stress-
induced disorders, such as anxiety, alcohol abuse and depression. These disorders
originate from a wide diversity of genetic, environmental and neurobiological fac-
tors including various interacting neurotransmitter and neuropeptide systems. Ucn1
and NPY peptides are both implicated in the control of anxiety, depression and
drug abuse (Jones et al., 1998; Thiele et al., 1998; Thorsell et al., 1999, 2000;
Skelton et al., 2000; Heilig and Thorsell, 2002; Gysling et al., 2004; Kozicz et al.,
2004; Linden et al., 2004, 2006; Korosi et al., 2005). Therefore, in this study we
focused our attention to these neuropeptides and their interaction in the npEW.
The main new findings of this study can be summarized as follows: (1) like in the
rat, Ucn1-ir neurons as well as NPY-ir fibers are present in the human npEW; (2)
NPY axon terminals are juxtaposed to Ucn1-neurons in the human, as well as in
the rat npEW; (3) most of the Ucn1 cells co-express NPY Y5 receptor, and only a
few exhibit NPY Y1 receptor in the rat npEW; and finally (4) i.c.v. administering
synthetic NPY recruits Ucn1 neurons in the npEW, resulting in an increased ex-
pression of Ucn1 mRNA. As follows we will discuss these results, and the pos-
sible biological significance of the interaction of Ucn1 and NPY in the npEW.
Our data on the presence of NPY fiber terminals in the npEW, on the fact
that NPY terminals are juxtaposed to Ucn1 cell bodies in the npEW in both men
and rats, as well as on the stimulation of npEW-Ucn1 neurons by central NPY
administration that seems to be very similar in its dynamics to those seen upon
various acute challenges (Kozicz et al., 2001b; Gaszner et al., 2004) all point to the
possibility that locally released NPY can modulate the activity of Ucn1 cells, thereby
controlling the actions of Ucn1 in the brain. It is apparent that npEW-Ucn1 neurons
specifically respond to stress. They are recruited by various acute stressors (Kozicz
et al., 2001b; Gaszner et al., 2004), and show an increased mRNA expression in
response to acute restraint stress (Weninger et al., 1999; Kozicz et al., 2001b). In
contrast, these cells show a habituated stress response accompanied by a marked
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down-regulation of Ucn1 mRNA in repeatedly challenged mice (Korosi et al., 2005).
Such an opposing process organization would serve to adequately terminate the
stress responses, and protect against adverse consequences. This is suggestive for
a role of Ucn1 in anxiolysis. In support for this notion, Ucn1-null mice exhibit
increased anxiety-like behavior (Vetter et al., 2002). Similarly to the dynamics of
npEW-Ucn1 system in stress, NPY-containing neurons also show a bi-directional
stress response (for review see Heilig and Thorsell, 2002). Upon acute physical
restraint, which promotes experimental anxiety, NPY mRNA and peptide levels
are suppressed within the amygdala and cortex, whereas repeated exposure to the
same stressor is accompanied by up-regulation of NPY expression in the amygdala
(Thorsell et al., 1999). In addition, central administration of NPY causes anxiolysis
(Britton et al., 2000; Sorensen et al., 2004). Based on these evidences and the
herein presented results we suggest that anxiolysis may be an important function
of interactions between Ucn1 and NPY neuronal structures in the npEW. This may
offer a candidate neuronal circuitry that acts as an endogenous “alarm-system”,
and becomes active when the organism is faced with stressful challenges in order
to maintain “allostasis” (McEwen and Wingfield, 2003).
Besides a role of NPY in the control of anxiety-related behaviors (Heilig et
al., 1992, 1993), evidence suggests that NPY is also involved in the neurobiological
effects of ethanol (Thiele et al., 1998, 2000; Heilig and Thorsell, 2002). The lack of
NPY has been associated with high ethanol consumption in NPY-knockout mice,
whereas NPY over-expression has been linked with low ethanol consumption in
NPY-over-expressing mice (Thiele et al., 1998). However, little is known about the
central site, where NPY would act to control ethanol consumption. Based on the
present data, we hypothesize that interaction of NPY with Ucn1neurons in the npEW
might also control alcohol-dependence, both in human and rats. This notion is strongly
supported by experimental data on differences in Ucn1 expression in animals selected
for alcohol preference (Bachtell et al., 2003b; Murphy et al., 2006), and by results of
mapping immediate early gene expressions in alcohol-consuming mice (Bachtell et
al., 2002b). Furthermore, the high sensitivity of npEW-Ucn1 neurons to both voluntary
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and involuntary administration of alcohol points to the significance of npEW-Ucn1
cells in alcohol consumption (Weitemier et al., 2001; Ryabinin et al., 2002; Bachtell
et al., 2002a, 2003b, 2004; Ryabinin and Weitemier, 2006).
Meanwhile, the NPY receptor subtypes that could mediate the action of NPY
in the npEW had to be identified. In line with this effort we studied the NPY receptor
subtypes expressed by npEW-Ucn1 neurons and found that most of the Ucn1 cells
co-express NPY Y5 receptor, whereas only a minority of them contains NPY Y1
receptor. It is generally believed that NPY acts via its receptors as an inhibitory
neuromodulator (Silva et al., 2003; Fu et al., 2004; El Bahh et al., 2005; Brain et al.,
2006). Our results, however, are clearly in contrast to this notion, although the finding
of NPY as a stimulatory factor is not new. NPY modulates the secretion of various
hypothalamic neuropeptides, and plays a physiological role in the regulation of the
HPA axis (Small et al., 1997; Krysiak et al., 1999). At the level of the HPA-axis, NPY
exerts a direct stimulatory effect on both ACTH and CRF release (Suda et al., 1993)
and the central administration of NPY elevates hypothalamic CRF mRNA levels
(Tsagarakis et al., 1989) and increases CRF-ir (Haas et al., 1987). This stimulatory
effect is exerted directly on CRF neurons (Suda et al., 1993). Thus, it may be that the
stimulatory effect of NPY on npEW-Ucn1 neurons is brought about in a direct way,
where NPY interacts with Ucn1-containing neurons, and predominantly via NPY Y5
receptor may control the responses of this nucleus.
In conclusion, by showing that NPY innervates Ucn1 neurons in both the
rat and human npEW, this study proposes NPY as one of the possible modulators
for the action of Ucn1 in the brain. In support of this, central administration of
NPY indeed activated these neurons. Furthermore, the presence of NPY Y1 and
Y5 receptors in the rat npEW suggests that NPY acts via these receptors in the
npEW. However, given the more abundant distribution of NPY Y5 receptor, we
propose that the actions of NPY are predominantly mediated via the NPY Y5
receptor. Further studies on the relationship of Ucn1 and NPY in the npEW are
currently in progress in our laboratory in an attempt to elucidate the possible
contribution of this neuronal circuitry to adequate stress adaptation.
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Abstract
Period 2 (Per2) is an important clock gene involved in the regulation of the major
circadian clock in the mammalian central nervous system, the suprachiasmatic
nucleus. In addition, Per2 is expressed in many other stress-sensitive brain
structures. We have previously shown that the non-preganglionic Edinger-Westphal
nucleus (npEW) is the main site of the corticotropin-releasing factor peptide family
member urocortin 1 (Ucn1) and that this peptide undergoes conspicuous expression
changes in response to various stressors. Here we hypothesized that in the rat
npEW both Per2 and Ucn1 would be produced in a diurnal, rhythmical fashion.
This hypothesis was tested by following this expected rhythm for two days in rats
sacrificed at four time points each day (‘Zeitgeber’ times 0, 6, 12 and 18). We
showed the co-existence of Per2 and Ucn1 in the npEW with double-label
immunofluorescence and demonstrated with quantitative RT-PCR and semi-
quantitative immunocytochemistry diurnal rhythms in Per2 mRNA expression and
Per2 protein content, respectively, with a minimum at lights-off and a maximum at
lights-on. We furthermore revealed a diurnal rhythm in the number of Ucn1-
immunopositive neurons and in their Ucn1 peptide content, with a minimum at
night and at the beginning of the light period and a peak at lights-off, while the
Ucn1 mRNA content paralleled the Per2 mRNA rhythm. The rhythms were
accompanied by a diurnal rhythm in corticosterone titer.
Our results are in line with the hypothesis that both Per2 and Ucn1 in the
rat npEW are produced in a diurnal, fashion, a phenomenon that may be relevant
for the regulation of the diurnal rhythm in the stress response.
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Introduction
Corticotropin-releasing factor (CRF) is an important mediator of endocrine,
autonomic and behavioral aspects of the stress response. Its main production site
is the paraventricular nucleus of the hypothalamus (PVN), a nervous component
of the hypothalamo-hypophyseal-adrenal (HPA-) axis, which is generally considered
to be the major control center of the stress response (e.g. Dunn and Berridge,
1990; Armario, 2006; Smith and Vale, 2006). Besides CRF, another member of the
CRF-neuropeptide family, urocortin 1 (Ucn1), has been implicated in stress
adaptation (Skelton et al., 2000; Gaszner et al., 2004; Gysling et al., 2004) as well
as in feeding regulation (Spina et al., 1999). Ucn1 is abundantly expressed in the
non-preganglionic Edinger-Westphal nucleus (npEW) in the midbrain (Kozicz et
al., 1998; Yamamoto et al., 1998; Bittencourt et al., 1999; Kozicz, 2007). The
urocortinergic npEW corresponds to a choline acetyltransferase-negative neuronal
population, which is located dorsomedially to the cholinergic neurons that project
to the ciliary ganglion and lack Ucn1 (for review see Kozicz, 2007). The npEW
responds to various stressors with c-Fos activation (Kozicz et al., 2001b) and
changed expression of Ucn1 mRNA and Ucn1 peptide content (Gaszner et al.,
2004; Kozicz et al., 2004; Korosi et al., 2005; Kozicz, 2007). In addition, in CRF-
deficient mice Ucn1 is up-regulated in npEW neurons following restraint stress
(Weninger et al., 2000), whereas npEW-Ucn1 mRNA is markedly down-regulated
in CRF-over-expressing mice (Kozicz et al., 2004). These results suggest that the
npEW-Ucn1 system and the HPA-axis comprise two anatomically separate but
functionally interrelated entities (Kozicz, 2007).
The stress response has a diurnal rhythmical character as appears from the
daily variation in the titers of hormones involved in stress adaptation, like CRF,
adrenocorticotrope hormone and corticosteroids (e.g. Watabe et al., 1987; Kalsbeek
et al., 2003). It is supposed that this rhythmicity depends on the diurnal activity of
the HPA-axis (Dunn et al., 1972; Kant et al., 1986; Atkinson et al., 2006). The
HPA-axis rhythm, in turn, seems to be controlled by the circadian master clock in
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the suprachiasmatic nucleus of the anterior hypothalamus (SCN) (Rusak and Zucker,
1979). The SCN clock is driven by circadian expression of various clock genes, of
which Per1 and Per2 are major products (Shieh, 2003; Asai et al., 2001). During
recent years, the importance of Per1 and Per2 for the organism’s diurnal stress
responsivity has become even more evident, as clock proteins appear to occur in
various diurnally active brain areas that are known to play a role in stress adaptation
(e.g. Forray and Gysling, 2004). Such centers do not only include the CRF-producing
PVN but also the dentate gyrus (DG) of the hippocampus, the central (CeA) and
basolateral (BLA) nuclei of the amygdala as well as the oval nucleus of the bed
nucleus of the stria terminalis (BNST-ov; Shieh, 2003; Amir et al., 2004; Forray
and Gysling, 2004). In addition, Per2 mRNA and Per 2 protein contents exhibit
diurnal rhythmicity, for instance in the BNST-ov, DG, CeA and BLA (Amir et al.,
2004; Lamont et al., 2005; Segall et al., 2006). Consequently, Per2 protein and
Per2 mRNA expressions are considered to be reliable tissue clock gene markers
(Amir et al., 2004), and for this reason we have chosen the mRNA and protein
product of the per2 clock gene as a marker to show diurnal activity of Ucn1-
containing neurons in the npEW.
In view of the proposed functional relationship between the npEW-Ucn1
system and the diurnally active HPA-axis, and considering the fact that both systems
are involved in stress adaptation, we hypothesized that both Per2 and Ucn1 in the
rat npEW would have diurnal, rhythmical dynamics. We have tested this hypothesis
using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and
semi-quantitative immunocytochemistry.
Materials and Methods
Experimental animals
Thirty-nine in-house-bred male albino Wistar-R Amsterdam rats (250-300 g) were
housed in six-per-cage groups in standard plastic cages (40x50x20 cm) at 22 oC
117
and 55% humidity, on a 12-hours light/12-hours dark cycle (light intensity: 200
lux; lights-on at 6:00 AM = ‘Zeitgeber’ time 0, ZT0), and were allowed to drink
tap water and eat rodent chow ad libitum. To prevent possible litter differences
among experimental groups, animals housed in the same home cage were weaned
and culled previously from multiple dams. Procedures were conducted in accordance
with the Declaration of Helsinki and with the guidelines for animal experimentation
based on the Law of 1998, XXCIII, on Animal Care and Use in Hungary as tested
by the Advisory Committee for Animal Resources of Pécs University, Medical
Faculty, Pécs, Hungary.
Experimental groups
Two experiments, one qualitative and one quantitative, were carried out. The purpose
of the qualitative experiment was to show co-localization of Per2 and Ucn1
immunoreactivities in the npEW by double immunocytochemistry, using three rats
sacrificed between ZT6 and ZT9. The quantitative experiment was performed to
show diurnal Ucn1 and Per2 rhythms on two consecutive days. On day 1, 16 rats
(n=4/group) were sacrificed at ZT0, ZT6, ZT12 and ZT18, respectively, and their
brains prepared for semi-quantitative Ucn1- and Per2-immunocytochemistry. The
other 20 animals (n=5/group) were sacrificed on day 2, at the same ZT, and their
brains prepared for qRT-PCR.
Fixation for immunocytochemistry
At the respective ZTs, animals for immunocytochemical study were deeply
anesthetized with intraperitoneally administered nembutal (100 mg sodium-
pentobarbital/kg body weight; Sanofi, Budapest, Hungary). Their chest cavity was
opened, a small incision was made in the left ventricle, and a 3 ml blood sample
was collected in an EDTA-containing tube for corticosterone assay (for details see
below). The animals were perfused transcardially with 50 ml 0.1 M sodium
phosphate-buffered saline (PBS; pH 7.4), for 2 min, followed by perfusion with
250 ml ice-cold 4% paraformaldehyde in 0.2 M PBS (pH 7.4), for 20 min. Blood
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sampling and perfusion were started within 5 min after the intraperitoneal
administration of anesthetic. Then, rats were decapitated and their brains were
quickly dissected and postfixed in the same fixative, for 12 hrs.
Sectioning
Following postfixation, 20 µm-coronal sections of midbrains were cut on a Lancer
Vibratome (Ted Pella Inc., Redding, CA, USA), and divided sequentially over 5
series. Sections were placed into an anti-freeze solution consisting of 30% glycerol
(Cat No: 49781; Fluka, Zwijndrecht, The Netherlands), 20% ethylene glycol (Cat
No: 293237; Sigma, Zwijndrecht, The Netherlands) and 0.1 M PBS, and stored at
-20 C° until further use.
Double immunofluorescence of Ucn1 and Per2
After antifreeze solution had been removed by 6x10 min washes in PBS, sections
were incubated in 0.5% Triton X-100, for 30 min, and subsequently in 5% normal
donkey serum (Jackson Immunoresearch, West Grove, PA, USA) in PBS, for 1 h at
20°C. Then they were incubated in rabbit polyclonal anti-Ucn1 (generous gift from
Dr. W.W. Vale, The Salk Institute, La Jolla, CA, USA) diluted 1:30,000 in PBS, for
48 hours at 4 °C and, in case of double-labeling, subsequently in Per2 antiserum
(1:1,000), for another 48 hours at 4 °C. Sections were rinsed in the donkey serum,
for 10 min, followed by 3x10 min rinses in PBS. Incubation in secondary antiserum
cocktail (Cy2-conjugated anti-goat IgG, 1:50 in PBS and, in case of double-labeling,
Cy3-conjugated anti-rabbit IgG, 1:100 in PBS, respectively) lasted 3 hours.
Secondary antisera were from Jackson Immunoresearch. After 3x10 min rinses in
PBS, sections were mounted on glass slides, cover-slipped with anti-fade mounting
medium (Vectashield, Vector Lbs Ltd., Peterborough, UK) and studied with a Nikon
Microphot FXA microscope (Nikon, Tokyo, Japan) in epifluorescence mode.
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Semi-quantitative immunocytochemistry with diaminobenzidine
Two series of sections of brains fixed at the four ZTs were used to demonstrate
diurnal rhythms in Ucn1 peptide and Per2 protein amounts in the npEW, using
semi-quantitative immunocytochemistry. In addition, sections at the level of the
SCN of ZT12 group were also used for Per2 immunocytochemistry. Free-floating
nickel-diaminobenzidine (DAB) immunocytochemistry (modified after Lamont et
al., 2005) was carried out by washing sections 6x10 min in cold Tris-buffered
saline (TBS) (pH 7.6) and incubating them in a quenching mixture of TBS and 3%
H2O2 (1:1 v/v), at 20 C°, for 30 min. After washing in cold TBS, sections were
incubated in 3% Triton X-100 (Sigma Chemical, St. Louis, MO) in blocking buffer
consisting of TBS (TBST), 3% normal goat serum (NGS) and 5% milk powder,
for 30 min. Then sections were incubated for 48 hrs at 4 °C with an affinity-purified
rabbit polyclonal antiserum raised against Per2 (Alpha Diagnostic International,
San Antonio, TX, USA) diluted to 1:1,000 with blocking buffer. After a wash in
cold TBS, they were incubated with biotinylated goat anti-rabbit IgG, diluted 1:200
with TBST and containing 2% NGS, for 24 hrs at 4 C°. Sections were rinsed in cold
TBS, incubated in avidin-biotin-complex (Vectastain Elite ABC Kit, Vector
Laboratories, Burlingame, CA, USA), for 2 hours at 4 C°, and rinsed with cold
TBS, for 3x10 min and with cold 50 mM Tris HCl (pH 7.6), for 10 min. Finally,
they were treated with 0.05% diaminobenzidine (DAB; D 5637; Sigma Chemical)
in the Tris-HCl buffer, for 10 min, and then with this buffer containing 0.02%
DAB, 0.02% Ni(NH4)2(SO4)2 and 0.00003% H2O2, for about 10 min; the reaction
was controlled under a stereomicroscope and stopped with Tris buffer. After 3x10
min washes in TBS, sections were mounted on gelatin-coated glass slides, air-dried,
treated with xylene for 2x10 min, cover slipped with DePex, and studied with the
Nikon Microphot FXA microscope equipped with a Spot RT color digital camera.
For all brains of all experimental groups, all staining procedures were
carried out simultaneously, so that differences in staining intensity cannot be due
to technical variations in the immunocytochemical procedure.
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Antiserum characterization and immunocytochemistry controls
The Ucn1 antiserum had been generated against the whole rat Ucn1 peptide (amino
acids 1-40), and its high specificity has been verified previously by preadsorption
and Western blot analyses (Bittencourt et al., 1999; Turnbull et al., 1999). The
Per2-antiserum had been raised against the 23-amino-acid C-terminal part of the
protein (Alpha Diagnostics Inc, http://www.4adi.com/adishop/index.php/action/
item/id/2441/prevaction/category/previd/2/prevstart/0/). The high specificity of this
serum was reported by Amir et al. (2004). We confirmed the serum specificities by
preadsorption with the respective synthetic peptides to which they had been raised
(Per 2: Alpha Diagnostics Inc; for ref. see URL above, Ucn1: generous gift from
Dr. J.E. Rivier, The Salk Institute), which abolished staining in all cases. In addition,
serum omission or replacement of a serum by non-immune goat or rabbit serum at
the dilution of the respective primary antiserum, completely prevented
immunoreaction.
Microscopy, digital imaging and morphometry
For qualitative purposes, digital images were edited to obtain optimal contrast,
using Photoshop 7.0.1 (Adobe, San Jose, CA, USA). Per animal, the amount of
Per2 protein and Ucn1 peptide in the npEW was estimated by counting all Per2-
immunoreactive (ir) cell nuclei and Ucn1-ir perikarya present in 4 serial sections,
each interspaced by 60 µm, at the midlevel of the npEW (Bregma –5.3 to –6.5 mm;
see Paxinos and Watson, 1997). The signal intensity of Ucn1 immunofluorescence
was measured in 10 perikarya per section using Image J software (version 1.37,
NIH, Bethesda, MD). Data were corrected for the background density outside the
npEW, yielding the specific signal density (SSD), which was expressed in arbitrary
units (A.U.) per perikaryon. The mathematical correction factor for section thickness
of cell counts according to Floderus (1944) was nearly 1 (0.965). Therefore no
correction for sections thickness was performed.
All data were expressed as group mean and standard error of the mean +
SEM. A random selection procedure was maintained throughout all experiments,
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and all quantitations were performed according to a double-blind protocol, by an
observer experienced in the anatomy of the midbrain but unaware of the identity of
the sections and the aim of the study.
Microdissection of npEW for qRT-PCR
For the qRT-PCR study, at each ZT, 5 animals were decapitated, and after collection
of 3 ml trunk blood in EDTA-tubes, their brains were quickly dissected and frozen.
This procedure took less then two minutes per animal. Plasma samples were used
for corticosterone assay. Brains were used for the demonstration of diurnal rhythms
in Per2 and Ucn1 mRNA amounts, using qRT-PCR. Using a coronal brain matrix
(Cat no 15007; Ted Pella) a 1 mm thick slice was made by coronal cuts with two
razor blades, at 3 and 4 mm in front of the transverse fissure containing the npEW.
Then, the slice was gently pulled out from the brain matrix together with the razor
blades, preventing direct contact with adjacent brain tissue that might contaminate
the slice with mRNAs. Slices were placed on a chilled plastic mat and the npEW
was punched out under a stereomicroscope. The samples included the ventral
periaqueductal gray, oculomotor nuclei as well as the Cajal nucleus, but were
dominated by the Edinger-Westphal nucleus (Fig. 1). Punched samples revealed
only minimal variations in size and weight. They were stored at -70 oC until use.
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Figure 1. Microdissection of the tissue samples in the midbrain. A: coronal cross section of
the rat midbrain 4 mm anterior to the transverse fissure, anterior view. Insert shows the
neuroanatomy of the area indicated by the white box. B: the slice, depicted in A after punching
out the rostro-ventral midbrain. Inserts show the neuroanatomy of the punched area
(encircled) and the tissue sample containing the npEW. Dots in inserts represent Per2–ir
nuclei in npEW. aq, cerebral aqueduct; mlf, medial longitudinal fascicle; npEW, non-
preganglionic Edinger-Westphal nucleus; PG, periaque-ductal grey; III-oculomotor nucleus.
Scale bars: 1 mm.
Quantitative RT-PCR
Microdissected brain samples were placed into 500 µl Trizol (Invitrogen, Breda,
The Netherlands), sonicated, and their RNA isolated using chloroform and
centrifugation (12,000g; 15 min at 4 °C). Supernatant was collected in isopropanol,
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and RNA precipitated overnight at -20 °C. Then, samples were centrifuged (12,000g;
20 min at 4 °C), washed with 75% ethanol, air-dried, and dissolved in DEPC water.
RNA concentrations were measured with a spectrophotometer (Eppendorf AG,
Hamburg, Germany) at 260 nm absorbance, and RNA purity was evaluated using
the ratio of absorbance at 260/280 nm.
cDNA synthesis was performed using 1 ìg of RNA in 11 ìl DEPC-water.
One µl of d(N)6 random primers (5 mU/µl) (Roche) was added, followed by
incubation at 70 °C for 10 min. Then, first strand buffer (5x; Invitrogen) and 8 µl
mastermix containing 200 U/µl Superscript II (Invitrogen), 0.1 M DTT (Invitrogen),
10 mM dNTP-s (Roche) and 40 U/µl RNasin (Promega, Leiden, The Netherlands)
was added. After incubation for 75 min at 37 °C followed by 10 min at 95 °C,
samples were stored at -20 °C until further use.
Quantitative RT-PCR was carried out using Q-PCR GeneAmp 5700
Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Per
sample 14 µl of Power SYBR Green PCR Master Mix (Applied Biosystems; L/N
0611038) was added to 5 µl reverse and forward primers and 5 µl cDNA. To
demonstrate Per2 and Ucn1 mRNAs, the following primers were used (Biolegio,
Nijmegen, The Netherlands): rat Per2 (Fahrenkrug et al., 2006), reverse:
CAAGATGATTCTATTCCAGAAGCATT, forward: GCAGGCTCACTGCCAGAACT,
and Ucn1 reverse: CAGATTCGGATCCTGGACCA, forward:
CCATCTTGCACTGGATAGACAC. The mRNA for rat ribosomal constituent 18S
(18S) was used for normalization, using reverse: CCATCAATCGGTAGTAGCG
and forward: GTAACCCGTTGAACCCCATT primers. The thermal cycler profile
consisted of 10 min denaturation at 95 °C, with 40 cycles each consisting of 15 sec
at 95 °C for denaturation, 30 sec at 60 °C for annealing and 33 sec at 72 °C for
extension. The amplifying PCR products were detected each cycle, and data were
digitally stored continuously. Data analysis was based on dissociation curves
generated by ramping the temperatures of the samples between 60 °C and 95 °C,
while fluorescent emission was measured continuously. To show different
expression levels, the initial mRNA copy numbers were determined using the cycle
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threshold method (Ct) using the manufacturer’s (Applied Biosystems, Nieuwerkerk,
The Netherlands) software baseline settings. As a standard, a wide range of serial
dilutions of reference cDNA were used (100.00, 50.00, 25.00, 12.50, 6.25 ng/
sample), and a clear linear correlation was found between log cDNA concentrations
and the Ct values. The primer efficiency (Cteff) for Ucn1 was 1.86 with variation
co-efficient R2 = 0.988, for Per2 Cteff = 1.615 with R
2= 0.988, and for 18S Cteff =
1.812 with R2= 0.9962. Dissociation curves in all cases showed only one peak
indicating one specific amplification product. Furthermore, the size of amplified
PCR product was verified by agarose gel electrophoresis with molecular DNA size
markers. Non-template controls did not give any amplification product, and no
bands were seen on gel. To statistically evaluate differences between experimental
group means, ∆Ct values were calculated by subtracting the Ct value of 18S mRNA
from the Ct values of Ucn1 mRNA or Per2 mRNA (Ct values are given in Table 1).
In Fig. 5 the qRT-PCR results have been presented in a graphical way as arbitrary
units (A.U.) using the formula AmRNA=2
-∆Ct.
Corticosterone radioimmunoassay
The blood samples from all animals of day 1 and day 2 were centrifuged at 3,000
g for 10 min, and 50 µl plasma aliquots were stored at -20 °C until further use. For
corticosterone (CORT) radioimmunoassay 5 µl of plasma sample was used, as
described previously (Gaszner et al., 2004), using 3H-corticosterone (12,000 cpm;
90-120 Ci/mmol, NET-399; Perkin-Elmer, Boston, MA, USA) and CS-RCS-57
antiserum (Jozsa et al., 2005). The inter- and intra-assay co-efficients for variation
were 9.2% and 6.4%, respectively.
Statistics
Statistical analyses were performed using one-way analysis of variance (ANOVA)
after testing for normality (Shapiro-Wilk test; Shapiro and Wilk, 1965) and for
homogeneity of variance (Bartlett’s Chi-square test; Snedecor and Cochran, 1989).
CORT hormone titer values were evaluated by two-way ANOVA in order to detect
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possible differences due to differences in blood sampling (see Results). Post hoc
analyses were carried out using Fisher’s test using Statistica (StatSoft, Tulsa, OK)
(α=5%).
Results
Corticosterone radioimmunoassay
We measured corticosterone titers during both days of the experiment, to assess
the physiological status of the animals. Moreover, we compared the titers on day 1
with those on day 2, to detect a possible effect of the blood sampling procedure,
which differed between the two days (day 1: sampling by cardiac puncture; day 2:
sampling from trunk blood). Plasma samples collected on day 1, collected from
the left ventricle prior to perfusion at lights-on (ZT0) contained only 178.8±7.1
nmol/l CORT, whereas at ZT6 (241.8±5.7 nmol/l; p<0.001), ZT12 (709±17.0 nmol/
l; p<0.001) and ZT 18 (413±12.25 nmol/l; p<0.001) markedly higher levels were
present in the blood (Figs. 4, 5; dotted lines). A very similar diurnal rhythm was
also found from assaying the trunk blood plasma samples of day 2: at lights on
they contained 165.6± 5.9 nmol/l CORT, whereas 6 hours later the titer increased
to 234.6±12.48 nmol/l (p<0.02). At ZT12 we measured the highest values
(688.4±9.98; p<0.001) and in the middle of the dark period CORT levels dropped
to 397.6±13.2 nmol/l (p<0.001; Fig. 6).
Two-way ANOVA revealed no significant main effect of the factor
“sampling procedure” (F7,36=1.6; p>0.2), and CORT values showed a clear diurnal
rhythm both in the perfused (F3,16=220.4; p<0.001) and the decapitated animals
(F3,20=241.4; p<0.001), which shows that the animals had a physiologically normal
diurnal rhythm that had not been influenced by the blood sampling procedure.
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Co-localization of Per2 and Ucn1 immunoreactivities
At ZT12, a strong immunoreaction against Per2 was observed in nuclei of neurons
of the SCN (Fig. 2), confirming the suitability of the Per2-antiserum to stain neuronal
Per2 in our material. Applying the Per2-antiserum to the npEW, we found high
Per2-ir in most neurons (Fig. 2). To test neuronal co-localization of Per2 and Ucn1,
double immunofluorescence labeling was performed (Fig. 3). This revealed that
neurons with Ucn1-ir cytoplasm had a Per2-ir nucleus.
Figure 2. Nickel-diaminobenzidine immunocytochemistry of Per2 in the rat brain. A: non-
preganglionic Edinger-Westphal nucleus (npEW). B: suprachiasmatic nucleus (SCN). C: high-
power magnification of the npEW area in A, indicated by rectangle. D: scheme of the distribution
of Per2-ir nuclei in the npEW. Encircled area in D corresponds to microdissected rostroventral
midbrain for qRT-PCR studies. aq, cerebral aqueduct; EW, preganglionic Edinger-Westphal
nucleus; GN, geniculate nucleus; mlf, medial longitudinal fascicle; npEW, non-preganglionic
Edinger-Westphal nucleus; ox, optic chiasm; PG, periaqueductal gray; sc, superior colliculus;
SN, substantia nigra; III, oculomotor nucleus; 3rd, third ventricle. Bar A,B: 50 µm; in C:  25 µm.
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Figure 3. Double-immunofluorescence of Per2 and Ucn1 in the rat npEW. A: Ucn1
immunoreactive (ir) neuronal cell bodies (green). B: Per2-ir cell nuclei (red) in the same
section as A. C: merged image of A and B revealing that the several Ucn1 neurons have
Per2-ir nuclei. D, E, and F are details of A, B and C, respectively. aq, cerebral aqueduct.
Scale bar in A-C: 50 µm; in D-F: 10 µm.
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Per2 and Ucn1 rhythms
First, we counted the number of Per2-ir cell nuclei in the npEW nucleus, at different
time points of the first day of the quantitative experiment (Fig. 4). This number was
high at lights-on (9.3±1.5 per section) and lower at the other time points (5.7±0.5 at
ZT6; 4.3±0.6 at ZT12; 4.6±0.1 at ZT18; p<0.001), which did not differ from each
other (p>0.05). One-way ANOVA revealed a main effect of ZT (F3,16=18.6, p<0.0001).
Figure 4. Per2 protein rhythm in the npEW, surging during a 24-hours period. A-D:
representative images of Per2-ir. The number of Per2-ir nuclei was high in the morning
(ZT0; A) and dropped during the day (ZT6; B) at lights off (ZT12; C) and in the middle of
the dark period (ZT18; D) as summarized in graph E. Dotted curve indicates the diurnal
change in blood corticosterone titer. Letters a-d on the top of columns indicate groups that
differ significantly (p<0.05). (means + SEM). The black-white line below histograms
indicates light and dark period. Scale bars: 50 µm.
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A different picture appeared from counting Ucn1-immunolabeled neurons
(ANOVA: F3,16=4.16, p<0.01; Fig. 5). At lights-on the number of Ucn1-ir cells was
relatively low (14.2±1.15 per section) whereas it was clearly higher 6 hours
(17.5±1.1; p<0.005) and 12 hours (16.9±0.9; p<0.05) later. At 18 hours after lights-
on, i.e., in the middle of the dark period, the number of Ucn1-ir cells (14.6±1.0)
was not different from that at lights-on (14.2±0.51; p>0.05). Assessment of the
SSD of the immune signal per neuron, revealed a similar picture (F3,16=6.76,
p<0.001), with relative low intensities at ZT0 (49.3±4.5) and at Z18, in the dark
period (39.8±6.1), whereas during the light period intensities were clearly higher
than at ZT0 (6 hours light: 57.2±6.2; p<0.005; 12 hours light: 69.1±7.3; p<0.01).
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Figure 5. Quantification of Ucn1-ir in the npEW. A-D: representative images of Ucn1-ir in
the npEW during 24 hours-cycle. Ucn1 cell counts and specific signal densities were low at
lights-on (ZT0; A), increase during the day (ZT6; B) and at lights off (ZT12; C), and than
dropped again in the middle of the dark period (ZT18; D). E: daily change in number of
Ucn1-ir cell. F: daily change in Ucn1 specific signal density (SSD). Dotted curve indicates
the diurnal change in blood corticosterone titer (means + SEM). Letters on top of columns
indicate groups that differ significantly (p<0.05). Black-white line below histograms indicates
light and dark periods. Scale bars: 50 µm.
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Then we performed qRT-PCR on day 2, to assess the amounts of Per2 and Ucn1
mRNA in the npEW at different ZT. In Table 1, results are given as ∆Ct values, and
in Fig. 6 these values were transformed into relative mRNA amounts.
The amounts of Per2 mRNA revealed a similar pattern as the numbers of
Per2-ir neurons (see above). One-way ANOVA showed a main effect of ZT (F3,20=5.78,
p<0.01). The highest Per2 mRNA content occurred at ZT18 (11.8±0.3) and at ZT0
(12.3±0.3), whereas Per2 expression was about 2 times lower at ZT6 (12.9±0.4;
p<0.05) and 4 times lower at ZT12 (13.7±0.5; p<0.002) when compared to ZT18.
Figure 6. Quantification of Per2 and Ucn1 mRNA contents in the npEW at different Zeitgeber
times (ZT) of the 24 hours-cycle using qRT-PCR. A: daily change Per2 mRNA. B: Ucn1
mRNA levels evaluated by quantitative RT-PCR. Both mRNAs show similar rhythms: high
expression at night and in the morning and lower levels at ZT6 and ZT 12. The relative
amount of mRNA, (AmRNA) is expressed in arbitrary units on the basis of AmRNA = 2
-∆Ct.
Dotted curve indicates the diurnal change in blood corticosterone titer (means + SEM).
Letters on top of columns indicate groups that differ significantly (p<0.05). Black-white
line below histograms indicates light and dark period.
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CT values ∆Ct values Relative amount (A) of
mRNA
(AmRNA = 2-∆Ct)
Per2 Ucn1 18S ∆Ct of Per2 ∆Ct of
Ucn1
Per2
(A.U.)
x10-5
Ucn1
(A.U) x10-
3
ZT0 27.41±0.63 22.71±0.56 15.27±0.31 12.29±0.26
(ZT12)
7.14±0.23
(ZT12)
1.99±0.04 7.11±0.23
ZT6 29.12±0.54 24.46±0.78 16.09±0.30 12.86±0.36
(ZT18)
7.76±0.44
(ZT18)
1.33±0.03 4.61±0.26
ZT12 30.02±1.56 24.29±0.43 18.16±0.72 13.74±0.49
(ZT0,
ZT18)
8.11±0.17
(ZT0,
ZT18)
0.72±0.03 3.69±0.08
ZT18 27.05±0.54 23.012±1.12 15.27±0.27 11.72±0.28
(ZT6,
ZT12)
6.69±0.41
(ZT6,
ZT12)
2.85±0.07 9.62±0.59
The Ucn1 mRNA concentration in the same animals showed similar fluctuation
(ANOVA: main effect of ZT; F3,20=4.31, p=0.02). Highest Ucn1 contents were
found at ZT18 (6.7±0.4) and ZT0 (7.1±0.2). Compared to ZT18, Ucn1 mRNA was
about 50% lower 6 hours after lights on (7.8±0.4; p<0.05), whereas the lowest
expression was found at ZT12 (8.1±0.4; p<0.005) with a 62% decrease.
The 18S housekeeping gene mRNA was also tested for diurnal changes
(Table 1). The statistical analyses did not show a difference between the four time
groups in 18S mRNA Ct values throughout the 24 hours cycle (F3,20=1.52; p=0.25).
Table 1: Quantitative RT-PCR data. Ct values of Per2, Ucn1 and 18S at four different
Zeitgeber time points in the npEW. Calculated ∆Ct values for Per2 and Ucn1. The relative
amount of mRNA (AmRNA) is expressed in arbitrary units (A.U.) on the basis of AmRNA = 2
-∆Ct
(means ± SEM). Significantly differing groups are indicated in brackets in the cells for ∆Ct
values; p<0.05, p<0.01.
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Discussion
We have tested our hypotheses that Per2 and Ucn1 would co-localize in the npEW
and that Per2 and Ucn1 protein and mRNA expressions would exhibit diurnal
rhythms. Our data support these hypotheses, as will be argued below. In addition
we will discuss the properties and possible regulation of these rhythms.
General considerations
Since the microdissected samples used for qRT-PCR analyses contained brain areas
other than the npEW, the observed daily rhythm in Ucn1 and Per2 mRNA expression
could theoretically be the result of rhythm in one or more of these areas. However,
none of the areas included in the microdissected midbrain samples contained Ucn1
or Per2 or their mRNAs as is clear from the literature (Shieh, 2003) and from the
present data. Therefore, data from qRT-PCR would reflect changes in Per2
expression in npEW (Fig. 1A).
We have used semi-quantitative immunocytochemistry and qRT-PCR to
detect a daily rhythm in the amounts of and mRNA expression of Ucn1 and Per2.
Upon interpretation of such data one should consider that the amount of a peptide
present in a cell, its stainability, is determined by the relation between the rates of
biosynthesis, breakdown and secretion. Therefore, a low cellular peptide content
does not necessarily mean that the cell does not produce the peptide, as it may be
producing it at a high rate, but transport it even faster out of the perikaryon to the
axon terminal to be secreted at a high rate, thereby depleting the cell body’s peptide
contents. Conversely, a strongly stained cell may be very inactive. Therefore,
stainability does not tell anything about cellular secretory activity, but it does indicate
that the secretory dynamics (rates of the above mentioned processes) have been
changed.
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Per2 and Ucn1 are diurnally expressed in the npEW
Our results strongly indicate that Per2 and Ucn1 in the npEW are produced
in a diurnal rhythmical fashion, for the following three reasons:
1. Per2 is expressed in the Ucn1 neurons of the npEW. The presence of
Per2 mRNA in the npEW is firstly indicated by qRT-PCR of punched npEW brain
samples. Then, the single- and double-immunolabeling studies to localize Per2 at
the neuron level revealed that Per2-ir was present in the nuclei of Ucn1-ir neurons
throughout the npEW. These observations have led us to conclude that Per2 prote-
in is synthesized in the Ucn1-producing neurons of the npEW. Although Per2
expression has been described in neuroendocrine dopaminergic neurons in the
hypothalamus (Sellix et al., 2006), this study provides the first demonstration of
Per2 protein in neurons outside the SCN involved in the regulation of the stress
response.
2. Per2 expression and storage are diurnal processes. Our qRT-PCR data
revealed a daily change in the degree of Per2 mRNA expression in the npEW, with
one peak in the morning and a minimum in the evening, at the beginning of the
dark phase. In accordance with these results, single-label Per2-ir cell nuclei were
more numerous at the beginning of the light phase than in the evening. Therefore,
the production of Per2 and its mRNA in the npEW appears to have a diurnal
character.
3. Ucn1-expression and storage are diurnal processes.
The qRT-PCR experiment demonstrated a diurnal pattern for Ucn1 mRNA, with a
minimum during the day and evening and a maximum during the night and early
morning. Also, the number of Ucn1-ir neurons and the degree of Ucn1-ir showed
clear diurnal rhythms with lowest values at night and in the morning and highest
value during the day and evening. Therefore, both production of Ucn1 mRNA and
dynamics of Ucn1 storage appear to be diurnal processes.
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Does the Per2 rhythm control the Ucn1 rhythm?
In this study, we showed diurnal rhythms of expression of Per2 and Ucn1 in the
npEW. Since Per2 is a clock gene involved in the regulation of diurnal rhythms
(Herzog, 2007) the question arises whether Per2 plays a role in the generation of
the Ucn1 rhythm. The following circumstantial evidence suggests that this is the
case. Circadian gene expression patterns are established by binding of transcriptional
factors, such as the binding of BMAL1/CLOCK to E-boxes (Muñoz et al., 2002,
2006). Per2 has an inhibitory effect on CLOCK/BMAL1, influencing the expression
of genes with the E-box-containing promoter (Shieh et al., 2005; Herzog, 2007).
Examining the DNA sequence 25206788 bp-25217618 bp upstream of the start
site of the rat Ucn1 gene (database: www.ensembl.org; Ensemble gene ID:
ENSRNOG00000006090; 6. Chromosome) reveals six E-boxes (CANNTG),
namely at loci (-614bp), (-1313bp), (-1746bp), (-1820bp), (-3448bp) and (-3671bp).
Therefore, in the rat npEW, CLOCK/BMAL1 might modulate the transcription of
the Ucn1 gene via E-boxes. In this study we found that Per2 protein ir peaked in
the morning and dropped to the minimum during the dark period, while Ucn1
mRNA peaked at ZT 18. As Per2 protein inhibits the CLOCK/BMAL1 transcription
factor binding to E-boxes (Shieh et al., 2005; Herzog, 2007) we speculate that in
the npEW Per2 may have an inhibitory effect via CLOCK/BMAL1 and E-boxes
on the Ucn1 gene transcription, causing the Ucn1 mRNA rhythms to be delayed
compared to the Per2 rhythm.
Possible regulatory mechanisms of the diurnal Per2 rhythm
As to the regulation of the Per2 rhythm in the npEW, various possibilities exist.
First, it may be exerted by the master clock in the SCN, because this clock possesses
robust rhythm in clock gene expression, and the SCN also controls the rhythmical
expression of Per2 in PVN via SCN-arginine vasopressin-containing neurons (Isobe
and Nishino, 2004). Furthermore, unilateral SCN lesion abolishes the Per2-rhythm
in the ipsilateral BNST-ov (Amir et al., 2004). However, to date no direct connection
between the SCN and npEW has been demonstrated. Secondly, adrenal
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corticosterone may be involved, because a) such a regulation has been shown for
the Per2-rhythm in the BNST-ov and CeA in the rat (Segall et al., 2006), b) adrenal
corticosterone secretion has a diurnal rhythm; and c) the rat npEW contains
glucocorticoid receptors (Cintra et al., 1994; Morimoto et al., 1996) especially in
its Ucn1-ir neurons (T. Kozicz, unpubl. res.). However, this idea awaits further
proof, as for instance the diurnal rhythms of the BLA and DG are not affected by
adrenalectomy in spite of the fact that they possess glucocorticoid receptors (Cintra
et al., 1994; Morimoto et al., 1996).
The patterns of expression, production and secretion of Ucn1 may differ from
each other
In the middle of dark phase and at lights-on we found a high concentration of Ucn1
mRNA but a low number of Ucn1-containing neurons and a low Ucn1-peptide
amount per neuron. This seeming discrepancy may be explained in two ways: 1)
the translation of Ucn1 mRNA into Ucn1-peptide may take several hours, and 2)
low cellular peptide might be linked to an increased secretory activity of the cell,
thereby depleting the cell body’s peptide contents explaining the low Ucn1 SSD at
ZT0. Such a daily rhythm for npEW-Ucn1 would well fit with the notion that the
activities of the HPA-axis and the npEW-Ucn1 show an inverse relationship (Kozicz,
2007). Specifically, in our experiments CORT peaked in the evening demonstrating
higher HPA-axis activity, and at the same time point Ucn1 cells stored more peptide
and produced less mRNA suggestive of a decreased cell activity and/or Ucn1 release.
On the other hand, at night, and in the early morning when the HPA-axis activity
drops in rodents, Ucn1 mRNA rises, and the peptide content decreases pointing to
a possible higher neuronal activity and/or increased release on Ucn1. However,
confirmation of this theory, by e.g. measuring Ucn1 peptide release in the target
areas of npEW neuronal projections remains at future issue.
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Conclusions
Our data indicate that there are diurnal rhythms in the expression of Per2 and Ucn1
mRNAs and in the production of Per2 and Ucn1 in the rat npEW. We suggest that
these diurnal rhythms play a controlling or at least modulating role in the regulation
of physiological rhythms such as in stress adaptation, sleeping behavior and food
intake.
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Chapter 7
General Discussion
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Stress is an adaptive response of the body involving physiological regulations that
strive to maintain or restore homeostasis. After the necessary adaptive physiological
measures have been taken, the stress response may be terminated. This occurs
when the activity of the main stress pathway, the classical HPA-axis, is down-
regulated to baseline level, via one or more inhibitory brain centers and/or via
negative corticosteroid feedback. Although the duration of the stress response
depends to some degree on the duration of the stress challenge, upon prolonged
stress the HPA-axis may habituate to the stressor, becoming insensitive to it, a
phenomenon that is considered as an adaptive mechanism (for reviews see Tsigos
and Chrousos, 2002; Leonard, 2006; Kyrou and Tsigos, 2007; Beddoe and Lee,
2008). However, in some cases, particularly when the stressor has a very adverse
character and remains acting over an extensive period, this adaptive mechanism
seems to be insufficient to maintain or regain homeostasis, and “maladaptation”
may subsequently lead to the development of various pathologies of body and
mind (for reviews see Westrin, 2000; Tsigos and Chrousos, 2002; Kluge et al.,
2007; Bao et al., 2008; Lo Sauro et al., 2008). This, of course, raises the question
as to the reason of such maladaptation. The answer is only partly clear. Obviously,
the functioning of the HPA-axis may become compromised upon prolonged and
severe stress as a result of inappropriate feedback on the main brain regulator of
the axis, CRF (Thomson and Craighead, 2008). However, other brain factors
involved in stress adaptation may underlie maladaptation as well. In this respect,
the CRF-related neuropeptide Ucn1 deserves special attention, as it acts on CRF
receptors and thereby can interfere with HPA-axis activity (Vaughan et al., 1995).
Recently, Ucn1 has also been implicated in the pathogenesis of stress-related mood
disorders (Kozicz 2007; Kozicz et al., 2008). Our research group focuses on the
role of Ucn1 in stress adaptation (for review see Kozicz, 2007). To get more insight
into the role of Ucn1 in stress adaptation and in stress-related pathologies as a
result of maladaptation to stress, this thesis research has been carried out, and
emphasis has been laid on various aspects of the functioning of the midbrain npEW,
as this nucleus is the major site of Ucn1 production in the mammalian brain.
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The npEW responds to stress in a stressor-specific way
The first aim of the research was to test our hypothesis that the npEW-Ucn1 system
responds to a stressful challenge in a stressor type-specific way. This aim has been
reached as will be explained as follows. Previously, it was demonstrated by
quantitative immunocytochemistry that the majority of urocortinergic neurons in
the npEW exhibited c-Fos expression, a general sign of cell activation, within two
hours after application of an acute pain stress (Kozicz et al., 2001b). This finding
indicates that the neurons increased their activity in two hours. This idea was in
line with the fact that quantitative immunocytochemistry also demonstrated that
within 24 hours the neurons changed (i.e., accumulated) the amount of Ucn1 present
in their cell bodies, and was further supported by the observation made using
quantitative RT-PCR that within the same period they increased their Ucn1 mRNA
contents, a sign of increased Ucn1 biosynthesis.
In the first study (Chapter 2), based on the recruitment of Ucn1-neurons
by an acute pain stress, we compared the effects of various acute stress paradigms
on these neurons. This revealed that acute ether stress, lipopolysaccharide injection
stress, and restraint stress all increased the activity of the urocortinergic neurons,
as shown by robust c-Fos activation, whereas, in contrast, but similar to unstressed
control rats, no activation was seen in Ucn1-neurons when rats were exposed to
acute stress by hemorrhage and hyperosmotic saline injection. From these data, we
conclude that the responsivity of the Ucn1-neurons in the rat npEW is highly
dependent on the type of stressor. This notion underpins the importance of the
npEW as a brain center that is involved in a stressor-specific adaptation of the
animal to environmental challenges.
In addition to the stressor-specific sensitivity of the npEW, another
remarkable property of the npEW appears from previous (Kozicz et al., 2001b)
and the present study (Gaszner et al., 2004): whereas all acute stressors studied
caused a high surge of the corticosterone titer, which indicates that they all evoked
a strong HPA-axis response, an interesting difference appeared between the c-Fos
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dynamics of the CRF-producing neurons in the PVN and the Ucn1-producing ne-
urons in the npEW. The hypophysiotropic CRF-neurons react very fast upon acute
stress, i.e., within 30 min, showing elevated CRF- and c-Fos mRNA levels and
increased Fos-immunoreactivity (Kovács and Sawchenko, 1996) and this activation
lasts for only about 2 hours, after which this cellular activity starts to drop
(Sawchenko et al., 2000). In the npEW, however, we showed that acute pain stress
induced a peak in c-Fos protein only after four hours post-stress, and it took Ucn1
24 hours to drop to control value (Kozicz et al., 2001b). This difference in PVN
and npEW secretory dynamics indicates that the npEW-Ucn1 system reacts to acute
stressors with much longer latency and much more prolonged than the HPA-axis.
This difference in dynamics between the two systems also appears from studies on
the effects of chronic stressors. Korosi et al. (2005) found that HPA-axis activity,
as revealed by the corticosterone titer habituates after three weeks of stressor
exposure, whereas the npEW keeps its chronic stress-induced activation for at
least 3 weeks of homotypic ether stress (Korosi et al., 2005) and for two weeks of
both variable stress and chronic variable mild stress paradigms (Gaszner et al.,
unpubl. res.). Findings using transgenic animal models are in line with these
observations as, for instance, CRF-null mice possess increased Ucn1 mRNA
expression in the npEW (Weninger et al., 2000). Moreover, CRF-over-expressing
mice (Kozicz et al., 2004), which are genetically modified in such a way that they
resemble animals with a chronically active HPA-axis, reveal decreased Ucn1
expression.
Adding these previous results on the stress-responsivity of the HPA-axis
and npEW-system to our current data on the effects of acute stress on the npEW as
described in Chapter 2, it can be concluded that the HPA-axis and npEW-Ucn1
system are two distinct but functionally interrelated systems (Kozicz, 2007): during
acute stress both are activated but during chronic stress the HPA-axis habituates
whereas the npEW-Ucn1 system remains activated. Possibly, this reflects a
complementary action of both systems that may be disturbed under severe stress,
leading to maladaptations.
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The effect of early life experience on the npEW
Many authors have related significant early life events, disturbances of the
functioning of the HPA-axis and stress-related mood disorders to each other (Bremne
and Vermetten, 2001; Gilmer and McKinney, 2003; Andersen and Teicher, 2004;
de Kloet et al., 2005; Lippmann et al., 2007). The second aim of this PhD research
was to demonstrate if the responsiveness of the npEW-Ucn1 system is affected by
stressors given in an early age, more in particular, if it is affected by early life
events such as the very strong stressor, MS. In Chapter 3 it is described that the c-
Fos activation of npEW neurons induced by acute stress is dampened in adult
animals with prolonged MS history. This finding supports our hypothesis that MS
negatively affects the stress response by the npEW in later life. The second main
finding in this study was that Ucn1 neurons in the npEW express BDNF and that
their BDNF contents are influenced by MS. This raises the idea that BDNF is
responsible for maintenance and survival of npEW-Ucn1 neurons and/or for neu-
rons receiving input from these cells, as urocortinergic terminals could co-release
BNDF as well. Based on the distribution of Ucn1 terminals we speculate that there
could be two candidate sites for Ucn1 and BDNF action involved in stress
adaptation: the lateral septum (LS) and the dorsal raphe (DR). The first idea is
supported by the work of Nonner et al. (1996), who added BDNF to the medium of
cultured lateral septum neurons and found enhanced survival of neurons in
hypoglycemic stress. Interestingly, in the LS, the BDNF mRNA expression is low,
but it shows high BDNF-ir. Conner at al. (1997) showed that BDNF is transported
to the LS via axons of neuronal perikarya located in the midbrain. Fawcett et al.
(2000) found that lesioning of dopaminergic afferents of the LS decreases the BDNF
protein level in LS, and concluded that midbrain catecholaminergic neurons are
partial sources of BDNF in the LS. As Ucn1 neurons project to the LS as well
(Bittencourt et al., 1999; Ryabinin and Weitemier, 2006) it is very likely that npEW-
BDNF at least in part promotes the survival of CRF2-expressing neurons in the
LS. The sensitivity of the DR- and serotonin-utilizing pathways by MS has been
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shown in many respects: MS increases the serotonin 5-HT1A, 5-HT1A and 5-
HT2A receptor levels in the cortex and hippocampus (for review see Holmes et al.,
2005), and more recently Lee et al. (2007) reported decreased hippocampal serotonin
content and low serotonin reuptake transporter mRNA expression in the DR of MS
rats. Gartside et al. (2003), using an electrophysiological approach, found that the
sensitivity of alpha1 adrenoceptors on serotoninergic neurons in the DR was reduced
by MS. There is an npEW projection to the dorsal raphe nucleus (Turek and
Ryabinin, 2005a,b; Bachtell et al., 2003a,b) containing Ucn1. The co-release of
Ucn1 and BDNF in the DR could influence this serotoninergic system as it contains
both CRF 1 and CRF 2 receptors (Van Pett et al., 2000). In addition, serotoninergic
neurons in the DR express TrkB receptor mRNA (Madhav et al., 2001) and show
TrkB and p75 receptor immunoreactivities (Yamuy et al., 2000).
Taken together, as MS increases the production of BDNF in the npEW
and, hence, affects the proper functioning of the npEW-Ucn1 neurons, MS might
influence their target areas as well. This could influence the function of the HPA-
axis LS via connections to the PVN (Herman et al., 2002) and, in addition, the DR
serotoninergic system is known to interact with the HPA-axis as well (Lanfumey et
al., 2008). MS causes profound changes in the HPA-axis, but we do not know the
mechanisms involved. Based on all these data, we propose that the changes in the
npEW-Ucn1 system caused by early life event will modulate the HPA-axis via the
LS and/or the DS.
Sex differences in npEW responsiveness
Another observation in the study described in Chapter 3 relates to our aim to
show sex-dependence of the npEW-stress response. Not only in the MS paradigm
(Chapter 3) but also recent findings in our ongoing research supports this
hypothesis, in three main aspects.
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First, in c-Fos expression we saw that male HMS15 with reduced
corticosterone values displayed higher c-Fos activation in Ucn1-neurons than
corresponding females. In one of our ongoing studies using the chronic variable mild
stress paradigm, we observed long-term c-Fos activation in Ucn1 neurons in males
only, but the female npEW habituated to this paradigm and the c-Fos values after 2
weeks stress returned to the baseline (Gaszner et al., unpubl. res.). Second, at the
Ucn1 peptide level upon acute stress we saw sex-specific differences, as in MS-
treated rats acute stress increased the npEW Ucn1 content in males but decreased it
in females. Third, recently we examined different aspects of BDNF dynamics using
a chronic, variable, mild stress paradigm, which revealed that a) at the protein level,
female rats displayed a stronger BDNF response to the stressor than males, and b) at
the mRNA the expression pattern of BDNF transcripts showed sex-specific
differences: both in exon 2 and exon 9 females showed higher BDNF mRNA levels
than males, and c) At the level of signal transduction, the level of pERK (the
phosphorylated form of extracellular signal-regulated kinase involved in BDNF
signaling; Barnea et al., 2004) was higher in males than in females; moreover, acute
stress induced a pERK increase in males, while females did not respond. Also, upon
chronic, variable, mild stress both sexes reacted in opposite ways, males with a
decreased, females with an increased amount of pERK (Gaszner et al., unpubl. res.).
These results support our hypothesis that the response of the npEW to
stressors is gender-related, at various levels: immediate early gene (c-fos) reaction,
Ucn1 peptide, and BDNF expression, protein content and intracellular signaling.
Gender-differences may be explained by the facts that npEW-Ucn1 neurons contain
estrogen beta-receptors (Derks et al., 2007) and Ucn1 mRNA expression depends
on the phase of the estrous cycle (Derks et al., unpubl. res.). In addition, the Ucn1
gene promoter is regulated by estrogen receptors (Haeger et al., 2006). The
importance and translational relevance of gender-differences are underlined by
our finding that Ucn1 and BDNF mRNAs in the npEW reveal sex-specific
differences between non-treated, depressed patients that had committed suicide
and controls (Kozicz et al., 2008).
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Daily rhythm of the npEW
A further aim of this thesis was to examine whether the npEW-Ucn1 system shows
a daily secretory rhythm. This aim was reached, as is clear from the experiment
reported in Chapter 6. In this work first the presence of Per2 in npEW-Ucn1
neurons was demonstrated, suggesting that these neurons may be rhythmically
active, like other Per2–containing neurons, such as in the SCN, BNST, CeA and
BLA (Amir et al., 2004; Lamont et al., 2005; Segall et al., 2006). Subsequently, the
presence of such a rhythm was confirmed indeed, by quantitatively assessing the
amounts of Per2 mRNA and Per2 protein in these neurons during a 24 hours period.
We proposed that the Per2 rhythm drives the demonstrated Ucn1 rhythm in the
npEW, as its phase is about 6 hours advanced compared to the phase of the Ucn1
rhythm. The demonstration of these rhythms in the npEW is in support of the
notion that the npEW and HPA-axis are coupled in some way (Kozicz, 2007; this
thesis), as the HPA-axis is diurnally rhythmical as well. Nevertheless, the possibility
cannot be excluded that each of these two adaptation centers receives clock
information from a third center, namely the SCN, which is the master clock in the
brain (Rusak and Zucker, 1979). Therefore, it is of interest to study in what way the
npEW and the HPA-axis are interrelated. One likely possibility would be that they
are linked via Ucn1 release from npEW neurons at the level of centers regulating the
HPA-axis, like the LS (see above). Conversely, the HPA-axis may control the npEW
via corticosterone, as Ucn1 neurons contain glucocorticoid receptors, which have
been demonstrated immunocytochemically in our lab (Korosi et al., unpubl. res.).
Inputs to the npEW
To increase our knowledge about the way(s) the secretory activity of the npEW-
Ucn1 neurons is regulated, inputs to the npEW were investigated into some detail
(Chapters 4 and 5). Since in the neighborhood of Ucn1-neurons numerous
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monoaminergic and peptidergic fibers were seen, these neurotransmitter types
seemed likely candidates for controlling npEW. As is dealt with in Chapter 4,
using immunocytochemistry against tyrosine-hydroxylase and dopamine-b-
hydroxylase, a high number of dopaminergic fibers contacting Ucn1-neurons was
revealed, whereas noradrenergic fibers ending near or on these neurons were rare.
After depleting the dopaminergic system with 6-OHDA, stress-induced activation
of c-Fos was unaffected, suggesting that the monoamines are not crucial in acute
stressor-induced activation.
A different picture arises from the studies on a possible NPY-input to the
npEW-Ucn1 system. As is shown in Chapter 5, centrally administered synthetic
NPY induced c-Fos expression and Ucn1 mRNA up-regulation in the npEW, most
likely via Y5 receptors located on the Ucn1 neurons. This finding may have strong
clinical relevance, as both NPY (Heilig et al., 1989; Sajdyk et al., 1999) and Ucn1
(Vetter et al., 2002; Linden et al., 2004; Zalutskaya et al., 2007) have anxiolytic
actions and have been implicated in drug abuse such as excess alcohol consumption
(Heilig and Thorsell, 2002; Bachtell et al., 2004; Weitemier and Ryabinin, 2006).
In this respect it is noteworthy that we found indications for NPY input to the
npEW of humans as well (this thesis).
The origin of the NPY input to the npEW is not known. It may arise from
NPY-containing nerve cells located ventrally to the cerebral aqueduct but it should
be realized that the distribution of NPY-neurons involves many other brain areas,
such as the cortex, basal ganglia, amygdala, and numerous nuclei in the brainstem
(Yamazoe et al., 1985; Gustafson et al., 1986; Aoki et al., 1990; Ostergaard et al.,
1995; Delalle et al., 1997). Ongoing tract tracing studies will help to determine the
origin of afferents to Ucn1 neurons, which concern, besides NPY, many other
neurochemical inputs, such as orexin A (Nambu et al., 1999), CRF (A. Korosi et
al., unpubl. res.), pituitary-adenylate cyclase activating peptide (Hannibal, 2002),
serotonin (Clements et al., 1985) and noradrenalin and dopamine (Kwiat and
Basbaum, 1990).
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A model
Taken together, we have fulfilled the aims of the thesis, as we have been able to
show that the npEW is specifically activated by a variety of stressors and that the
dynamics of the npEW-Ucn1-system depend on stressor type, early life experience,
gender and phase of the diurnal light cycle. As all these factors are important in
stress physiology, our results underline and extend the notion that the npEW is
crucially involved is stress adaptation. In numerous cases insufficiency of adaptive
mechanisms leads to maladaptation to stress. Based on our results we propose that
the npEW-Ucn1 system could play a role in stress adaptation c.q. maladaptation,
for which we have constructed a tentative model (Fig. 1). Hopefully, further research
in this field will provide new insights into the psychopathophysiology of stress-
related mood disorders, with therapeutic relevance.
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Figure 1. The role of the npEW-Ucn1 system in the stress response. The classical HPA-axis
(gray) is influenced by the limbic system, lateral septum (LS) and dorsal raphe nucleus
(DR) (yellow). Stress affects the HPA-axis via the limbic system, and probably via NPY-
input the urocortinergic neurons of the Edinger-Westphal nucleus (blue). NPY via Y1 and
Y5 receptors induces c-Fos activation, which might influence Ucn1 production.
Corticosterone and estrogen may exert an endocrine control on Ucn1 production because
the Ucn1-neurons possess glucocorticoid receptors (GR) and estrogen β receptors (ERβ).
The Ucn1 and BDNF co-expressing neurons project predominantly to the LS and DR,
suggesting their modulatory role on the HPA-axis activity. The HPA-axis shows daily rhythms
in hormone production and, similarly, urocortinergic neurons show daily fluctuation in Per2
and Ucn1 production, which may influence HPA-axis rhythmicity. The rhythms in the npEW
could be under the control of orexin A fibers and/or corticosterone. Dopaminergic (DA),
serotonergic (5HT) and numerous other fibers contact the Ucn1 neurons (green); their role
in stress (mal)adaptation remains for future investigations.
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Perspectives with fundamental and clinical relevance
Major depression, anxiety and suicide are worldwide severe public health issues.
Despite many years of research and after numerous theories about the pathogenesis
of stress-related mood disorders (concerning monoamines, glucocorticoids, HPA-
axis, neurotrophins; for reviews see e.g. de Kloet, 2004; Kugaya and Sanacora,
2005; Duman and Monteggia, 2006; Kiss, 2008) we do not know exactly the causes
of psychopathologies. However, there is no doubt that CRF and the HPA-axis are
involved. In our laboratory we study the role of Ucn1 in stress adaptation, and we
have obtained strong circumstantial evidence that Ucn1 plays a role in the
development of stress-related mood disorders, such as major depression and suicidal
behavior (Kozicz et al., 2008). In the future, further research must clear the role of
the npEW-Ucn1 system on this issue.
Gender-differences are well known for many aspects of depression and
other psychopathologies. Future research may help to find more efficient, sex-
specific therapeutic strategies to treat depression. Such studies may be based on
current research in our laboratory. For instance, Derks, working on sexual
dimorphism of the npEW, has found that estrogen-beta receptor is present in the
npEW and showed that Ucn1 production depends on the phase of the estrus cycle
(Derks et al., 2007), whereas Rouwette, in collaboration with the Department of
Anesthesiology-UMCN, studies the effect of neuropathic pain on the functioning
of the npEW. Depression, alcoholism and obesity are diseases that often show co-
morbidity. Ryabinin et al. focus on the role of npEW in alcohol consumption and
alcoholism. From their results, it seems evident that Ucn1-neurons are affected by
ethanol intake (Ryabinin and Weitemier, 2006), and we have shown that these
neurons are contacted by NPY axon terminals that may be involved in mediating
information about alcohol consumption (Chapter 5).
A number of colleagues in our laboratory work on other aspects of the
npEW stress response. Xu et al. have shown that Ucn1-neurons contain leptin
receptors, which may inform the npEW via leptin about the sate of the organism’s
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adipose tissue and satiety level (see also Robertson et al., 2008). Other neuropeptides
like CART and nesfatin 1 are involved in the regulation of food intake (Maciewicz
et al., 1984; Brischoux et al., 2002; Kozicz, 2003; Brailoiu et al., 2007; Kozicz et
al., unpubl. res.) and have been localized at the light microscope (Xu et al., unpubl
res.) and ultrastructural level (van Wijk and Roubos, unpubl. res.) in the npEW-
Ucn1-neurons. To establish the role of the npEW it will be crucial to know its
connections with its input areas and its targets. Van Wijk is studying the pre- and
postsynaptic elements of the npEW-Ucn1 system, both at light- and electron
microscopical level. At the behavioral level, Sterrenburg searches for the link
between the HPA-axis and the npEW using animal models for depression-like
phenotype and transgenic animals like Ucn1-deficient mice. Together with Peeters
(NV Organon/part of Schering Plough) she aims at developing novel antidepressant
drugs with the npEW-Ucn1 system as a target. Finally, corticosterone could be
another good candidate regulator of the npEW with clinical implications, as
glucocorticoid receptors were shown in the npEW by our laboratory (Korosi et al.,
unpubl. res.).
Conclusion
In conclusion, this thesis research has opened many new avenues for future research
on the basic mechanisms and clinical potential of the urocortin 1-mediated stress
adaptation response in animals and man, which is in the core of the research of our
Department of Cellular Animal Physiology.
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Summary in English
The way animal organisms, including humans, cope with conditions that challenge
their internal homeostasis (‚stressors‘), is a central issue in physiology and
pathophysiology. Many decades of research have indicated the important role of
the hypothalamus-pituitary-adrenal (HPA-) axis and its final output in this process
of ‚adaptation‘, CORT (corticosterone, c.q. cortisol in fish and primates). However,
the neuronal mechanisms underlying adaptation and the stress-related mood
disorders resulting from maladaptation, are still largely obscure.
In addition to corticotropin-releasing factor (CRF), the key neuropeptide
controlling HPA-axis activity, other members of the CRF-peptide family, c.q.
urocortins seem to play major roles in ‚coping with stress‘. Urocortins bind with
high affinity to CRF receptors, indicating their role in the stress response. This
thesis research focuses on the role of urocortin 1 (Ucn1) in adaptation to stress.
Ucn1 is predominantly expressed in the midbrain non-preganglionic Edinger-
Westphal nucleus (npEW), and pays special attention to the plastic properties of
this nucleus in response to various stressors.
After a general introduction to the scientific problem (Chapter 1), in
Chapter 2 the specific responses of Ucn1 neurons in various stress paradigms
have been investigated. We show that urocortinergic neurons are differentially
recruited by different stressors. Whereas challenging rats with intravenous
lipopolysacharide injection, restraint stress or ether inhalation results in robust c-
Fos protein expression, indicating activation of the npEW-Ucn1 neurons,
hypotensive hemorrhage and hyperosmotic stress paradigms do not induce c-Fos
production in these neurons. This paradigm-specific stress-responsivity of the
npEW-Ucn1 system supports the idea that the npEW represents an adaptation-
regulating center with a high degree of selectivity.
Stress-related mood disorders have a high impact on society and public
health. Maternal separation of rodent pups is an often used animal research model
to elucidate mechanisms of anxiety and depression caused by maternal neglect in
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early life. Chapter 3 shows that maternal separation selectively dampens the
recruitment of npEW-Ucn1 neurons (i.e., c-Fos production) in response to stress.
In addition, in such rats the expression of brain-derived neurotrophic factor (BDNF)
is also compromised.
Another aspect of the regulation of stress adaptation that is receiving much
attention is the possible involvement of catecholamines. In Chapter 4, we studied
if noradrenergic and dopaminergic nerve terminals juxtaposed to Ucn1 neurons
had a significant role in the npEW activation. After chemically removing
catecholaminergic inputs, we found that these catecholamines were not crucial for
activation of the npEW.
Previous morphological studies revealed the presence of neuropeptide Y
(NPY)-containing nerve terminals in the periaqueductal gray. In Chapter 5 we
show in both the rodent and human brain, that these terminals contact Ucn1 perikarya
of the npEW. Moreover, in the rat, intracerebrally administered NPY induces the
production of c-Fos protein and the expression of Ucn1 mRNA in npEW neurons,
probably via Y1 and/or Y5 receptors.
Elaborating on the fact that the stress-induced CORT-response by the HPA-
axis has a daily rhythm, we demonstrate in Chapter 6 that npEW-Ucn1 neurons
contain the ‚clock gene‘ Period 2 (Per2), and that Per2 as well as Ucn1 possess a
daily rhythm at both the transcriptional and translational level.
Finally, on the basis of the result of this thesis research, in Chapter 7 we
propose a working hypothesis for the way Ucn1 neurons in the npEW act in stress
adaptation and, furthermore, discuss the possible clinical consequence of
malfunctioning of this nucleus for the development of stress-related brain disorders
such as anxiety and major depression.
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Samenvatting in het Nederlands
Een centraal thema in de Fysiologie en Pathofysiologie is de vraag hoe dierlijke
organismen, inclusief de mens, omgaan met omstandigheden die hun inwendige
homeostase bedreigen (‘stressoren’). Tientallen jaren van onderzoek hebben
gewezen op de belangrijke rol in ‘adaptatie’ van de hypothalamus-hypofyse-bijnieras
(HHB-as) en het eindproduct van die as, CORT (corticosteron, c.q. cortisol in vissen
en primaten). Echter, de neuronale mechanismen die ten grondslag liggen aan
adaptatie aan stress en aan stemmingsziekten die, als gevolg van falende adaptatie,
door stress worden veroorzaakt zijn nog grotendeels onbekend.
Behalve corticotropin-releasing factor (CRF), het belangrijke neuropeptide
dat de activiteit van de HHB-as reguleert, lijken ook andere leden van de CRF-
peptidenfamilie een belangrijke rol te spelen in het omgaan met stress. Deze
urocortines binden met grote affiniteit aan CRF-receptoren, hetgeen hun
betrokkenheid bij de stress-respons duidelijk aangeeft. Het onderzoek dat in deze
thesis is uitgevoerd, richt zich op de rol in adaptatie van urocortine 1 (Ucn1), dat
vooral aanwezig is in de niet-preganglionische Edinger-Westphal nucleus (npEW)
in de middenhersenen, en het besteedt bijzondere aandacht aan de plastische
eigenschappen van deze kern onder verschillende stresscondities.
Na een algemene inleiding op de wetenschappelijke vraagstelling
(Hoofdstuk 1), worden in Hoofdstuk 2 de specifieke responsen van Ucn1-neuronen
in verscheidene stressparadigmata behandeld. We laten zien dat verschillende
stressoren de activiteit van urocortinerge neuronen differentieel activeren. Terwijl
stressortypen als intraveneuze injectie  met lipopolysachariden, bewegingsbeperking
en ether stress leiden tot sterke expressie van c-Fos, hetgeen wijst op activatie van
npEW-Ucn1 neuronen, hebben hypotensieve bloeding en hyperosmotische
stressparadigmata geen enkel effect op c-Fos productie in deze neuronen. De
ontdekking van deze paradigma-selectieve stress-respons van het npEW-Ucn1-
systeem ondersteunt de gedachte dat de npEW adaptatie aan stress reguleert met
een hoge mate van selectiviteit.
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Stemmingsziekten die door stress zijn veroorzaakt hebben een zeer grote
impact op de maatschappij en op de volksgezondheid. Scheiding van knaagdierpups
van hun moeder is een zeer gewild onderzoekmodel naar de mechanismen die
verantwoordelijk zijn voor het ontstaan in een vroege levensfase van
angststoornissen en zware depressie. In Hoofdstuk 3 wordt aangetoond dat
verwijdering van de moeder leidt tot een selectieve demping van de stress-respons
door de npEW-Ucn1 neuronen (i.e. c-Fos activatie). Bovendien is in zulke ratten
ook de expressie van ‘brain-derived neurotrophic factor’ (BDNF) verstoord.
Een ander belangwekkend aspect van regulatie van adaptatie aan stress is
de mogelijke betrokkenheid van catecholamines. In Hoofdstuk 4 worden
experimenten beschreven om na te gaan of noradrenerge en dopaminerge
zenuweindigingen die dicht tegen Ucn1-neuronen aanliggen een betekenisvolle
rol spelen in de activering van de npEW. Nadat we deze catecholaminerge input op
chemische wijze hadden verwijderd, ontdekten we dat catecholamines niet cruciaal
zijn voor activatie van de npEW.
Vroegere morfologische studies hebben laten zien dat het neuropeptide Y
(NPY) aanwezig is in zenuweindigingen in de periaqueductale grijs. In Hoofdstuk
5 laten we zien dat deze eindigingen, zowel in het knaagdier- als in het menselijke
brein, contact maken met de cellichamen van Ucn1-neuronen in de npEW.
Bovendien blijkt dat intracerebraal toegediend NPY in npEW neuronen van de rat,
de productie stimuleert van c-Fos en de expressie van Ucn1 mRNA, processen die
waarschijnlijk verlopen via Y1 en/of Y5 receptoren.
Voortbouwende op het al eerder ontdekte feit dat de door stress geactiveerde
CORT-respons van de HHB-as een dagritme vertoont, laten we in Hoofdstuk 6 zien
dat npEW-Ucn1 neuronen het ‘clock gene’ Period 2 (Per2) bevatten, en dat zowel Per2
als Ucn1 een dagritme bezitten op zowel het transcriptie- als het translatie-niveau.
Tenslotte stellen we in Hoofdstuk 7, op basis van de resultaten die uit dit
proefschriftonderzoek zijn verkregen, een werkhypothese op voor de manier waarop
Ucn1-neuronen in de npEW functioneren tijdens adaptatie aan stress, en wordt voorts
bediscussieerd wat de klinische gevolgen kunnen zijn van het slecht functioneren
van de npEW op de ontwikkeling van hersenziekten zoals angst en zware depressie.
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Összefoglalás magyarul
Az állati szervezetek és az ember belsõ környezetének homeostasisát veszélyeztetõ
állapotok (‘stresszorok’), és az azok elleni megküzdési stratégiák az élettan és
kórélettan fontos kérdései. Több évtizedes kutatómunka eredményeképpen ismertté
vált a hypothalamus-hypophyisis-mellékvese (HPA) tengely és az annak kimenetét
képezõ CORT (corticosterone, ill. cortizol fõemlõsökben és halakban) szerepe az
adaptáció folyamatában. Az idegi mechanizmusok, melyek az adaptációhoz
vezetnek, illetve a stressz által kiváltott hangulatzavarokat okozó máladaptáció
mögött bújnak meg, még napjainkban is jórészt ismeretlenek.
A corticotropin releasing factor (CRF), a HPA-tengelyt szabályozó
kulcsfontosságú neuropeptid mellett, a CRF peptidcsalád egyéb tagjainak
(urocortinok) is fontos szerepe lehet a stresszel való megküzdésben. Az urocortinok
nagy affinitással kötõdnek CRF receptorokhoz, mely a stresszválaszban betöltött
szerepüket bizonyítja. Ezen doktori értekezés az urocortin 1 (Ucn1), egy elsõsorban
a középagy non-preganglionáris Edinger-Westphal (npEW) magjában expresszálódó
neuropeptid stresszadaptációban betöltött szerepét vizsgálja, különös tekintettel a
mag különféle stresszorokra adott válaszaiban megjelenõ plasztikus tulajdonságaira.
A tudományos probléma elsõ fejezetben található általános bevezetése után,
az Ucn1 neuronok különbözõ stresszparadigmák által kiváltott specifikus
válaszreakcióival foglalkozik a második fejezet. Az urocortinerg idegsejteket eltérõ
stresszorok különbözõ mértékben aktiválják: intravénás lipopolysacharid injekció,
restraint stressz és étergõz inhaláció nagymértékû c-Fos protein expressziót okoz,
mely az npEW-Ucn1 neuronok aktivációjára utal. Vérzéses hypotensio, és
hyperosmotikus stressz ezzel ellentétben, nem idézi elõ c-Fos termelõdését ezekben
a neuronokban. A paradigma szelektív stresszválasz-készség az npEW-Ucn1
rendszerben azt támasztja alá, hogy a npEW egy erõsen specifikus adaptációt
irányító központ.
A stressz által kiváltott hangulatzavaroknak nagy társadalmi és
népegészségügyi jelentõsége van. Újszülött patkánykölykök anyai megvonását,
186
mint modellt, gyakran használják az anyai gondoskodás csecsemõkori elégtelensége
által kiváltott szorongás és depresszió tanulmányozására.  A harmadik fejezetben
bizonyítjuk, hogy az anyai megvonás mindkét nemben szelektíven károsítja az
npEW-Ucn1 neuronok stressz (c-Fos) válaszkészségét, valamint a brain-derived
neurotrophic factor (BDNF) termelõdése is megváltozik.
A stresszadaptáció másik felmerülõ aspektusa a katecholaminok lehetéges
szerepe, melyet a negyedik fejezetben tárgyalunk. Noradrenerg és dopaminerg
terminálisok végzõdnek az Ucn1 neuronokon, és ezek, a mag aktivációjában
esetlegesen betöltött szerepét vizsgáltuk. A mag dopaminerg bemenetének
elpusztítása után azt találtuk, hogy ezek a rostok nem szükségesek az npEW
aktiválódásához.
Korábbi morfológiai kutatások kimutatták neuropeptide Y (NPY) tartalmú
idegvégzõdések jelenlétét a periaqueductalis szürkeállomány területén. Az ötödik
fejezetben leírjuk, hogy mind rágcsálóban, mind emberben, ezek a terminálisok
Ucn1 tartalmú sejttestekkel kapcsolódnak az npEW területén, valamint, a NPY
intracerebroventricularis beadása mind a c-Fos fehérje és az Ucn1 mRNS
expresszióját fokozza npEW neuronokban, valószínûleg Y1 és/vagy Y5 receptorokon
keresztül.
A HPA-tengely CORT válaszának jól ismert napi ritmusa alapján, a hatodik
fejezetben bemutatjuk, hogy az npEW-Ucn1 neuronok tartalmazzák a Period 2
nevû óragén termékét (Per2), valamint, hogy mind a Per2 mind az Ucn1 napi ritmust
mutat mind transzkripciós mind transzlációs szinten.
A PhD kutatási program eredményei alapján az utolsó, hetedik fejezetben
felállítunk egy hipotézist, mely az npEW mag Ucn1 neuronjainak stresszválaszban
betöltött szerepét írja le, továbbá, a mag hibás mûködésébõl eredõ lehetséges klinikai
vonatkozásokat taglaljuk, különös tekintettel a stressz által kiváltott pszichopatológiákra,
mint a szorongás és depresszió.
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